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ABSTRACT
The marine bacterium Vibrio fischeri establishes a specific, mutualistic
association with its animal host, the Hawaiian bobtail squid Euprymna scolopes. The V.
fischeri-E. scolopes symbiosis provides a natural model to investigate the mechanisms
involved in host-microbe interactions. Colonization by V. fischeri is a dynamic process,
in which the bacteria sense and respond to host-derived signals. To coordinate cellular
behavior in response to environmental stimuli, V. fischeri employs a variety of regulatory
devices, including two-component signaling (TCS) systems. Importantly, TCS regulators
control one of the earliest stages of host colonization, the formation of a biofilm
aggregate on the surface of the squid’s symbiotic light organ. Biofilm formation requires
the sensor kinase RscS and the response regulator (RR) SypG, which regulate
transcription of the symbiotic polysaccharide locus (syp). Preliminary studies suggested
that the RR SypE may also exert control over biofilm formation. For my dissertation, I
investigated the role of SypE in regulating biofilm formation and symbiotic colonization.
Bioinformatic analysis predicted that sypE encodes a novel, multi-domain RR
consisting of a central receiver (REC) domain flanked by two terminal, effector domains
of putative opposing function: an N-terminal RsbW-like serine kinase and a C-terminal
PP2C-like serine phosphatase domain. Based on these preliminary studies, I
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hypothesized that SypE could exert dual regulatory control over syp biofilm formation,
depending on which of the terminal effector domains was active.
To understand the role of SypE in biofilm regulation, I performed a genetic
analysis and assessed the contribution of the SypE domains to overall protein function. I
found that the N- and C- terminal effector domains of SypE do indeed possess negative
and positive regulatory activities, respectively. My studies further suggest that the central
REC domain regulates these opposing activities. Finally, colonization studies indicate
that regulation of SypE activity by the HK RscS is critical to permit symbiotic
colonization of E. scolopes.
To further elucidate the role of SypE, I assessed the downstream targets of SypE’s
regulatory activities. Bioinformatic analyses revealed that SypE’s effector domains
exhibit similarity to proteins found in partner-switching systems. Coimmunoprecipitation studies revealed that SypE interacts with another putative partnerswitching regulator, the STAS-domain protein, SypA. Using biochemical and genetic
approaches, I determined that SypE regulates the phosphorylation state of SypA, and that
phosphorylation inhibits SypA activity. Furthermore, I found that biofilm formation and
symbiotic colonization require unphosphorylated SypA. This study demonstrates that
regulation of SypA activity by the novel regulator SypE is a critical mechanism by which
V. fischeri regulates biofilm development and colonization of its animal host. That
regulation of SypA activity is critical for both biofilm formation in vitro and symbiotic
colonization further demonstrates the utility of the V. fischeri-squid symbiosis as a model
for the role of biofilm formation in host colonization.
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CHAPTER ONE	
  
LITERATURE REVIEW
INTRODUCTION
Throughout life, animals continuously encounter and enter into associations with
a diverse array of bacterial species. In regards to the animal host, these bacterial
interactions can result in both beneficial and detrimental outcomes. A common public
concern is the development of host diseases resulting from infection by pathogenic
bacteria. The threat of evolving bacterial pathogens has prompted numerous
investigations into the mechanisms by which pathogenic bacteria promote host infection.
Similarly, the continued rise in antibiotic resistance among various disease-causing
bacteria emphasizes the need for identifying new antimicrobial targets and treatments.
While historically, focus has been on understanding pathogenic interactions,
growing evidence indicates that many, if not all, animals also establish long-lived,
cooperative associations with specific bacterial consortia [1]. Importantly, these
mutualistic associations are often essential for promoting and maintaining host
homeostasis [2]. Studies using germ-free animals have revealed that interactions with
symbiotic bacteria contribute to host development, nutrition, reproduction, and defense
[3,4]. An example of such a cooperative association can be found in the mammalian gut,
in which colonization by beneficial bacteria not only provides the host with nutritional
benefits, but also promotes host immune system development [2].
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Host colonization by both beneficial and pathogenic bacteria is a dynamic
process, in which the bacteria continually sense and respond to the presence of their
animal host. Importantly, many of the cellular and molecular mechanisms by which
beneficial bacteria establish colonization of their animal hosts are similar to those
described for bacterial pathogens. Like pathogens, beneficial symbionts have evolved
mechanisms to sense and respond to host environments and to interact with host surfaces.
Therefore, understanding the mechanisms by which bacteria establish and maintain
beneficial associations with their animal hosts can also yield insight into the development
of pathogenic interactions.
The ability of bacteria to detect and respond to specific conditions within the host
is essential for establishing colonization. To coordinate cellular behavior in response to
host signals, bacteria employ a variety of signaling and regulatory devices, including twocomponent signaling (TCS) systems and partner-switching networks. TCS pathways
involve histidine-aspartate phosphotransfer between a histidine kinase and a response
regulator, and represent the predominant form of signaling in bacteria. Partner switching
systems are comprised of a network of proteins whose interactions are controlled through
a reversible serine phosphorylation event. Partner switching systems consist of three
primary conserved regulatory elements, a serine kinase/anti-sigma factor, a serine
phosphatase, and an antagonist protein. Importantly, both TCS and partner switching
systems have been shown to regulate key processes required for colonization by both
pathogenic and beneficial bacteria [5].
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Recent studies have identified a critical role for bacterial biofilms in
promoting bacterial-host interactions. Biofilms, or multi-cellular, bacterial communities
encapsulated in a matrix, represent a common mode of growth for many bacterial species.
Importantly, both pathogenic and beneficial bacteria have been shown to produce
biofilms to promote and/or maintain colonization of their animal hosts [6]. Production of
a biofilm often contributes to multiple stages of colonization, including promoting
association with host tissues and providing resistance to both host-derived defenses and
antibiotics [7]. Given the importance of biofilms in mediating bacteria-host interactions,
understanding the processes involved in biofilm formation is necessary for the
development of approaches to control bacterial infections.
The mutualistic association between the marine bioluminescent bacterium Vibrio
fischeri and its animal host, the Hawaiian squid Euprymna scolopes, provides an elegant,
model system for investigating the mechanisms underlying bacteria-host interactions
[8,9,10]. Research into this symbiosis has yielded novel insights into the bacterial and
host processes required for colonization. Importantly, studies have demonstrated that V.
fischeri possesses multiple TCS systems, several of which regulate symbiotic processes
required for host colonization. This includes the regulation of one of the earliest events
in colonization, the formation of a bacterial biofilm aggregate. Finally, work presented in
this dissertation demonstrates that partner-switching regulators provide critical regulation
over the production of this symbiotic biofilm and host colonization.

	
  

	
  

	
  

4	
  

MUTUALISTIC ASSOCIATION OF VIBRIO FISCHERI AND EUPRYMNA
SCOLOPES
Introduction
The marine bioluminescent bacterium V. fischeri establishes a specific,
mutualistic association with its animal host, the Hawaiian bobtail squid E. scolopes. The
V. fischeri-E. scolopes mutualism has been extensively studied for over 20 years [8,9,10].
In this symbiosis, V. fischeri exclusively colonizes the squid’s specialized symbiotic
organ, termed the light organ. Upon colonization of the light organ, the bacteria grow to
high cell density (approximately 1011 bacteria cells/ml) and produce bioluminescence, the
end product of the symbiosis [8]. The squid host is proposed to utilize the
bioluminescence produced by the bacteria as a form of camouflage, termed
counterillumination [8,11], during the animal’s nocturnal activities.
The light organ of a juvenile E. scolopes is aposymbiotic upon hatching [8,12],
and therefore the animal must acquire the V. fischeri cells from the surrounding seawater
[12]. The light organ is centrally located within the squid’s mantle cavity and consists of
two lobes. The surface of each lobe features a pair of ciliated appendages that extend
into the mantle cavity [12]. The ciliated epithelial fields located on the surface of these
appendages function in the recruitment of the symbiotic bacteria by directing the
surrounding seawater toward pores that provide entry into the light organ (Fig. 1). Each
lobe contains three pores, approximately 5-15 µM in diameter, which serve as entrances
to one of three, distinct epithelium-lined crypts (Fig. 1). The pores located on the light
organ surface open into the ciliated ducts, which lead to an antechamber space and,
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ultimately, the deep crypt spaces (Fig. 1). It is within these epithelium-lined, deep
crypts that the colonizing V. fischeri cells reside [12] [13].
The process of host colonization is highly dynamic and typically initiates within
the first few hours post-hatching [12]. Upon establishing symbiotic association, the squid
host is proposed to maintain a monospecific culture of V. fischeri for the duration of its
lifetime [12]. The squid controls the levels of V. fischeri contained within its light organ
by expelling the majority of bacteria (~90-95%) on a daily basis. Each morning, muscle
tissue surrounding the light organ contract and expel the light organ contents, including
V. fischeri symbionts, into the surrounding seawater [14,15]. The remaining bacterial
symbionts repopulate the light organ over the course of the following day [14,15]. In this
manner, the animal host plays an active role in maintaining colonization by controlling
the bacterial load [14,15].
Most, if not all, animals are believed to establish long-term, specific associations
with particular consortia of bacteria. The utility of the V. fischeri-E. scolopes mutualism
as a model system is the ability to independently study both symbiotic partners, as both
the animal host and bacterial symbiont can be naturally maintained and investigated
separately. Furthermore, this symbiosis is highly specific, as only V. fischeri is capable
colonization. This permits researchers to investigate the direct mechanisms by which a
single bacterium and its animal host naturally establish and maintain a symbiotic
association. Current evidence indicates that colonization is a tightly regulated process
that involves specific communication between the squid and its bacterial symbiont.
Indeed, studies have identified a variety of both bacterial and host processes, which
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Figure 1. Diagram of the squid light organ and colonization by V. fischeri. This
figure was modified from a diagram by Emily Yip. Juvenile E. scolopes (shown on the
left) contains a bilobed light organ, which is colonized by V. fischeri. The inset (shown
on the right) depicts one of the light organ lobes and the general stages of colonization:
(i) attachment and aggregation of V. fischeri cells in host mucus (tan) on the light organ
surface. (ii) migration through the ciliated ducts and antechamber. (iii) colonization and
persistence in the deep crypt spaces. Within the deep crypts, V. fischeri cells proliferate
to high cell density and produce bioluminescence (shown in yellow).
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contribute to particular stages of the colonization process. The process of symbiotic
colonization proceeds in a series of progressive stages, including initiation,
accommodation, and persistence [8]. During the initiation stage, recruited V. fischeri
cells attach to the light organ surface and form compact, biofilm-like aggregates [16].
Following initiation, V. fischeri cells disperse from the aggregate and proceed to migrate
into the light organ where they establish colonization within the deep crypts. During this
accommodation stage, V. fischeri adapt to the light organ environment and proliferate to a
high cell density. In the final persistence stage, V. fischeri and E. scolopes establish a
daily pattern of symbiotic behaviors, which promote maintenance of the symbiosis for the
lifetime of the animal host. In the following section, I will discuss in further detail the
key host and bacterial responses involved in these various stages of colonization.
Initiation of the V. fischeri-E. scolopes mutualism
(A) Overview
Colonization of the squid light organ by V. fischeri occurs rapidly, generally
within 12 hours after the juvenile squid hatch. Investigations into the E. scolopes-V.
fischeri symbiosis indicate that colonization is not a passive process, but rather involves a
number of adaptive responses on the part of both the squid host and bacterial symbiont.
Newly hatched, juvenile squid are aposymbiotic, and therefore acquire their V. fischeri
symbionts from the surrounding seawater. An early study found that V. fischeri cells
constitute a small percentage (less than 0.1%) of the total bacteria within the ambient
seawater [16,17]. Upon hatching, the juvenile squid ventilates seawater through its
mantle cavity (approximately 1.3 µL every half second), which passes the bacteria	
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containing seawater across the light organ surface [16]. This results in approximately
one V. fischeri cell present per ventilation [16]. Despite its relatively low abundance, V.
fischeri successfully gains access to the light organ by entering one of the six pores
located on the light organ surface.
The initiation of colonization typically occurs within the first 3 hours after the
juvenile E. scolopes and V. fischeri come into contact. One of the earliest events in
colonization involves the formation of a bacterial aggregate on the surface of the
symbiotic light organ [16,18]. The light organ possesses two features that appear to
facilitate aggregate formation and colonization. First, the ciliated epithelial fields located
on the surface appendages help direct seawater, containing both V. fischeri and other
bacteria, towards the six pores that lead into the light organ [16]. Second, epithelial cells
surrounding the pores secrete mucus, which promotes surface attachment by the bacterial
cells present within the ventilated seawater [16]. Both V. fischeri and other Gramnegative bacteria are capable of aggregating within the squid-derived mucus layer, but V.
fischeri quickly dominates in the secreted mucus [16,18,19]. The ability of V. fischeri to
form aggregates in the squid-derived mucus depends upon the production of a specific
extracellular polysaccharide [20]. The formation of this exopolysaccharide requires the
symbiosis polysaccharide (syp) locus, whose gene products contribute to the production
of a specific biofilm [21,22]. These host and bacterial responses serve to promote
interaction between the symbiotic partners and initiate the colonization process.
(B) Host responses during colonization initiation
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Accumulating evidence indicates that the juvenile squid actively recruit the V.
fischeri symbionts from the surrounding seawater. This recruitment occurs early in the
initiation stage, in which the ciliated appendages and mucus secretion concentrate the
bacteria near the light organ pores [16]. Staining with fluorescently labeled lectins
identifed N-acetylneuraminic acid and N-acetylgalactosamine as two components present
in the squid-derived mucus [16]. Mucus production was found to be induced upon
exposure of the squid to seawater containing either Gram-negative or Gram-positive
bacteria, but not to sterilized seawater alone [19]. This finding suggested that mucus
shedding by the juvenile squid occurs in response to a bacterial product. Additional
experiments identified that peptidoglycan, a common component of the bacterial cell
envelope, is sufficient to induce this mucus shedding [19]. Peptidoglycan is categorized
as a Microbe-Associated Molecular Pattern (MAMP), and is typically recognized through
binding to specific MAMP receptors, including peptidoglycan recognition proteins
(PGRPs) [23]. Analysis of an expressed sequence tag cDNA (EST-cDNA) library
generated from the tissues of juvenile squid identified four putative PGRPs (EsPGRP14), which may contribute to the host response(s) to peptidoglycan [23]. Indeed, a recent
study revealed that one of these PGRPs, EsPGRP2, localizes to the mucus secreting,
surface epithelia and associates with the secreted mucus [24]. These studies suggest that
binding of peptidoglycan to one or more of the EsPGRPs may mediate mucus shedding
by the surface epithelia and promote bacterial aggregation.
(C) Bacterial responses during colonization initiation
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A key process in the initiation of colonization involves the attachment of V.
fischeri aggregates within the secreted mucus on the light organ surface [16].
Aggregation within the squid-secreted mucus is not limited to V. fischeri, as other Gramnegative, non-symbiotic species also aggregate [16]. However, a study revealed that V.
fischeri rapidly dominates within the aggregates, accounting for approximately 99% of
the aggregated cells [18]. This study further determined that the enhanced propensity of
V. fischeri to aggregate could not be attributed to increased growth, but rather the
accumulation of pre-existing V. fischeri cells [18]. These studies suggest that V. fischeri
detects an-as-yet unidentified signal that specifically triggers the symbionts to form
aggregates on the light organ surface.
Subsequent studies found that the V. fischeri aggregates represent a form of
bacterial biofilm formation [25]. Investigation into this biofilm has led to the
identification of a number of the genes involved in the formation and regulation of this
biofilm. In particular, transposon insertional mutagenesis screens for mutants defective in
colonization identified the regulatory gene rscS (regulator of symbiotic colonization,
sensor), which encodes a histidine sensor kinase (HK) protein, and the syp biofilm locus,
an 18-gene polysaccharide locus [21,26](Fig. 2). Both rscS and syp mutants exhibit
severe defects in the initiation of colonization, which can be attributed to the inability of
these mutants to aggregate on light organ surface [20,26]. The syp genes encode a
number of structural proteins involved in the synthesis and export of a polysaccharide
[21]. Mutational analyses determined that the majority of these structural syp genes are
required for biofilm formation and efficient host colonization [21,22]. Current evidence
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indicates that the syp locus and aggregate formation are under tight regulatory control
[25]. In addition to the syp structural proteins, the syp locus encodes four regulatory
proteins, including the HK SypF, the response regulators (RRs) SypG and SypE, and the
putative anti-sigma factor antagonist SypA [21](Fig. 2). Genetic studies determined the
HK RscS functions upstream of the RR SypG to control transcription of the syp locus
[20,27] (Fig. 3). The overexpression of rscS activates the syp locus, resulting in increased
aggregation on the light organ surface and enhanced colonization competency [20]. In
laboratory culture, induction of the syp locus through rscS overexpression results in the
production of biofilm phenotypes [20,21]. In addition to RscS, the HK SypF also appears
to regulate syp locus activation, most likely through activation of SypG [28]. Current
evidence suggests that the RR SypE also contributes to the regulation of syp-dependent
biofilms [27]. The role of SypE in regulating biofilms and its relevance during host
colonization are the subjects of this dissertation.
In addition to aggregation, early studies established that motility and chemotaxis
are critical behaviors during the initiation [29,30,31]. V. fischeri motility is mediated by a
polar tuft of flagella [32]. Analysis of motility mutants revealed that loss of motility does
not dramatically impact aggregate formation, but does impair migration into the light
organ [16]. These results indicate that migration is an active process, in which motile
bacteria direct their movements toward the light organ. The directed migration of V.
fischeri suggests that the cells respond to specific chemotactic signals. Indeed, several
studies demonstrated that V. fischeri mutants defective in the chemotaxis regulators,
CheY, CheA, or CheR, exhibit impaired host colonization [33,34,35].
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Figure 2. The syp polysaccharide locus of V. fischeri. The syp locus consists of 18
genes arranged in four operons. The syp genes encode proteins with putative regulatory
activities (red) or functions involved in polysaccharide synthesis and/or export (blue).
The predicted or known functions of the individual syp genes are listed below.
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Figure 3. Transcriptional regulation of the syp locus. The HK RscS acts upstream of
the syp-encoded RR SypG to control syp transcription. The current model predicts that
RscS is activated upon sensing some as-yet-unidentified signal and serves as a
phosphodonor for SypG. Phosphorylation is proposed to activate SypG, resulting in
SypG-mediated activation of the individual syp operons. In addition to RscS, the sypencoded HK SypF is also proposed to serve as a phosphodonor to SypG. Dashed arrow
indicates potential direct phosphorylation of SypG by SypF.
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V. fischeri have been shown to migrate towards a variety a chemoattractants,
including several squid-derived compounds [34,36]. Specifically, V. fischeri performs
chemotaxis to both N-acetylneuraminic acid, a component of the squid-secreted mucus,
and squid-derived chitin [34,36]. Chemotaxis toward chitin is critical for V. fischeri to
migrate through the pores and ducts leading into the light organ [34]. These studies
suggest that V. fischeri uses gradients of host-derived chemoattractants to efficiently
colonize the light organ.
Migration and accommodation of V. fischeri within the light organ
(A) Overview
Following attachment and aggregation, V. fischeri cells disperse from the
aggregate and migrate to one of six pores located on the light organ surface. The bacteria
enter the pores, travel through the ciliated ducts, and migrate through an antechamber
before reaching and colonizing the deep crypt spaces. Entrance to the deep crypts is
restricted by a bottleneck region, which limits access to the crypt spaces. Within the deep
crypt spaces, V. fischeri cells closely associate with the host epithelial, making direct
contact with the microvilli located on the surface of the crypt epithelia [37].
During their migration, V. fischeri cells encounter a variety of host-derived
antimicrobial defenses. These host defenses are presumed to function as specificity
determinants, which restrict colonization by non-symbionts, while simultaneously
enriching for V. fischeri cells [15,38,39]. After colonization, V. fischeri induces a series
of morphological changes within the host light organ [13,37]. These symbiont-induced
developmental changes occur within the tissues in direct contact with the bacteria (i.e. the
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deep crypts) and in tissues distant from the site of infection. Studies in which
antibiotics were used to cure E. scolopes of their V. fischeri symbionts revealed that some
of these developmental changes are reversible, while others are permanent. Altogether,
these host changes may serve to prevent further infection of the light organ by nonsymbionts. In the following sections, I will discuss in further detail the host and bacterial
behaviors that contribute to V. fischeri accommodation within the symbiotic light organ.
(B) Host responses during symbiont migration and accommodation
In addition to recruiting its bacterial symbionts, the squid host also possesses a
variety of mechanisms that function in controlling and ensuring the specificity of
colonization. These include the production of antimicrobial compounds that restrict entry
and colonization by non-symbiotic bacteria. Soon after aggregating on the light organ
surface, V. fischeri cells are exposed to low levels of nitric oxide (NO) produced by
vesicles embedded in the host-derived mucus [40]. NO is a reactive nitrogen species that
is commonly employed by eukaryotes as an antimicrobial agent [41]. Both NO and nitric
oxide synthetase (NOS), the enzyme involved in NO production, are produced by
epithelial tissues throughout the light-organ. During their migration through the ciliated
ducts, V. fischeri cells are exposed to increased levels of NO [40]. The presence of NO
during these early stages of colonization suggests that NO production may serve as an
early specificity determinant. In support of this, the presence of NO-scavenging
molecules results in an increase in the aggregation of both V. fischeri and non-symbiotic
bacteria [40].
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E. scolopes has also been shown to produce hypochlorous acid, a reactive
oxygen species (ROS) that commonly functions as an antimicrobial agent [42,43]. An
early study utilizing a cDNA library generated from the light organ tissues determined
that a high proportion of the light organ transcripts encode putative ROS-generating
peroxidases [42]. These putative peroxidases included a homolog of mammalian
peroxidases, a halide peroxidase (HPO) involved in the production of hypochlorous acid
from halide ions and hydrogen peroxide [42,43]. The HPO gene was found to be
expressed at relatively higher levels in tissues that directly contact bacteria [43]. V.
fischeri is sensitive to hypochlorous acid, suggesting that hypochlorous acid may serve to
control the levels of colonizing bacteria. Together, the production of antimicrobial
molecules, such as NO and hypochlorous acid, represents a means by which E. scolopes
chemically responds to interaction with bacteria. These host responses may provide a
chemical barrier that promotes colonization specificity, restricting colonization to its V.
fischeri symbionts.
Similar to other cephalopods, E. scolopes possesses a single immune cell
population, the macrophage-like hemocytes [15]. These host hemocytes transverse the
epithelium of the light organ crypts and “sample” the crypt environment [15]. Similar to
macrophages, the hemocytes function to engulf and kill bacterial cells. Indeed, within the
light organ crypts of newly colonized juvenile E. scolopes, host hemocytes have been
observed containing internalized V. fischeri [15]. Interestingly, hemocytes within the
crypts of adult E. scolopes do not appear to engulf the bacteria, despite being surrounded
by V. fischeri cells [15,44]. These studies suggest that the host hemocytes are “educated”
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upon exposure to V. fischeri, eventually developing a tolerance for the bacterial
symbionts. Indeed, hemocytes isolated from colonized E. scolopes bind and phagocytose
V. fischeri to a lesser degree than related, non-symbiotic species [44]. This tolerance is
not observed in hemocytes isolated from adult E. scolopes cured of their bacterial
symbionts, suggesting that prior exposure to V. fischeri or a bacterial component is
required for tolerance [44]. This same study determined that V. fischeri cells deleted for
the outer membrane protein OmpU did not induce tolerance, and were engulfed by
hemocytes at a higher frequency than wild-type cells, suggesting that OmpU recognition
by host hemocytes contributes to V. fischeri tolerance and persistence [44]. The
mechanism by which V. fischeri OmpU promotes the specific tolerance of V. fischeri
cells currently remains unclear. Together, these studies reveal that the host immune
system responds to the presence of the bacterial symbionts, resulting in the hemocytes
developing an OmpU-dependent tolerance for the V. fischeri symbionts.
Colonization by V. fischeri induces a series of development changes in the host
light organ, several of which are reversible upon removal of the bacterial symbionts.
These symbiont-induced changes occur not only in areas in direct contact with the V.
fischeri cells (i.e. the deep crypts), but also in areas distant from the infection site (i.e. the
ciliated ducts and ciliated appendages) [45]. One of these symbiont-induced changes
involves the constriction of the ciliated ducts. Soon after V. fischeri colonizes the deep
crypts (approximately 6 hours post hatching), the tissues within the ducts exhibit an
increase in actin synthesis, which corresponds to an increase in the deposition of
filamentous actin at the apical surface of the duct epithelia, thus resulting in duct
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constriction [46]. Duct constriction decreases the diameter of the light organ duct,
which may serve to limit entry of additional bacteria after initial colonization [46].
Removal of the bacterial symbionts through antibiotic treatment results in the expansion
of the ducts to their original state [19]. The bacterial ligands responsible for inducing
these changes in the ducts remain to be determined.
Early in colonization, the epithelia of the ciliated appendages secrete mucus,
which promotes bacterial aggregation and the initiation of infection. Following V. fischeri
infection of the light organ, the presence of the symbiont induces the cessation of this
mucus shedding [19]. Similar to duct constriction, mucus cessation is a reversible event,
as removal of the bacterial symbionts restores mucus secretion by the ciliated epithelium
[19]. Another dramatic change induced by V. fischeri is the regression of the ciliated
appendages. Studies indicate that V. fischeri colonization delivers an irreversible signal
that triggers the loss of the ciliated surface epithelium [45,47]. Around 12 hours after
initial exposure, V. fischeri colonization signals the apoptosis of the ciliated epithelia and
the gradual regression of the appendages. While the cessation of mucus shedding occurs
relatively quickly after colonization (around 48 hours post initiation), the complete
regression of the ciliated appendages occurs gradually over a 4-5 day period [13].
The observation that V. fischeri infection triggers host morphological changes has
prompted investigations into the bacterial factors that signal these developmental
processes. Several studies have focused on components of the bacterial cell envelope as
possible bacteria-derived signals for host development. Similar to intact bacterial cells,
the exposure of juvenile squid to cell surface fractions isolated from V. fischeri was found
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to induce light organ development, including the apoptosis and regression of the
ciliated appendages, supporting a role for bacterial cell envelope components [48].
Additional studies determined that two components of the cell envelope,
lipopolysaccharide (LPS) and peptidoglycan (PG), are sufficient to induce light organ
morphogenesis. Bacterial LPS was first demonstrated to signal the apoptosis of the
ciliated epithelial fields, but did not induce regression of the ciliated appendages [49].
Further analysis determined that the induction of apoptosis is mediated by the lipid A
moiety of LPS. The effect of LPS on the apoptosis of the epithelial fields is not restricted
to V. fischeri lipid A, as LPS derived from non-symbiotic bacteria induced similar
changes [49].
That LPS alone induced apoptosis, but not full regression of the ciliated
appendages, suggested that additional bacterial molecules were required for inducing
light organ morphogenesis. Subsequent studies determined that peptidoglycan
represented the second signaling molecule [48]. Specifically, V. fischeri releases a
tetrapeptide PG monomer, termed tracheal cytotoxin (TCT), that promotes light organ
development [48]. Using a V. fischeri mutant defective in TCT release, it was
determined that TCT is required for inducing regression of the ciliated appendages [50].
Although capable of triggering the regression of the ciliated appendages, TCT alone does
not induce apoptosis in the epithelial field [48]. However, when TCT is provided in
combination with LPS, the two morphogens have a synergistic effect on light organ
morphogenesis, resulting in both apoptosis and ciliated appendage regression [48].
Together, TCT and LPS mimic the irreversible signal induced by intact V. fischeri cells,
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indicating that the sensing of these bacterial molecules by E. scolopes is sufficient to
signal light organ development.
Both LPS and PG are common bacterial components, produced by both V. fischeri
and other non-symbiotic bacteria, and yet light organ development is specific to V.
fischeri infection. It has been established that V. fischeri must enter the crypts in order to
induce light organ morphogenesis, suggesting that engagement with host receptors likely
occurs within the crypt spaces. Therefore, specificity in LPS and PG signaling is likely
conferred through restricting host receptor activation to areas exclusively inhabited by V.
fischeri cells.
(C) Bacterial symbiont responses during migration and accommodation
Following entry through the pores, V. fischeri cells migrate through the ciliated
ducts leading to the light organ crypts. In addition to a role in colonization initiation
[29,30], motility is also likely to be required for transit of the bacteria through the ciliated
ducts and antechamber, as the ducts are lined with dense cilia that generate an outward
directed current, thus generating an obstacle for the migrating bacterial cells [45]. The
role of motility during duct migration is difficult to directly test, however, as nonmotile
cells exhibit a severe initiation defect as a result of their failure to migrate to the pores
[30].
During migration into the light organ, V. fischeri cells encounter a variety of hostderived antimicrobial defenses, including NO and ROS. Microarray analysis revealed
that exposure of V. fischeri cells to NO results in the upregulation of an alternative
respiratory oxidase (AOX) [38,51]. Importantly, AOX is relatively NO-resistant, which
	
  

	
  

	
  

21	
  

allows aerobic respiration to proceed in the presence of NO when other cellular
oxidases are inhibited [51]. A recent study determined that V. fischeri also possesses a
homolog of the Escherichia coli flavohaemoglobin, Hmp, which is involved in the
detoxification of NO by E. coli [39]. Transcriptome analysis indicates that, similar to
AOX, Hmp expression is upregulated upon exposure of V. fischeri to NO. Furthermore,
reporter studies revealed that hmp expression is activated at the initial aggregation stage
of colonization, in which the cells first encounter squid-derived NO [39]. Importantly,
Hmp is required for NO resistance in V. fischeri, as an hmp mutant fails to detoxify NO
in culture and exhibits impaired host colonization, partially due to a defect in colonization
initiation [39]. V. fischeri also possesses mechanisms to resist stress induced by the
exposure to host-derived hypochlorous acid. V. fischeri encodes a periplasmic catalase,
KatA, that converts hydrogen peroxide, a precursor to the production of hypochlorous
acid, to water and oxygen [52]. This suggests that V. fischeri may prevent the host
production of hypochlorous acid through the catalase activity of KatA. Indeed, a katA
mutant exhibits a competitive colonization defect during mixed-culture infections,
indicating that the catalase activity of KatA indeed contributes to colonization fitness
[52]. These studies reveal that V. fischeri has evolved specific mechanisms to cope with
the various host defenses it encounters during colonization.
Persistence of V. fischeri within the light organ
(A) Overview
Once V. fischeri reaches the deep crypt spaces, the bacteria proliferate in the
nutrient-rich environment within the light organ [53]. Within 12 hours after initial
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encounter, the bacteria achieve a high cell density and produce bioluminescence.
Luminescence is regulated in a cell density-dependent manner, through a pheromonemediated process termed quorum sensing. Quorum sensing describes a mechanism in
which bacterial cells determine the population density through the release and detection
of pheromones, or chemical signals termed autoinducers. The accumulation of these
autoinducers at high-cell densities results in a change in gene regulation, including the
induction of bioluminescence. Bioluminescence is required for successful colonization,
as V. fischeri mutants deficient in light production initiate colonization, but fail to persist
within the light organ [54,55]. These studies suggest that the squid host possesses
mechanisms to ensure light production by its bacterial symbionts. Indeed, the E. scolopes
light organ contains tissues capable of detecting and responding to light production [56].
Once association between E. scolopes and V. fischeri is established, both
organisms develop a daily rhythm in their symbiotic behaviors. One of the most evident
of these daily rhythms is the expulsion of the light organ contents, including V. fischeri
cells and host hemocytes, into the surrounding seawater. Every dawn, E. scolopes expels
approximately 95% of its bacterial symbionts within a thick mucus secretion [14,15].
Over the course of the following day, the remaining V. fischeri cells re-populate the light
organ [14]. The process of daily expulsion and re-growth likely serves to control the
population of bacterial symbionts. Another daily rhythm established during persistent
colonization is the controlled variation in bacterial luminescence [14]. Luminescence
varies greatly within the squid host, with levels typically reaching a peak in the hours
before night [14]. A recent microarray study revealed that V. fischeri metabolism also
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exhibits a daily rhythm [57]. V. fischeri appears to adjust its metabolic profile in
response to the host’s daily rhythm of light organ expulsion [57].
(B) Host responses involved in V. fischeri persistence
Following the completion of colonization, E. scolopes initiates a daily cycle of
symbiont expulsion and regrowth. A recent microarray analysis determined that, just
prior to light organ expulsion, E. scolopes undergoes a dramatic change in gene
expression, particularly in genes involved in cytoskeletal rearrangement [57]. Analysis
of the light organ epithelium found that these changes in cytoskeletal gene expression
coincide with the effacement of the epithelium and the release of epithelial tissue into the
crypt spaces [15,57]. Early studies determined that this expulsion event is specifically
triggered in response to light exposure, as animals maintained in the darkness fail to
release their symbionts [14,58]. The relevance of expulsion to the light organ symbiosis
currently remains unclear. It is likely that expulsion benefits the maintenance of
symbiosis, possibly by controlling the levels of the symbiont population or by promoting
luminescence. Additionally, expulsion may serve to increase the concentration of V.
fischeri in the local environment, thus promoting transmission to newly hatched
juveniles.
The production of bacterial luminescence represents a key contribution of V.
fischeri to the light organ symbiosis. Light emission is proposed to aid E. scolopes
during its nocturnal activities, serving as a form of camouflage. The squid host appears
to exert control over the emission of bacterial luminescence. The ink sac and other tissues
surrounding the light organ, including a layer of reflective tissues, serve to direct the light
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emission downward, thus providing counter-illumination and masking the animal’s
shadow [11]. In addition to directing the emission of light, the squid also appears to exert
a level of control over the production of luminescence, occasionally suppressing light
production [14]. Analysis of the specific luminescence, or the amount light produced per
cell, found that V. fischeri cells within the light organ exhibit a daily rhythm of increasing
and decreasing levels of light production compared to released cells. Specifically, in
periods of low luminescence (i.e. during the day), the specific luminescence of colonizing
V. fischeri cells is decreased relative to released cells [14].
In addition to controlling light emission, the squid also possesses mechanisms to
ensure light production by the bacterial symbionts. V. fischeri mutants deficient in
luminescence are capable of initiating colonization, but fail to persist within the light
organ [54,55]. The inability of non-luminescent strains to persist within the light organ
may be due to a variety of reasons. One possibility is that E. scolopes is capable of
detecting bacterial light emission, and actively selects for luminescent symbionts.
Indeed, a recent transcriptome analysis of the light organ tissues revealed the expression
of genes whose proteins exhibit similarity to those found in visual transduction systems,
including photoreceptor proteins such as opsin [59]. The light organ is also surrounded by
accessory tissues that are structurally similar to those found in the eye. These include an
encapsulating layer of reflective tissue and a transparent, “lens”-like tissue layer [13]. A
subsequent study confirmed that these accessory tissues indeed possess the ability to
directly detect and respond to light stimulation [56]. Thus, the ability of the light organ
tissues to directly sense light production may provide an additional mechanism by which
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E. scolopes responds to its bacterial symbiont and, possibly, restricts colonization to
luminescent bacteria.
(C) Bacterial symbiont responses involved in persistence
Once V. fischeri establishes residency within deep crypts, the bacteria undergo a
change in cell morphology. Specifically, the bacterial cells become smaller and rounder
than those grown in culture [32]. V. fischeri within the deep crypts also become
nonflagellated, suggesting that motility at this stage of colonization is not required [32].
It currently remains unknown what signals or conditions within the light organ promote
these morphological changes. Additionally, it is unclear what role the loss of flagella may
play in colonization. It is has been proposed that the presence of flagella may be
detrimental at this stage [8].
Within the light organ crypts, V. fischeri cells proliferate to a high cell density,
reaching levels of approximately 1011 cells per mL of light organ fluid [60]. Growth of
the bacteria is supported by the nutrients provided by the light organ environment,
including host-derived amino acids [53]. Upon establishing colonization, V. fischeri cells
adjust their metabolism in response to the light organ environment. V. fischeri
metabolism exhibits a daily rhythm that coincides with the daily rhythm of the animal
host. A recent transcriptome analysis characterized the gene profiles of both the squid
host and bacterial symbionts at intervals throughout the daily cycle of light organ
expulsion and re-population [57]. This study found that V. fischeri cells undergo various
changes in gene expression (up to 17% of total genes) throughout the daily cycle of
symbiosis [57]. The most dramatic changes in gene expression occurred around dawn, the
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time period in which E. scolopes expels the contents of its light organ [57]. V.
fischeri exhibited specific changes in the expression of genes involved in the metabolism
of chitin and glycerol, both nutrient sources proposed to be provided by the squid host
[57]. Genes involved in chitin metabolism were up-regulated in the period prior to the
dawn expulsion, and subsequently down-regulated following the dawn expulsion and
throughout the remainder of the day [57]. In contrast, genes involved in glycerol
metabolism were significantly up-regulated in the hours following dawn and light organ
expulsion [57]. The authors of this study proposed that these alterations in metabolism
gene expression reflect the response of the symbionts to changes in the available hostsupplied nutrients that accompany light organ expulsion [57]. In particular, effacement
of the light organ epithelium during expulsion is thought to provide an increased source
of glycerophospholipids, from which glycerol may be obtained and metabolized by V.
fischeri [57]. Lipid analysis of V. fischeri cell membranes confirmed that the cells
indeed incorporate host-derived fatty acids [57]. This suggests that the bacteria adjust
their metabolism in response to the daily changes in the light organ environment and the
availability of host-derived nutrients.
Upon achieving a high cell density, the bacteria initiate the production of
luminescence via three quorum sensing systems. Each of these systems produce and
detect a distinct autoinducer signal. The signal synthase protein LuxI produces the
autoinducer N-3-oxohexanoryl-L-homoserine lactone (3-oxo-C6-HSL), which is secreted
into the supernatant and, upon reaching an equilibrium, binds to the cellular receptor
LuxR [61,62]. Together, LuxI-LuxR activate transcription of the lux genes, which encode
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the proteins responsible for bioluminescence [63,64]. V. fischeri possesses two
additional autoinducers: an N-octanoyl-homoserine lactone (C8-HSL) produced by the
synthase AinS, and a proposed furanosyl borate diester, called autuinducer-2 (AI-2)
produced by the synthase LuxS [65,66]. C8-HSL and AI-2 are predicted to signal
through two independent receptors, the hybrid sensor kinases AinR and LuxP/Q,
respectively [67,68]. Proliferation of V. fischeri to high cell densities within the deep
crypts results in the accumulation of these autoinducers, which are subsequently detected
by their cognate receptor proteins and induces expression of the lux luminescence genes
[68]. Mutational studies of the lux genes and their regulators demonstrate that loss of
bioluminescence impair symbiotic colonization [54,55].
Conclusion
The symbiotic association between E. scolopes and V. fischeri has been
established as an elegant model system for investigating the processes involved hostmicrobe interactions. The study of this system over the last 20 years has yielded
numerous insights into the mechanisms by which a bacterium and its animal host
establish, develop, and maintain a symbiotic partnership. An important feature of this
model system is the exclusive nature of the association, as only V. fischeri is capable of
establishing successful colonization of the squid light organ. This exclusive partnership
allows for direct investigation into the processes by which the bacterial symbiont and its
animal host promote and ensure specificity over colonization. Both V. fischeri and E.
scolopes actively participate in the colonization process, as each organism detects and
adaptively responds to the presence of its symbiotic partner. V. fischeri has evolved a
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variety of mechanisms that promote host interaction and allow the bacteria to adapt to
conditions within the squid host. Similarly, E. scolopes contributes to colonization
through the initiation of a number of physiological and developmental processes, many of
which are triggered by interaction with its bacterial symbiont. Although two decades
worth of investigation has resulted in the identification of many of the bacterial and host
factors required for establishing colonization, many questions remain. In particular, the
mechanisms by which V. fischeri regulates the expression of colonization factors, such as
syp biofilm formation, remain areas of active study. This dissertation examines a
particular mechanism by which V. fischeri regulates colonization of its animal host.
TWO-COMPONENT REGULATORY SYSTEMS
Introduction
The ability to sense and respond to changes within the environment is critical for
the survival of any living cell. To modulate gene expression in response to environmental
cues, cells employ a variety of signaling devices. A common mechanism by which
bacteria coordinate cellular behavior in response to environmental cues is through the
regulation of protein phosphorylation by protein kinases and phosphatases. Upon
detection of an environmental stimulus a protein kinase autophosphorylates and then
donates the phosphoryl group to a substrate protein(s). Kinases typically phosphorylate
substrate proteins on specific amino acid residues, including serine (Ser), threonine (Thr),
tyrosine (Tyr), histidine (His) and aspartate (Asp) residues [69,70]. As a result,
phosphorylation can regulate a target protein’s activity, either by inducing specific
conformational changes or by impacting protein-protein interactions [69].
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In bacteria, a common form of signal transduction is through two-component
signal (TCS) transduction systems involving His-Asp phosphotransfer [71]. In its
simplest form, TCS systems consist of a histidine sensor kinase (HK) that
autophosphorylates at a conserved histidine residue, and a downstream response regulator
(RR) that catalyzes the transfer of the phosphoryl group from the HK to a conserved
aspartate residue located within the RR [71](Fig. 4).
The typical HK protein consists of a variable N-terminal sensory domain
connected to a highly conserved kinase catalytic domain [72]. Typically, sensing of an
environmental stimulus by the HK’s sensory domain results in the activation of the
protein’s ATP-dependent kinase domain, which subsequently autophosphorylates on a
conserved His residue located in the kinase core. HKs are generally thought to function
as homodimers and autophosphorylation occurs via an in trans mechanism, in which one
HK subunit catalyzes the phosphorylation of the conserved His residue in the second
subunit [72,73].
RRs catalyze phosphoryl transfer from the phospho-histidine of the HK to a
conserved aspartate residue located within the RR’s N-terminal regulatory receiver
(REC) domain [74](Fig. 4). Phosphorylation generally regulates the activity of an
attached C-terminal effector domain [75,76]. The vast majority of RR proteins contain a
DNA-binding effector domain and function as transcription factors [77,78]. As a result,
RR phosphorylation commonly results in a change in DNA binding and, thus, altered
gene expression [reviewed in [78]]. Alternatively, the RR REC domain may be attached
to a large variety of other output domains, including those involved in protein-protein
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Figure 4. Two-component signal transduction pathways. (A) In the typical twocomponent signaling (TCS) pathway, a HK protein autophosphorylates on a conserved
histidine (His) and then donates the phosphoryl group to an aspartate-containing receiver
(REC) domain on a cognate RR protein. REC Phosphorylation changes the activity of an
output domain, resulting in a cellular response. Simple HK proteins consist of a variable
sensory domain and a conserved kinase module, which includes a catalytic and ATPase
(CA) domain responsible for ATP binding and catalyzing autophosphorylation at a His
residue located in the dimerization and autophosphorylation (DHp) domain. (B)
Phosphorelays represent a more complex (TCS) pathway, involving multiple
phosphotransfer events. A hybrid HK protein transfers phosphoryl groups from the
conserved His to an internal REC domain. A histidine phosphotransferase (HPt) protein
then shuttles the phosphoryl groups to the cognate RR. The Hpt module may exist either
as an independent protein or as part of the hybrid HK.
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interaction, ligand binding, or enzymatic activity [78,79].
The simple TCS system described above involves a single phosphotransfer event
between a single HK and its cognate RR protein. However, many characterized TCS
systems possess a more complex signaling circuitry involving multiple His-Asp phospho
transfer events [71,80](Fig. 4B). Multi-step phosphorelays represent a more elaborate
form of the TCS system and include multiple phosphoprotein intermediates; upon
autophosphorylation of the histidine kinase, the phosphoryl group first transfers to a
conserved Asp residue located within a REC domain, followed by transfer to a second
conserved His residue within in a histidine-containing phosphotransfer (HPt) domain, and
finally to a second conserved Asp located in the REC domain of a second RR [80](Fig.
4B). The intermediate His- and Asp-containing domains function as phosphotransfer
elements and can be found either as independent signaling elements or “fused” in a single
protein, as observed in hybrid HK proteins [71]. In the case of hybrid HKs, the proteins
possess both the ATP-dependent, catalytic kinase domain (containing the phosphoacceptor His residue) and a REC domain (containing the intermediate Asp residue) (Fig.
4B). The HPt-domain, containing the intermediate phospho-accepting His residue, may
also be found as a component within the hybrid HK or may exist as a separate protein
(Fig. 4B). The HPt domains themselves do not exhibit kinase or phosphatase activity, in
comparison to the catalytic, histidine kinase domain, but instead shuttle the phosphoryl
group to the downstream RR. As a result of these multiple phospho-intermediates, the
phosphorelay system provides an opportunity for additional regulatory checkpoints, as
well as additional signaling inputs, to be incorporated into the signaling cascade [80].
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In addition to phosphorelay systems, another means by which the simple TCS
system can be modified to achieve greater complexity, and thus regulatory control, is
through the incorporation of multiple HKs and/or RRs. In these more complex TCS
systems, multiple HKs can mediate phosphorylation of a single, downstream RR protein
(Fig. 5). Alternatively, a single HK may serve as a phosphoryl donor to multiple
downstream RRs (Fig. 5). For example, the HK CheA, which regulates chemotaxis in E.
coli, functions as a phosphoryl donor to two downstream RRs, CheY and CheB [81].
Similarly, the Lux quorum sensing system controlling bioluminescence in Vibrio harveyi
provides an elegant example of multiple HK proteins (LuxQ, LuxN, and CqsS) that serve
as phosphoryl donors to a single RR protein, LuxO [82,83]. These more complex
variations on the TCS system, as with the phosphorelay scheme, provide greater control
over cellular responses by integrating multiple signaling inputs [80].
The number of TCS systems within a particular bacterium varies greatly among
different species, with the average bacterium utilizing between 10-50 TCS systems [71].
The observation that a single bacterium may possess multiple TCS components raises an
important question as to how distinct TCS pathways achieve signal specificity or fidelity.
One means by which cells may achieve specificity within TCS pathways is through
regulating the relative levels of HK and RR pairs. Indeed, many cognate HKs and their
RRs are often genetically linked, such that the expression of the HK and RR are coregulated. Another mechanism by which bacteria prevent aberrant signaling between
distinct TCS pathways is through controlling protein interactions between cognate HK
and RR pairs [84]. Several studies have examined the structure of cognate HK/RR
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Figure 5. Variations on the two-component signaling pathway. Depicted are two
possible variations in signaling between HK proteins and downstream RR proteins. In
the “One-to-Many” scenario, a single HK protein can function as a phosphodonor to
multiple downstream RR proteins (RR1 and RR2). Alternatively, the “Many-to-One”
scenario involves multiple HK proteins (HK1 and HK2) that both serve as
phosphodonors to a common downstream RR. This figure was modified from Laub and
Goulian (2007) [88].
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complexes and utilized these structures to characterize the interacting interfaces and
residues involved in HK/RR pairing [85,86]. By comparing the structures of the different
HK/RR complexes reported in these studies, researchers have shown that binding
between HK/RR pairs involves several conserved interacting interfaces between the RR’s
regulatory REC domain and the histidine kinase domain of the cognate HK (reviewed in
[84]). These initial studies have led to further computational analyses investigating the
potential variable residues within these interaction interfaces that may confer binding
specificity between cognate HK/RR pairs [87]. These studies indicate that specific
residues within the interaction interfaces of cognate HK/RR pairs may function to control
specificity in TCS pathways. Specificity between cognate HK/RR pairs may also be
achieved through controlling RR dephosphorylation. Multiple HKs have been reported to
possess bifunctional activity, capable of both phosphoryaltion and dephosphorylating
their cognate RR [71,88]. Studies have investigated the role of HK phosphatase activity
in controlling RR activation, and suggest that RR dephosphorylation by cognate HK may
serve to prevent aberrant RR activation by non-cognate HKs [89,90]. Additionally,
dedicated proteins phosphatases may serve to control RR phosphorylation and thus
provide further control of gene expression. These studies suggest that TCS systems may
possess multiple mechanisms to ensure proper signal transmission.
TCS systems have been implicated in the regulation of diverse bacterial
processes, including the expression of factors involved in host colonization and
pathogenesis [5]. Importantly, recent studies have shown that V. fischeri utilizes multiple
TCS systems during colonization of E. scolopes [33,91]. These TCS systems contribute
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to the regulation of numerous symbiotic behaviors, including bacterial aggregation,
motility and bioluminescence [33,91,92]. In the following sections, I will summarize the
key components of HKs and RRs and their roles in signal transduction. In addition, I will
discuss the role of TCS systems during the V. fischeri-E. scolopes symbiosis, focusing on
two-component regulators of V. fischeri aggregate formation and colonization initiation.
Structure and function of histidine sensor (HK) kinases
HK proteins typically possess a modular domain architecture and consist of at
least three conserved domains that participate in distinct functional roles. The typical HK
contains a variable sensory domain connected to conserved dimerization and catalytic
kinase domains (Fig. 4). The key features of these HK domains and their roles in HK
activity/function are discussed below.
(A) Sensory domain
The central function of a HK is to provide detection of specific environmental
signals and to elicit the appropriate cellular response by modulating the activity of a
downstream RR(s). The detection of specific environmental stimuli is mediated directly
or indirectly by the HK’s N-terminal sensory domain. The sensory domains between
individual HKs exhibit high sequence variability, suggesting that these domains have
evolved to sense diverse environmental ligands [93]. In most cases, the specific ligands
sensed by the sensory domain and the mechanism of detection remain unknown. The
organization of the sensory domain within HKs can vary depending upon the detected
stimulus. In the typical membrane-spanning HK, the sensory domain is formed by a
folded, extracellular loop located between two transmembrane domains [94]. In other
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membrane-spanning HKs, the sensor domain may be embedded within the membrane
or located within the cytoplasm either N- or C-terminal to the protein’s transmembrane
domain(s).
(B) The catalytic kinase core
In contrast to the variable sensory domain, the catalytic kinase core is highly
conserved among HK proteins. The kinase core is composed of two key domains: a
dimerization and histidine phosphotransfer (DHp) domain and a catalytic and ATPbinding (CA) domain [72]. The kinase core functions to bind an ATP molecule and
autophosphorylate at a conserved His residue. The CA domain of histidine kinases
belongs to the ATPase/Kinase GHKL (gyrase, Hsp90, histidine kinase, MutL)
superfamily of proteins [95]. Members of the GHKL superfamily possess a structural
kinase core that contains a conserved ATP-binding fold, termed the Bergerat fold [95].
The structure of the ATP-binding Bergerat fold consists of an α/β sandwich with a fourstranded antiparallel β sheet and three α helices [95]. The catalytic ATP-binding domain
also includes several conserved amino acid motifs involved in ATP binding and
hydrolysis. In the CA domain of HKs, these conserved amino acid motifs are termed the
N, G1, G2, and G3 boxes. The N-box contains a conserved asparagine residue that
coordinates the binding of a Mg2+ ion required for connecting the ATP phosphoryl
groups to the nucleotide binding cleft [95]. The G-box motifs contain conserved glycine
residues that contribute to the flexibility of the protein’s ATP-lid, which serves to cover
the ATP binding pocket [72,95]. In contrast to other members of the GHKL superfamily,
HKs contain an additional conserved motif, termed the F box, which furthers contributes
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to the ATP-lid and the binding of ATP [72]. The DHp domain of HKs consists of a
conserved H box motif, which contains the phospho-accepting His [72]. Phosphate
transfer is proposed to occur through a nucleophilic attack on the γ-phosphate of the ATP
molecule bound by the CA domain by the recipient His residue [96].
Autophosphorylation by several characterized HKs has been demonstrated to occur via
an in trans mechanism [73]. In this manner, the conserved His residue located in one
subunit receives a phosphoryl group from the ATP bound by the CA domain in the other
subunit [73,97]. Evidence suggests that HK autophosphorylation can also occur through
an in cis mechanism, in which the phosphoryl group is transferred from the CA domain to
the conserved His residue within the DHp domain of the same subunit [85].
Structure and function of response regulators (RRs)
In TCS systems, the RR serves as the downstream component that mediates a
cellular response upon receiving a phosphoryl signal from a cognate HK or a small
phosphodonor (e.g. acetyl phosphate) [107,108]. The typical RR possesses a modular
domain structure consisting of two key domains: a conserved regulatory receiver domain
and an attached variable, output domain (Fig. 4). The role of the individual RR domains
is described below.
(A) Regulatory receiver (REC) domain
The regulatory REC domain functions as a phosphorylation-mediated molecular
switch, and contains a conserved aspartate (Asp) residue that serves as the phosphoacceptor site. The REC domain is mostly commonly found attached to other domains
present in multi-domain RRs or hybrid HKs. The REC domain may also exist as a stand	
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alone module, as in the case of the single-domain RR CheY, which regulates bacterial
chemotaxis by interacting with a component of the flagellar apparatus [98]. The RR
CheY serves as a model for understanding the structure and function of the REC domain.
The REC domain generally adopts a double wound α/β fold topology consisting of a
parallel, five-stranded β-sheet surrounded by five α-helices [99,100,101]. The active site
of the REC domain consists of several highly conserved residues. In CheY, these include
three Asp residues, Asp 12, Asp 13, and Asp 57, which participate in the binding of a
Mg2+ cation required for phosphoryl transfer [102,103]. One of these Asp residues, Asp
57 for CheY, was identified via mass spectrometry to be the phospho-acceptor site,
receiving phosphoryl groups from the cognate HK CheA [104]. The REC active site
contains two additional, highly conserved threonine (Thr 87) and lysine (Lys 109)
residues, which are not required for REC phosphorylation, but are critical for signal
transduction [102,105].
An early study found that RRs are capable of catalyzing their own
autophosphorylation in the absence of their cognate HKs [106]. Using purified RR
proteins CheY and CheB, Lukat et al. demonstrated that RRs can catalyze their own
phosphorylation using small molecule phosphodonors, such as acetyl-phosphate [106]. In
addition to this initial in vitro study, subsequent investigations have since demonstrated
that autophosphorylation using relevant, small phosphodonors can also occur in vivo
[107,108]. Together, these studies revealed that the REC domain plays an active role in
promoting RR phosphorylation.
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RR phosphorylation is proposed to occur through a similar mechanism
regardless of whether the RR autophosphorylates using a small phosphodonor or through
interaction with a cognate HK. REC phosphorylation requires the presence of bound
divalent cation, typically a Mg2+ metal ion, coordinated by the three conserved Asp
residues [103]. Structural studies of Mg2+-bound CheY, indicate that the carboxylate side
chains of the Asp residues form a Mg2+ binding cleft [109]. The bound Mg2+ ion is
thought to facilitate the coordination of the phosphoryl group’s oxygen atoms [109].
REC phosphorylation is then proposed to proceed through a nucleophilic attack on the
phosphorous atom by the carboxylate side chain of the phospho-accepting Asp (Asp 57 in
CheY) [109].
The additional residues conserved within REC domains are proposed to
participate in the subsequent signal transduction events following phosphorylation.
Structural studies indicate that phosphorylation of the RR REC domain induces subtle
conformational changes within the protein [101,110]. A study examining the structures of
CheY in either the unphosphorylated, Mg2+ -bound state or upon binding of
beryllofluoride (BeF3-), which mimics the phosphorylated state [111], revealed that
phosphorylation promotes subtle conformational changes across the surface of the REC
domain [110]. Specifically, the largest phosphorylation-induced changes were observed
in the α4/β5/α5 face of the REC domain, including a repositioning of the loop region
between β sheet 4 and α helix 4 (β4/α4) and a modest change in the loop region between
β sheet 5 and α helix 5 (β5/α5) [110]. The other highly conserved Thr 87 and Lys 109
residues within the REC domain are found within these structural regions [110]. These
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residues likely contribute to REC domain signal transduction by mediating the
conformational changes induced by phosphorylation. These studies indicate that the REC
domain possesses both inactive and active conformational states, with phosphorylation
generally favoring the active conformation. Indeed, recent studies have suggested that the
REC domain may exist in an equilibrium state, in which the protein shifts between both
the active and inactive conformations [112,113]. In this case, phosphorylation would
serve to shift the balance toward stabilization of the active conformational state
[112,113].
A critical step in any TCS system is the termination of the cellular response
through the removal of the phosphoryl group from the REC domain of an activated RR.
The dephosphorylation of an activated RR can occur through several possible
mechanisms, including RR autodephosphorylation [114,115]. RR dephosphorylation can
also be achieved through the phosphatase activity of the cognate HK(s) or a dedicated
protein phosphatase(s). A number of HK proteins have been demonstrated, either
genetically or biochemically, to possess phosphatase activity toward their
phosphorylated, cognate RRs [71, 107, 116]. In this manner, HKs can tightly regulate the
longevity of a cellular response by controlling both the phosphorylation and
dephosphorylation of their cognate RR. Finally, bacteria may also utilize dedicated
phosphatase proteins to control the RR phosphorylation. For example, the Rap
phosphatases in B. subtilis function in the signaling cascade to control sporulation by
promoting the dephosphorylation of the RR Spo0F, thus inhibiting sporulation [117].
(B) RR effector domains
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The majority of bacterial RRs are multi-domain proteins, typically containing
the regulator REC domain in combination with one or more effector or output domains.
In general, phosphorylation of the REC domain elicits a cellular response through
inducing the activation, or occasionally the inactivation, of an attached effector domain.
Unlike the highly conserved REC domain, RR effector domains exhibit great diversity
and, thus, participate in a wide range of cellular functions [78]. Additionally, a number
of RRs lack an effector domain altogether, and exist as single-REC domain proteins
[118]. The chemotaxis protein CheY and the sporulation regulatory protein Spo0F
provide well-characterized examples of such single-domain RRs. The RR CheY exerts
regulatory control over bacterial chemotaxis through a mechanism involving proteinprotein interactions. Upon phosphorylation, CheY is activated to bind to the flagellar
switch component FliM and induce a switch in flagellar rotation [98,119]. In contrast,
the RR Spo0F regulates sporulation in Bacillus subtilis by participating in a
phosphorelay, in which Spo0F shuttles phosphoryl groups from two cognate HKs
(KinA/KinB) to a downstream HPt protein, Spo0B [120]. These studies demonstrate that
the REC domain alone can exert regulatory activity. Although the REC domain can
function as a stand-alone protein, most RRs contain the REC domain in combination with
an effector domain, of which there are a variety. I will therefore provide a brief overview
of the major classes of RRs containing characterized effector domains.
The majority of characterized RRs possess the REC domain attached to a DNAbinding effector domain, and therefore often function as transcriptional regulators [78].
Consequently, REC phosphorylation typically results in a change in DNA binding and
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altered target gene expression. A comprehensive analysis of RRs with DNA-binding
effector domains, indicated that most can RRs be classified into three major classes: the
OmpR class, the FixJ/NarL class, and the NtrC class [78]. The OmpR class represents
the most abundant family of RRs (30.1% of all RRs), and includes RRs containing a
winged helix-turn-helix DNA-binding domain [78]. The FixJ/NarL class is the second
most abundant class of RRs (10.1% of total RRs), and consists of RRs containing a helixturn-helix DNA-binding domain [78]. Finally, the NtrC class of RRs (representing
~9.1% of all RRs) includes those that contain three distinct domains: a REC domain
combined with both a σ54 interacting-ATPase domain and a DNA-binding domain [78].
In addition to DNA-binding domains, the REC domain may also be found in
combination with a variety of other effector domains, including those involved in proteinprotein interactions, RNA-binding, or enzymatic activity [78]. Due to the large diversity
of RR effector domains, I discuss here several representative examples of characterized
RRs containing non-DNA binding effector domains. The RR PhyR, which regulates the
general stress response in Methylobacterium extorquens, provides an interesting example
of a RR that functions through the regulation of protein-protein interactions [121]. PhyR
contains an N-terminal REC domain connected to a C-terminal effector domain that
exhibits sequence similarity to the σE subunit of RNA polymerase [122]. The σE-like
effector domain of PhyR was found to regulate the general stress response by binding to
and sequestering an anti-sigma factor, NepR, which allows the genuine sigma factor,
σEcfG, to associate with RNA polymerase and promote activation of stress response genes
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[122]. Phosphorylation is proposed to activate PhyR’s σE-like effector domain and
permit binding to NepR [123].
In recent years, the list of characterized RRs containing effector domains with
proposed enzymatic activity has greatly expanded. These effector domains often possess
enzymatic activities that further participate in signal transmission, such as enzymatic
domains that function as diguanylate cyclases, phosphodiesterases, and serine/threonine
protein kinases and phosphatases [78]. Among the best characterized of these RRs
include CheB-like chemotaxis regulators, which combine the REC domain with a Cterminal methylesterase domain [124,125]. Another example of an extensively studied
RR containing an enzymatic effector domain is the RR PleD, which regulates flagellar
ejection and stalk biogenesis in Caulobacter crescentus [126]. PleD contains two REC
domains (an active, N-terminal REC domain linked to a second, inactive REC domain),
which are connected to a C-terminal diguanylate cyclase (GGDEF) domain involved in
the synthesis of bis-(3’-5’)-cyclic diguanosine monophosphate (c-di-GMP), a bacterial
second messenger [127]. In the case of PleD, REC phosphorylation is proposed to
activate the attached GGDEF domain, resulting in the production of c-di-GMP, which
ultimately serves to down-regulate motility and promote stalk production [128].
In addition to these characterized RRs, recent surveys have identified putative
RRs containing the REC in association with a variety of effector domains with putative
functions in signal transduction, including serine/threonine kinases, PP2C type serine
phosphatases, c-di-GMP phosphodiesterases, and adenylate cyclases [79]. Together, these
studies demonstrate the modular nature of the RR REC domain. The ability of the REC
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domain to be connected to a variety of output domains provides great diversity in the
functions of RR proteins.
Two-component regulators of the V. fischeri-E. scolopes symbiosis
(A) Overview
Bacteria typically employ a variety of colonization factors during infection of
their respective eukaryotic hosts. Expression of these colonization factors is often under
tight regulatory control, thus allowing the bacterium to coordinate its behavior in
response to host-derived signals. TCS systems represent a common mechanism by which
bacteria regulate the expression of colonization factors in response to environmental
conditions. During the course of host colonization, V. fischeri cells encounter a variety of
unique environmental conditions. These include exposure to host-derived antimicrobials
in the ciliated ducts, association with the crypt epithelial cells, and interaction with host
immune cells. Given the range of environments that the bacteria encounter, it is not
surprising that V. fischeri employs multiple TCS systems to sense and adaptively respond
to the various conditions and host signals. Indeed, V. fischeri contains 40 putative and
known RR proteins, a subset of which has been shown to contribute to colonization
fitness [33]. Of the TCS systems reported to impact host colonization, several appear to
impact colonization fitness through global effects on cell physiology. The GacS/GacA
regulatory system represents a well-studied example of a global TCS system. V. fischeri
mutants lacking the RR gacA fail to efficiently colonize E. scolopes [129]. Further
analyses determined that a gacA mutant exhibits defects in a number of symbiotic traits,
including luminescence, motility, LPS production, and growth [91,129]. Due to the
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pleiotropic effects of a gacA mutation, the specific role(s) of this global regulator
during the colonization process remains an area of active study.
In contrast, other characterized TCS systems have been shown to regulate specific
symbiotic traits and, therefore, contribute to particular stages of host colonization, such
production of luminescence. Cell density-dependent light production in V. fischeri
involves an intricate network of regulators, including multiple TCS regulatory proteins
that control activation of the lux luminescence genes. The Lux phosphorelay consists of
three hybrid HKs (LuxN, LuxP/Q, AinR) that donate phosphoryl groups to the HPt
protein LuxU, which shuttles phosphoryl groups to the RR LuxO [130]. Mutations within
several of these Lux regulatory genes result in the dysregulation of luminescence and
defects in colonization [68,130,131]. In addition to luminescence, TCS regulators have
also been shown to control one of the earliest stages of host colonization, the formation of
a biofilm aggregate on the surface of the symbiotic light organ [15,16,25]. In the
following section, I will discuss the role of TCS regulators in controlling syp aggregate
formation and the initiation of host colonization, as knowledge of this regulatory network
is pertinent to this dissertation work.
(B) Two-component regulation of symbiotic biofilm formation
An early event in the initiation of host colonization involves the formation of a
biofilm-like aggregate by V. fischeri cells on the surface of the symbiotic light organ [16].
The production of this biofilm requires the symbiosis polysaccharide (syp) locus [21].
Current evidence indicates that activation of the syp locus and biofilm production is
under tight regulatory control [25]. In particular, V. fischeri does not produce a syp
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biofilm in vitro under normal, laboratory conditions, suggesting that syp expression
and biofilm formation are restricted to conditions in which the bacteria encounter the host
squid. Indeed, transcriptional reporter assays indicate that the syp locus is poorly
expressed under normal culture conditions [20,27]. The regulation of syp biofilm
formation involves multiple two-component regulator proteins, including the HK RscS
[20,27](Fig. 3). Similar to syp mutants, an rscS mutant exhibits a defect in the ability of
the cells to aggregate and initiate host colonization [20,26]. Overexpression of an rscS
allele, rscS1, was found to activate syp transcription, resulting in a 100-fold increase
relative to a vector control [20]. The rscS1 allele contains a silent mutation at codon
Leu25 and a mutation within the putative ribosome binding site; these changes are
proposed to enhance ribosome binding and increase protein production [20,132]. rscS1
overexpression also induces the production of syp-dependent biofilm phenotypes. In
vivo, cells overexpressing rscS1 form increased symbiotic aggregates on the light organ
surface [20] (Fig. 6A). In laboratory culture, rscS1 overexpression results in wrinkled
colony formation on solid agar media and the formation of a biofilm pellicle at the airliquid interface of static cultures [20] (Fig. 6B).
Mutational analysis of V. fischeri RRs determined that RscS activation of syp
transcription and induction of biofilm phenotypes requires the syp-encoded RR SypG
[27]. SypG belongs to the NtrC-like familiy of σ54-dependent transcriptional activators
and contains an N-terminal REC domain linked to a central σ54 interaction domain and a
C-terminal DNA-binding domain. Similar to rscS, sypG overexpression results in the
activation of the syp locus [27]. The promoter sequences upstream of the four putative
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Figure 6. syp-dependent biofilm phenotypes induced by RscS. (A) Representative
confocal microscopy images of GFP-labelled V. fischeri (green) aggregates on the surface
of the symbiotic light organ of E. scolopes (counterstained in red). Images were taken
from Yip et al., 2006 [20]. (B) Representative images of in vitro biofilm phenotypes
produced by wild-type cells carrying empty vector (pKV282) or pRscS plasmid
(pARM7). rscS-overexpressing cells form a pellicle at the air-liquid interface of static
cultures (Top panel) and exhibit wrinkled colony morphology (bottom panel) on solid
agar media.
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syp operons contain putative binding sites for σ54-carrying RNA polymerase and
SypG. The current model (Fig. 3) predicts that RscS, upon sensing an as-yet unidentified
signal, initiates a phospho-relay and donates a phosphoryl group to SypG [27]. REC
phosphorylation is proposed to activate SypG’s DNA-binding domain, resulting in the
binding of SypG to the syp promoters and activation of syp transcription [27](Fig. 3).
Another two-component regulator encoded by the syp locus is the hybrid HK
SypF (Fig. 3). A recent study found that overexpression of an increased activity allele of
sypF, sypF*, results in the production of robust biofilm phenotypes [28]. sypF* carries
two mutations, resulting in a phenylalanine substitution at serine 247 (S247F) and
isoleucine substitution at valine 439 (V439I) [28]. Genetic studies indicate that SypF acts
upstream of the RR SypG to activate syp transcription and induce biofilm formation [28].
Additionally, SypF was reported to function upstream of a second RR, VpsR, to control
activation of another biofilm locus, the bcs cellulose locus [28]. What role, if any, SypF
may play during symbiotic colonization remains an area of active research.
In addition to SypG, the syp locus encodes a second RR SypE. SypE is a novel
RR consisting of a central regulatory REC domain flanked by two effector domains that
exhibit sequence similarity to partner-switching regulatory elements. SypE’s N-terminal
effector domain exhibits sequence similarity to HPK (histidine protein kinase)-like serine
kinases, including the serine kinase/anti-sigma RsbW of B. subtilis [133]. Additionally,
SypE’s C-terminal effector domain exhibits sequence similarity to PP2C-like serine
phosphatases, including the B. subtilis phosphatase RsbU [133]. The presence of a
central REC domain flanked by two effector domains of apparent opposing function
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distinguishes SypE as a unique RR protein with a novel domain architecture.
Interestingly, SypE appears to exert opposing control over syp biofilm formation
depending on whether rscS or sypG is overexpressed. Specifically, overexpression of
RscS in a strain lacking sypE results in diminished biofilm phenotypes, indicated by a
decrease in wrinkled colony formation relative to wild-type cells, suggesting a positive
regulatory role for SypE [27]. In contrast, SypE strongly inhibits biofilms induced by
SypG: overexpression of SypG in wild-type cells results in smooth colony formation and
poor pellicle production, while its overexpression in a ΔsypE strain induces robust
biofilms similar to that of an RscS-overexpressing wild-type strain [27]. The mechanism
by which SypE exerts control over syp-dependent biofilm formation remains unknown.
Furthermore, what role, if any, SypE’s opposing activities may play in regulating host
colonization, particularly during symbiotic aggregation, has yet to be determined. This
dissertation investigates the role of SypE in the regulation syp-dependent biofilm
formation and symbiotic colonization.
Conclusion
TCS systems represent one of the most common mechanisms by which bacteria
sense and adaptively respond to changes in their environment. The domains of TCS
proteins possess a highly modular design, which permits different TCS pathways to sense
diverse signals and elicit a multitude of cellular responses. HKs possess a variety of
unique sensory domains, allowing the proteins to detect and elicit a signal cascade in
response to diverse environmental stimuli. Similarly, RRs can possess the conserved
REC domain in combination with a variety of different effector domains. As a result,
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signal transmission to a RR can induce a specific cellular response dependent upon
the RR’s particular effector domain.
The modularity of TCS domains also allows these regulatory components to be
integrated into a variety of signaling systems with varying degrees of complexity. The
simplest TCS systems consist of a single phospho-transfer event between a HK and a
cognate RR. In contrast, more complex TCS systems, such as phosphorelays, incorporate
the HK, HPt, and RR domains in various combinations and involve multiple steps of
phospho-transfer. These multi-step, phosphorelay systems provide opportunities for
additional regulatory checkpoints or for the integration of various signaling inputs. In
HKs that possess both kinase and phosphatase activities, the regulation of these opposing
activities can control the levels of RR phosphorylation, and thus the duration of the
cellular response. It is also possible for RRs to receive phosphoryl signals from multiple
HKs, and therefore the net activities (either kinase or phosphatase) of these HKs can
provide even tighter control over RR phosphorylation levels.
V. fischeri utilizes multiple TCS systems to regulate symbiotic colonization of its
host E. scolopes [33,129,134]. Importantly, TCS regulators control one of the earliest
stages of host colonization, the formation of a biofilm aggregate on the surface of the
squid’s symbiotic light organ. The formation of this biofilm depends on the HK RscS and
the RR SypG, which regulate transcription of the syp biofilm locus [20,21,27].
Additionally, the syp-encoded RR SypE appears to contribute to syp biofilm regulation;
however, the role of SypE in the regulation of biofilms and host colonization has not been
fully investigated. The presence of two putative effector domains of opposing enzymatic
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functions suggests that SypE may play regulatory dual roles. In this dissertation, I
investigate the putative regulatory role of SypE in controlling syp biofilm formation and
colonization initiation.

SERINE/THREONINE PHOSHORYLATION IN BACTERIA
Introduction
Two-component signaling (TCS) systems involving phosphorylation of conserved
histidine (His) and aspartate (Asp) residues represent a common form of signal
transduction in bacteria [71]. While most bacterial signaling pathways utilize His-Asp
phosphotransfer, the use of other phosphorylated amino acids to accomplish signal
transduction has also been reported. These include signaling cascades that utilize the
phosphorylation of conserved serine (Ser), threonine (Thr) or tyrosine (Tyr) residues.
Ser/Thr phosphorylation cascades account for the majority of signaling pathways in
eukaryotes, and initially were thought to be absent in bacteria [70]. However, several
early studies indicated that Ser/Thr phosphorylation may also occur in bacteria [70,135].
Studies in the Gram-negative bacterium E. coli were the first to report the occurrence of
Ser/Thr protein phosphorylation in a bacterial system [136]. These studies identified that
the activity of the E. coli protein isocitrate dehydrogenase (IDH), an enzyme involved in
the tricarboxylic acid cycle, was regulated through the phosphorylation and
dephosphorylation at a conserved Ser residue [136]. A later study found that IDH
phosphorylation was controlled through the activity of a cognate bifunctional
kinase/phosphatase protein, AceK [137]. Subsequent research has since identified a
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number of additional Ser/Thr kinases and phosphatases present in a variety of
bacterial systems [70,135].
The typical Ser/Thr signaling system includes a Ser/Thr kinase (STK) protein and
a downstream substrate protein(s). Ser/Thr phosphorylation pathways also generally
include a cognate Ser/Thr phosphatase (STP) protein, which functions to dephosphorylate
the substrate protein. The requirement for dedicated STPs within Ser/Thr signaling
pathways is due to the stable nature of phosphorylated Ser and Thr residues. This feature
distinguishes Ser/Thr signaling systems from the typical TCS system. Compared to the
phospho-His and phospho-Asp residues present in TCS systems, which possess a high
free energy and therefore undergo rapid hydrolysis [138], phospho-Ser and phospho-Thr
residues are significantly less labile [138,139]. Therefore, the removal of the phosphoryl
groups by a cognate STP is necessary for the controlled termination of the signaling
response.
While the role of TCS systems in bacterial is well-established, the importance of
signaling systems utilizing Ser/Thr phospho-transfer has only recently been appreciated.
In recent years, a number of studies have demonstrated that, like TCS systems, Ser/Thr
phospho-transfer systems are widespread among bacterial species and contribute to the
regulation of diverse cellular responses [70]. In the following sections, I will discuss the
key features of bacterial Ser/Thr kinases and phosphatases, focusing on the components
relevant to this dissertation work.
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Structure and function of bacterial serine kinases
Since the discovery that the E. coli protein IDH was regulated through Ser
phosphorylation, the role of Ser/Thr phosphorylation in bacterial signaling systems has
been heavily investigated. As a result, a large number of Ser/Thr kinases (STKs) have
been identified and characterized in a variety of bacterial organisms. These STKs can
generally be classified into two, broad groups based on the catalytic kinase domain: those
whose catalytic domain shares structural homology to eukaryotic Ser/Thr kinases
(eukaryote-like serine kinases, eSTKs) and those that are distinct from eukaryotic Ser/Thr
kinases (non-eSTKs). In this section, I provide a brief overview of these two groups of
bacterial STKs, but focus particularly on the structure/function of non-eSTKs, which is
pertinent to this dissertation.
(A) Eukaryote-like serine kinases
The first eukaryote-like serine kinase (eSTK) identified in bacteria was the
Myxococcus xanthus protein Pkn1, which contributes to M. xanthus development [140].
Pkn1 was demonstrated to autophosphorylate on conserved Ser and Thr residues, and
analysis of the protein’s catalytic domain indicated that it shared sequence homology
with eukaryotic, or Hanks type, STKs [140]. Bacterial genome analyses have since
identified numerous eSTKs present in a wide range of bacterial systems. This includes
the Mycobacterium tuberculosis protein kinase PknB, which represents the first bacterial
eSTK to be crystallized and its structure determined [141]. Analysis of PknB, and
subsequent bacterial eSTKs, indicated that, in addition to sequence homology, the
catalytic domains of these proteins are structurally similar to eukaryotic STKs. As
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observed in eukaryotic STKs, eSTKs possess a kinase catalytic domain that adopts a
two-lobed structure in which ATP binding occurs in a catalytic cleft located between
these two lobes [70]. In general, the N-terminal lobe participates in the binding and
coordination of the ATP nucleotide, while the C-terminal lobe is involved in binding to
the substrate protein and the initiation of phosphatase transfer [70]. These eSTKs are
further characterized by the presence of 12 highly conserved residues that are located
within the N- and C-terminal lobes of the catalytic domain. These conserved residues
participate directly or indirectly in catalyzing phosphate transfer, either through
coordination of the ATP molecule (phosphoryl donor) or substrate protein binding [70].
(B) Non-eukaryote-like serine kinases
Ser/Thr kinases that are homologous to those found in eukaryotes (eSTKs)
represent the majority of STKs identified in bacterial systems. However, studies have
also described a number of bacterial STKs that are distinct from eSTKs in both their
overall protein sequence and structural features. These non-eSTK proteins include a class
of Ser/Thr kinases that are more closely related to histidine sensor kinases (HKs)
commonly found in TCS systems. These HPK (Histidine protein kinase)-like serine
kinases exhibit both sequence and structural homology to HKs. The serine kinase
SpoIIAB, which regulates the sporulation pathway in Bacillus subtilis and related
Bacillus species, provides an example of a well-characterized HPK-like serine kinase
[142](Fig. 7). Crystal structure analysis of SpoIIAB demonstrated that the HPK-like
kinase domain contains the core elements of the ATP-binding Bergerat fold, conserved in
the ATPase/Kinase superfamily of proteins [95,143]. Similar to HKs, the ATP-binding
	
  

	
  

	
  

55	
  

Figure 7. Characteristics of SpoIIAB and non-eSTK proteins. (A) Schematic diagram
of the catalytic kinase core domain of non-eSTK proteins. Shown are the locations of the
N, G1, G2, and G3 boxes. (B) Schematic of B. subtilis non-eSTK proteins SpoIIAB and
RsbW. Shown are key conserved residues within the individual motifs: invariant
asparagine (N) of the N Box and the conserved aspartate (D) and glycine (G) residues of
the G1 Box.
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domain of HPK-like serine kinases consists of several conserved amino motifs termed
the N, G1, and G2 boxes, which participate in Mg2+ ion coordination and ATP binding
[95,142](Fig. 7). HPK-like serine kinases, however, lack the additional H-box motif
containing the conserved His residue, which serves as the site of autophosphorylation in
HKs [95]. As a result, HPK-like serine kinases phosphoryate their substrate proteins by a
different mechanism than HKs. Phosphate transfer by HKs involves HK transautophosphorylation at a conserved His residue, followed by phosphoryl transfer to an
Asp located in the REC domain of a downstream RR. In contrast, HPK-like serine
kinases do not autophosphorylate, and are proposed to directly transfer the phosphoryl
group from ATP to a Ser residue within a cognate, substrate protein [142,144]. The
mechanism of phosphate transfer by HPK-like serine kinases is proposed to occur
through a direct nucleophilic attack on the γ-phosphate of the bound ATP by the Ser
residue located on the substrate protein [142,144]. Therefore, although histidine kinases
and HPK-like serine kinases share structural homology, they differ in their mechanisms
of phosphate transfer and their amino acid targets.
Structure and function of serine phosphatases
The removal of phosphoryl groups from phosphorylated substrate proteins is
critical for the termination of a signaling cascade and resetting of the system. In bacteria,
the majority of characterized Ser/Thr phosphatases (STPs) exhibit homology to
eukaryotic protein phosphatases [70]. These eukaryote-like Ser/Thr phosphatases
(eSTPs) are categorized into two structurally distinct phosphatase families: the
phosphoprotein phosphatases (PPPs) and the metal-dependent phosphatases (PPMs) [70].
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Figure 8. Structural and domain characteristics of PP2C serine phosphatases. (A)
Diagram depicting the catalytic core domain of the serine phosphatase PP2C belonging to
the metal-dependent protein phosphatase (PPM) family. Indicated are the conserved
aspartates (shown in red) and the neighboring residues involved in metal ion
coordination. (B) The B. subtilis PP2C serine phosphatases SpoIIE and RsbU. Shown are
the conserved aspartates required for catalytic activity.
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Many eSTPs of the PPP family have been demonstrated to possess “dual specificity”
and are capable of cleaving phosphoryl groups not only from Ser/Thr residues, but also
from phospho-tyrosine and phospho-histidines [70]. I focus here on the structure and
function of eSTPs belonging to the PPM family of phosphatases, as an understanding of
these characteristics is relevant to the work presented in this dissertation. eSTPs of the
PPM family are manganese/magnesium ion (Mg2+/Mn2+)-dependent phosphatases and
share a conserved catalytic core domain with the human phosphatase PP2C
[145,146](Fig. 8A). The PP2C catalytic core domain consists of a central β-sandwich
composed of two β sheets each flanked by a pair of α helices [147]. Crystal structure
analysis indicates that the central β-sandwich forms a metal-binding cleft, in which two
metal cations (either Mg2+ or Mn2+) are located at the base of the cleft and hexacoordinated with water and neighboring amino acids [147]. The proposed mechanism of
dephosphorylation occurs through a nucleophilic attack of the target phosphorous atom
by the metal-activated water molecule [147].
PP2C-like eSTPs have been identified in a variety of both Gram-positive and
Gram-negative bacteria. The phosphatases PstP of Mycobacterium tuberculosis and
PphA of Thermosynechococcus elongatus are among the best characterized of these
PP2C-like eSTPs [147]. Studies indicate that PstP and PphA, and similar bacterial eSTPs,
possess little overall sequence similarity to PP2C and other eukaryotic serine kinases of
the PPM family [70,147]. Despite weak overall sequence homology, crystal structure
analyses indicated that the catalytic domains of both PstP and PphA, and similar bacterial
eSTPs, are structurally identical to those observed for the eukaryotic PP2C phosphatases
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[147]. Additionally, both PstP and PphA were found to possess several, highly
conserved amino acid residues that form the metal-binding pocket of the active site of
PP2C phosphatases [147]. These include several invariant Asp residues that have been
demonstrated to be required for metal ion binding and Mg2+/Mn2+-dependent catalysis by
both eukaryotic and bacterial PP2C-like phosphatases [145,146,148].
Conclusion
Protein phosphorylation on conserved Ser/Thr residues provides an additional
mechanism by which a cell can facilitate signal transduction. The typical Ser/Thr
phosphorylation cascade includes cognate Ser/Thr kinase and phosphatases, which
together regulate the phosphorylation state of a downstream substrate protein(s). Signal
transmission is initiated by the activation of a Ser/Thr kinase, which facilitates the
phosphorylation of a downstream, substrate protein. Activation of a cognate Ser/Thr
phosphatase protein(s) terminates the signaling cascade and resets the system.
Although bacteria can utilize Ser/Thr phosphorylation as a means of signal
transduction, the majority of identified bacterial signaling systems utilize His-Asp
phosphotransfer (e.g. TCS systems). This is in stark contrast to eukaryotic systems in
which Ser/Thr phosphorylation represents the predominate form of signaling, and HisAsp phosphotransfer systems are relatively rare [71]. Currently, it remains unclear as to
the reason(s) behind this different distribution of signaling mechanism among bacteria
and eukaryotes. As previously discussed, a key difference between Ser-Thr and His-Asp
phosphotransfer systems is the increased, inherent stability of phosphorylated Ser/Thr
residues. While phosphorylated His/Asp residues typically undergo rapid hydrolysis,
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phosphorylated Ser/Thr residues are considerably less labile. As a result, Ser/Thr
phosphotransfer systems typically possess an additional, cognate Ser/Thr phosphatase
necessary to remove the phosphoryl group and terminate the cellular response. It remains
possible that bacterial cells may exploit these differences in the stability of the
phosphorylated amino acid targets to achieve controlled transmission of cellular signals.
Interestingly, several studies have identified bacterial signaling pathways in which
elements of both Ser/Thr and His/Asp phophotransfer systems are combined. An
interesting example can be found in the multi-domain response regulator (RR) protein
PA3346, which functions in a two-component signaling pathway to regulate swarming
motility in Pseudomonas aeruginosa. The RR PA3346 combines an N-terminal RR
receiver domain coupled to a central PP2C-like serine phosphatase domain and a Cterminal HPK-like serine kinase domain [149]. In the case of the RR PA3346, Asp
phosphorylation within the protein’s RR REC domain is proposed to regulate activity of
the attached serine kinase and serine phosphatase domains [150]. It remains unclear as to
the potential benefit(s) of integrating these distinct phosphotransfer pathways.

PARTNER SWITCHING REGULATORY SYSTEMS
Introduction
Many bacterial signaling systems utilize phosphate transfer as a means of signal
transmission. An additional mechanism by which a cell can facilitate signal transmission
is through the regulation of protein-protein interactions, such as partner-switching
systems. First coined by Alper et al. (1994), the term “partner switch” describes a
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network of interacting proteins whose interaction with cognate “partners” depends
upon a reversible serine phosphorylation event [133]. Dependent upon which partner
proteins interact, the outcome of this partner switching can either negatively or positively
regulate a target protein, generally a transcription factor or enzyme. Specifically, the
partner-switch mechanism involves several key regulatory elements, including a serine
kinase/anti-sigma factor, a serine phosphatase, an antagonist protein/anti-anti sigma
factor, and a target protein (often a sigma factor) [151].
The partner-switching mechanism has been best characterized in the Grampositive bacterium Bacillus subtilis. In B. subtilis and other Gram-positive bacteria,
partner-switching systems contribute to signaling networks that control the activity of
downstream sigma factors, the subunit of RNA polymerase that provides promoter
specificity. For example, B. subtilis possesses two distinct partner switching systems,
which function in the regulation of the stress-responsive sigma factors sigma-F (σF) and
sigma-B (σB) of the sporulation and general stress response pathways, respectively
[152,153]. The B. subtilis RsbU-RsbV-RsbW signaling network, which regulates σB of
the general stress response, represents one of the most well-characterized examples of a
partner-switching system (Fig. 9). In this regulatory pathway, an anti-sigma/serine kinase
RsbW negatively regulates σB activity by binding to σB and preventing its association
with the core RNA polymerase [154,155,156]. σB is released by the action of an antisigma factor antagonist protein, RsbV, which binds RsbW and prevents its sequestration
of σB [153].
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The ability of RsbV to function as an antagonist of RsbW depends on the
phosphorylation state of a conserved serine residue (S56) located in the protein’s sulfate
transport and anti-sigma factor antagonist (STAS) domain (Fig. 9). When
phosphorylated by RsbW (functioning as a kinase), RsbV is rendered unable to bind and
inhibit RsbW [153]. Dephosphorylation of RsbV is promoted by a set of serine
phosphatases, RsbU and RsbP, which are activated by environmental and energy stress
signals, respectively [157]. Thus, stress detection induces the dephosphorylation of
RsbV, the inhibition of RsbW, and the release of σB and subsequent activation of the σB
regulon [157]. In this regulatory network, RsbW functions as a regulatory switch, as it
reversibly interacts with its cognate sigma factor (σB) and anti-sigma factor antagonist
(RsbV).
Partner-switching systems have been identified in both Gram-positive and Gramnegative bacteria. In the following sections, I will briefly describe the key components of
partner switching proteins relevant to this dissertation work, and discuss the
characterization of partner-switching networks in other bacterial systems.
Structure and function of partner-switching proteins
(A) Anti-sigma factors/serine kinases
The canonical partner-switching system includes an RsbW-like regulatory protein
that functions as both an anti-sigma factor and serine kinase [154,158]. As described
above for the B. subtilis partner-switching paradigm, the RsbW regulator serves as a
“molecular switch” by reversibly interacting with both a cognate sigma factor (σB) and
anti-sigma factor antagonist (RsbV). RsbW and its homologs exhibit sequence similarity
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Figure 9. Model of the B. subtilis partner-switching system controlling σ B activity.
Detection of stress signals activates two serine phosphatases (RsbU/RsbP) that
dephosphorylate the STAS-domain protein RsbV. Unphosphorylated RsbV binds to the
anti-sigma factor RsbW, inducing the release of σB and subsequent activation of σB–
dependent genes. RsbW also functions as a serine kinase to phosphorylate RsbV,
resulting in the release of RsbW by RsbV. Released RsbW subsequently binds and
sequesters σB, inactivating the pathway.
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to HPK (histidine protein kinase)-like serine kinases, which are structurally related to
histidine sensor kinases of the bacterial two-component signal transduction systems
[159]. Like histidine kinases, HPK-like serine kinases possess several conserved amino
acid motifs, termed the N, G1, G2, and G3 boxes, involved in ATP-binding and kinase
activity [95](Fig. 7). For example, crystal structure analysis of the RsbW homolog
SpoIIAB from Bacillus stearothermophilus indicated that a conserved N box asparagine
(Asn 50) is required for chelating a Mg2+ ion that participates in ATP binding and kinase
activity [143](Fig. 7). Additionally, conserved glycine residues located within the G box
motifs contribute to the formation of an ATP-binding lid, a finding that is consistent with
other HPK-like serine kinases [95,143]. These studies revealed that the key structural
features of HPK-like serine kinases are conserved in SpoIIAB and its homologs,
including RsbW (Fig. 7).
Another feature of many HPK-like serine kinases is their propensity to function as
dimers [95]. Several studies have demonstrated that RsbW and SpoIIAB homodimerize
through an interaction interface localized to the region between β1 and α1 of each
monomer [143]. Additionally, both RsbW and SpoIIAB exist as dimers when bound to
their cognate sigma factors (σB or σF, respectively) or antagonist proteins (RsbV or
SpoIIAA, respectively), suggesting that dimerization is critical for mediating binding to
their cognate partner switching proteins [143,160]. In characterized partner switching
systems, an RsbW (or SpoIIAB) dimer typically forms a stable, long-lived complex with
a single σB (or σF for SpoIIAB) molecule [143,160]. Disassociation of the RsbW- σB
complex predominantly occurs through the binding of the RsbV antagonist protein, in
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which two RsbV monomers bind to the RsbW dimer and displace the bound σF
[161,162]. Analysis of B. stearothermophilus SpoIIAB bound to either its cognate sigma
factor (σF) or antagonist protein (SpoIIAA) revealed that both partner proteins bind to
similar, overlapping epitopes on SpoIIAB [162]. These binding sites are highly
conserved in B. subtilis RsbW and SpoIIAB [162]. These findings support a model in
which the release of the sequestered sigma factor (σF) is induced by the binding of the
antagonist protein (SpoIIAA) to common docking sites on SpoIIAB [162].
(B) Anti-sigma factor antagonists
In the canonical partner-switching pathway, the activation of an anti-sigma factor
antagonist protein (RsbV in B. subtilis) promotes its binding to a cognate anti-sigma
factor (RsbW), which induces the release of the sequestered sigma factor (σB) [154]. The
activity of the antagonist protein is regulated through the phosphorylation of a conserved
Ser residue located in the protein’s STAS (sulfate transporter and anti-sigma factor
antagonist) domain [142](Fig. 9). The structure and impact of phosphorylation has been
best characterized in the antagonist protein SpoIIAA of B. subtilis, which regulates the
sporulation pathway controlling σF activity. Crystal structure analysis of SpoIIAA
homologs from B. subtilis and related Bacillus species revealed that protein has a novel
fold, consisting of a four-stranded β sheet and 4 α helices with the site of
phosphorylation (Serine-58 for SpoIIAA) located at the N-terminus of the α-2 helix
[163,164].
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In characterized anti-sigma factor antagonsists, phosphorylation regulates
protein activity by reducing its affinity to bind its cognate anti-sigma factor [165,166].
Phosphorylation of a conserved Ser residue located in the protein’s STAS domain is
proposed to regulate the interaction with a cognate anti-sigma factor through multiple
mechanisms. The introduction of a negatively charged phosphate group on the antagonist
protein has been proposed to alter its binding affinity for its cognate anti-sigma factor
through electrostatic hindrance [167]. Additionally, nuclear magnetic resonance (NMR)
spectroscopy revealed that phosphorylation of the B. subtilis antagonist SpoIIAA at Ser58 induces subtle structural changes [167]. These phosphorylation-induced structural
changes primarily occurred within the protein’s α3 helix, a highly conserved region that
has been demonstrated to be involved in anti-sigma factor binding [167]. These studies
indicate that phosphorylation likely alters the binding affinity of the antagonist protein for
its cognate anti-sigma factor both through altering protein charge and by inducing subtle,
structural changes in the protein’s interaction interface.
Conservation of partner-switching systems in bacteria
(A) Partner-switching systems in Gram-positive bacteria
Since its initial characterization in B. subtilis, the partner-switching mechanism
has been identified as a signaling component in a wide range of Gram-positive bacteria.
These include Bacillus cereus [168], Bacillus anthracis [169], Mycobacterium
tuberculosis [170], Staphylococcus aureus [171], and Listeria monocytogenes [172,173].
In these systems, partner-switch modules are utilized in a manner similar to that observed
in B. subtilis: primarily, the regulation of sigma factor activity. However, the output of
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these modules varies among the individual bacteria. Partner-switching modules have
been demonstrated to contribute to the regulation of the general stress response of L.
monocytogenes and many other bacteria [172], biofilm formation in S. epidermidis [174],
and the expression of virulence-associated genes in M. tuberculosis [170,175].
Additionally, bacteria may possess multiple partner-switching pathways regulating
distinct sets of target proteins. For example, in addition to the RsbU/V/W module that
regulates the general stress response, B. subtilis possesses a second set of partnerswitching regulators, SpoIIAA/SpoIIAB/SpoIIE. Similar to the σB regulatory pathway,
these partner-switching proteins control the activity of σF, which regulates sporulation
[176]. The partner-switching mechanism, while similar among diverse Gram-positives,
has been adapted to regulate distinct cellular responses.
(B) Partner-switching systems in Gram-negative bacteria
Genome surveys suggest that partner-switching orthologs exist in a wide range of
eubacteria [177,178]. Despite its predicted widespread distribution, partner switching has
remained relatively uncharacterized within Gram-negative bacteria. Indeed, partnerswitching systems have only been characterized in several Gram-negative bacteria,
including Bordetella bronchiseptica and Chlamydia trachomatis [179,180]. The
respiratory pathogen B. bronchiseptica utilizes a partner-switching module to control
production of a type III secretion system (T3SS)[178]. The T3SS consists of a needlelike secretory apparatus that directly transports virulence proteins into the cytoplasm of
host cells. In B. bronchiseptica, the T3SS contributes to colonization of the host trachea
and the avoidance of the host immune response [178,181]. The production of the T3SS
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requires transcription of a gene cluster, the bsc locus, which encodes multiple
components of the secretory system [182]. Regulation of the T3SS depends upon a set of
genes adjacent to the bsc cluster, the btr locus, which encode orthologs of the B. subtilis
RsbU/V/W partner-switching proteins, BtrU/BrtV/BtrW. In vitro and in vivo analyses of
the B. bronchiseptica proteins demonstrated that they constitute a regulatory network
similar to their B. subtilis counterparts [179]. However, this partner-switching system
deviates from that of the B. subtilis RsbU/V/W paradigm. First, disruption of any
component of the BtrU/V/W partner-switching module results in the loss of Type III
secretion [178], a result that is inconsistent with the B. subtilis model. Second, positive
regulation of the T3SS requires both the formation of the BtrV/BtrW complex and its
dissociation, via phosphorylation of BtrV by BtrW [179]. Finally, although the
BtrU/V/W module regulates type III secretion, it does not control transcription of the bsc
locus [179]. Instead, Kozak et al. (2005) suggest that these partner-switching proteins
may regulate the T3SS at the posttranscriptional level possibly by interacting with yet
unknown regulatory proteins or playing a structural role in the secretory pathway. Thus,
although there is conservation of the partner-switching components, the regulatory
mechanism appears to vary from that of the Gram-positive paradigm.
Genome analysis of the obligate intracellular pathogen C. trachomatis identified
several components of a putative partner-switching module [180]. In vitro analysis of the
candidate genes demonstrated that these proteins indeed interact. As with B.
bronchiseptica, it appears that the C. trachomatis partner-switching system may vary
from the B. subtilis paradigm, as in vitro binding assays failed to demonstrate an
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interaction between the putative anti-sigma factor/serine kinase (RsbW) with any of
the three sigma factors encoded in the C. trachomatis genome [180]. However, the lack
of genetic tools and difficulty in culturing C. trachomatis have delayed analysis of this
potential partner-switching module in vivo.
Together, these studies suggest that the partner-switching mechanism, previously
observed only among the Gram-positives, also contributes to regulatory control in Gramnegative bacteria. It remains unknown how these partner-switching proteins regulate
downstream targets. Furthermore, it remains unclear how widespread this regulatory
mechanism is among Gram-negative bacteria.
Conclusion
Partner-switching systems represent an additional mechanism by which bacteria
facilitate signal transmission. These signaling pathways utilize both protein
phosphorylation and protein-protein interactions to achieve signal transduction and target
gene regulation. The partner-switching paradigm has been best characterized in B.
subtilis and other Gram-positive bacteria, in which partner-switching proteins typically
regulate the activity of a target sigma factor. Although genome surveys indicate that
partner-switching proteins are conserved in Eubacteria, the contribution of partnerswitching systems to signaling in Gram-negative bacteria remains unclear.
A role for partner switching regulators in V. fischeri has yet to be investigated.
Intriguingly, bioinformatic analysis suggests that partner-switching elements are present
within the effector domains of the syp-encoded RR SypE. SypE’s N-terminal domain
shares similarity to RsbW-like serine kinases, while the C-terminal domain of SypE
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shares similarity to PP2C-like serine phosphatases. In this dissertation, I investigated
the role of SypE in the regulation of biofilm formation and symbiotic colonization. In my
characterization of SypE, I assessed the contribution of these putative partner-switching
domains to the regulatory function of SypE.

BACTERIAL BIOFILM FORMATION
Introduction
Biofilms, or surface-associated community of cells encapsulated in a matrix, are
ubiquitous and likely represent the preferred mode of growth for many bacterial species
[7]. Throughout the environment, bacterial biofilms can be found attached to both abiotic
(e.g. air-liquid interface) and biotic surfaces (e.g. plant or animal host tissues). Biofilms
have been demonstrated to play multiple roles in the lifestyle(s) of diverse bacterial
species. The formation of a biofilm often dramatically impacts bacterial physiology and
can promote bacterial survival and growth by providing, among other things, antibiotic
resistance and nutrient access.
Additionally, biofilms can assist in the colonization of host tissues by both
pathogenic and non-pathogenic bacteria. Biofilms have been found to enhance various
stages of bacterial infection, including attachment to host cells and transmission within
the environment. Therefore, it is clear that understanding the processes involved in
biofilm formation and identifying means of controlling these processes remain significant
areas of research. In this dissertation, I investigate the regulatory mechanisms involved
in V. fischeri biofilm formation, and assess the impact of biofilms on symbiotic
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colonization of E. scolopes. In the following sections, I discuss several of the key
cellular processes and factors that contribute to biofilm development.
Stages of biofilm development
Biofilm formation is a dynamic process in which bacterial cells form complex,
multi-cellular communities in response to environmental conditions. Studies using model
biofilm-forming organisms, such as P. aeruginosa and E. coli, have demonstrated that
biofilm formation generally proceeds through a series of tightly regulated developmental
stages. The initial stages of biofilm formation generally involve transient association of
bacterial cells with a particular surface, in which the bacterial reversibly attach to the
surface [183]. Initial surface contact is often mediated by a variety of bacterial structures,
including flagella and pili. Upon contacting a surface, the bacterial cells undergo
irreversible adhesion and proceed to establish clusters or microcolonies. In
Pseudomonas, the formation of these bacterial clusters has been shown to involve
twitching motility, in which the bacteria utilize type IV pili-mediated gliding motility to
move across the attached surface [183]. The bacterial cells within the microcolonies
proliferate and produce an extracellular polymeric matrix that encapsulates the biofilm
cells. In the following stages, the microcolonies continue to mature and often develop
complex, organized structures. Research has revealed that biofilm structures often
exhibit intricate architecture, consisting of three-dimensional pillars and water channels
that permit nutrient and waste exchange [184]. The final stage of biofilm formation is
characterized by the dispersal of the biofilm-encased bacteria. The released bacterial
cells return to the planktonic lifestyle, and may proceed to colonize and re-initiate biofilm
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formation in a new niche. The dispersal from a biofilm may occur passively, as a
result of external physical forces that disrupt the biofilms, such as increased water flow.
Additionally, dispersal may involve regulated, active processes, such as the production of
enzymes that degrade the extracellular matrix.
Determinants of biofilm formation
Given the variety of environmental conditions under which bacteria exist, it is not
surprising that the mechanisms by which bacteria regulate and produce biofilms are also
diverse. However, research has revealed several key bacterial processes and products
that contribute to biofilm formation in many bacterial species. These include the use of
particular bacterial structures to promote interaction with and attachment to a surface and
the production of matrix components to encapsulate the attached cells. In the following
sections, I will provide a brief overview of several key determinants of biofilm formation.
Role of flagella and pili in biofilm formation
The initial stages of biofilm formation involve the transient attachment of
bacterial cells with a surface. Studies utilizing non-motile mutant strains either lacking
flagella or possessing paralyzed flagella revealed that flagella contribute to initial surface
attachment in a variety of bacteria [185,186,187]. It has been proposed that flagella-based
motility may allow bacterial cells to overcome the repulsive forces generated by surface
interaction [188]. Intriguingly, studies in other bacterial systems, such as Vibrio
cholerae, have demonstrated that flagella not only contribute to initial attachment, but
also play a role in later stages of biofilm formation. In particular, V. cholerae mot
mutants, which produce a paralyzed flagellum, fail to form rugose colonies indicative of
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biofilm formation. This failure to form biofilms can be attributed to the inability of
these mutant cells to produce an exopolysaccharide required for matrix production [189].
The authors of this study proposed that the flagellar rotation may therefore function to
both mediate motility and to signal the production of matrix components upon attachment
to a surface. In addition to flagella, pili have also been demonstrated to promote surface
attachment. Studies using mutants defective in pili production revealed a dramatic
impairment in bacterial adhesion to a surface, and thus these cells fail to initiate biofilm
formation [190]. Additionally, many bacteria have been shown to utilize retractable pili
to facilitate motility across a surface. Studies in the bacterium P. aeruginosa
demonstrated that type IV pili were required for twitching motility and the subsequent
aggregation of the surface-associated bacteria [191,192]. Together, these studies indicate
that bacteria utilize pili to promote multiple stages in biofilm formation.
Components of the biofilm extracellular matrix
The production of an extracellular matrix is a significant step in bacterial biofilm
formation. Matrix production has been shown to promote both biofilm development and
maintenance by contributing to cell-cell and/or cell-surface attachment.
Exopolysaccharides (EPS) represent a major component of most bacterial biofilm
matrices. The EPS composition generally varies among diverse bacterial species.
Furthermore, a bacterium may produce multiple types of EPS, which can contribute to
formation of distinct biofilms. For example, P. aeruginosa possesses three EPS loci,
which are involved in the production of three distinct types of EPS (termed alginate, Pel,
and Psl polysaccharides) [193,194]. Production of alginate, a polymer of β-1-4-linked
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mannuronic acid and guluronic acid, is involved in formation of a mucoid phenotype
commonly associated with P. aeruginosa isolates from cystic fibrosis (CF) patients, and
is proposed to contribute to persistence within the CF lung [195]. In contrast, lab strains
of P. aeruginosa are devoid of alginate and instead utilize the Pel and Psl EPS to form
biofilms. Analyses determined that the Pel polysaccharide contributes to the glucose-rich
matrix component, while the Psl polysaccharide contributes the mannose- and galactoserich matrix components [193]. Both the Pel and Psl EPS have been demonstrated to
contribute to cell-cell and cell-surface attachment [196].
In addition to EPS, proteins are a common component of most biofilm matrices.
Among the best-studied matrix proteins are curli fimbriae. Curli fimbriae are
proteinaceous surface appendages that contribute to matrix production and biofilm in
multiple organisms, including E. coli and P. aeruginosa. In E. coli, curli have been
demonstrated to function in both cell-cell and cell-surface adhesion [197]. P. aeruginosa
mutants defective in curli production exhibit impaired biofilm formation, suggesting that
curli are likely a component of the biofilm matrix [193].
Another common component of the biofilm matrix is extracellular DNA (eDNA).
Studies of P. aeruginosa biofilms revealed that eDNA is abundant within the biofilm
matrix, and likely contributes to the overall integrity and structure of the biofilm matrix.
In support of the role of eDNA in biofilm formation, studies demonstrated that DNase
treatment of P. aeruginosa cultures both inhibited biofilm formation and disrupted
previously formed biofilms [198]. The source of eDNA is generally chromosomal DNA,
which is proposed to be released through either cell lysis or secretion. Investigation into
	
  

	
  

	
  

75	
  

biofilm formation in Staphylococcus epidermidis found that eDNA was released into
the biofilm matrix through the activity of an autolysin, AtlE, which functions in cell wall
recycling and promotes cell lysis [199]. Together, these studies suggest that eDNA
release is an essential mechanism by which numerous organisms promote biofilm
formation.
Biofilm dispersal strategies
Dispersion of bacterial cells is a critical stage in the biofilm process, allowing the
bacteria to colonize new niches. Biofilm dispersal has been proposed to occur through
both passive mechanisms, as a result of environmental forces, and active, adaptive
processes. Bacteria have been shown to utilize multiple mechanisms to actively facilitate
biofilm dispersal. These include the secretion of enzymes that degrade the matrix
components. For example, P. aeruginosa secretes a lyase that degrades alginate and
promotes biofilm dispersal [200]. Recent studies of biofilms in the model organism B.
subtilis have identified additional bacterial-produced factors that promote dispersal. In
particular, B. subtilis produces both D-amino acids and norspermidine as molecular
triggers that disrupt essential matrix components [201,202]. Additional analyses
determined that D-amino acids induce the release of critical matrix proteins (amyloid
fibers)[202], while norspermidine collapses the EPS component of the matrix [201].
Together, these studies indicate that bacteria actively promote the disassembly of and
dispersal from biofilms.
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Conclusion
Biofilms play a critical role in the survival and persistence of bacterial cells
within the environment. The formation of a biofilm is a dynamic process, in which
bacterial cells tightly control both the assembly and disassembly of complex, multicellular communities. Although studies have identified many of the bacterial factors and
processes involved in biofilm formation, understanding the regulatory mechanisms
controlling biofilm formation remains an area of active research. A significant area of
research concerns understanding the roles biofilm formation plays during interaction of
bacteria with their respective eukaryotic hosts. Both pathogenic and non-pathogenic
bacteria have been shown to produce biofilms to facilitate colonization of host tissues and
provide protection from host-derived defenses and/or antimicrobials. Importantly, V.
fischeri has been demonstrated to produce a specific biofilm to initiate colonization of its
animal host E. scolopes. The V. fischeri-E. scolopes symbiosis therefore provides an
excellent model system to investigate the mechanisms by which bacteria control biofilm
production and the impact of biofilm formation on host colonization.	
  	
  
	
  
	
  

	
  

CHAPTER TWO
MATERIALS AND METHODS
Strains and Media. The bacterial strains used in this study are listed in Table 1. V.
fischeri strain ES114, an isolate from E. scolopes, was used as the parental strain
throughout this study [60]. V. fischeri derivatives were generated by conjugation, as
previously described [26]. E. coli strains Tam1 λ pir (Active Motif, Carlsbad, CA),
DH5α (Invitrogen, Carlsbad, CA), and GT115 (Invivogen, San Diego, CA) were used
for cloning and conjugative purposes. E. coli strains were routinely cultured in Luria
Bertani medium (LB) [203] or brain heart infusion medium (BHI) (Difco). For routine
culturing, V. fischeri strains were grown in complex medium Luria-Bertani salt (LBS)
[29]. For experimentation purposes, V. fischeri cells were occasionally grown in
complex Sea Water Tryptone (SWT) medium [21] or in HEPES minimal medium [HMM
[204]] containing 0.3% Casamino acids and 0.2% glucose [21]. The following antibiotics
were added to V. fischeri media, where necessary, at the indicated concentrations:
chloramphenicol (Cm) 2.5 µg mL-1, erythromycin at 5 µg mL-1, and tetracycline (Tc) at 5
µg mL-1 in LBS and 30 µg ml−1 in SWT. The following antibiotics were added to E. coli
media, where necessary, at the indicated concentrations: Cm at 25 µg/ml-1, kanamycin
(Kan) at 50 µg ml-1, Tc at 15 µg/ml-1, or ampicillin (Ap) at 100 µg ml-1. Agar was added
to a final concentration of 1.5% for solid media.
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Bioinformatics. Amino acid sequences of the B. subtilis 168 proteins (RsbW, RsbU,
RsbV, SpoIIAB, SpoIIE, SpoIIAA) and the B. bronchiseptica RB50 proteins (BtrU,
BtrV, BtrW) were obtained from the National Center for Biotechnology Information
(NCBI) database and the sequences of the V. fischeri ES114 SypA and SypE proteins
were obtained from the ERGO light database from Integrated Genomics
(http://www.ergo-light.com/ERGO). Amino acid sequence alignments of the SypA
proteins with the indicated B. subtilis and B. bronchiseptica proteins were generated
using the Clustal Omega multiple-sequence alignment program from EMBL-EBI
(http://ebi.ac.uk/Tools/msa/clustalo) [205].
Molecular and genetic techniques. The sypA and sypE alleles used in this study were
generated by PCR amplification using the primers listed in Table 3. PCR products were
cloned into mobilizable plasmids pVSV105 or pKV282 using standard molecular
techniques. For chromosomal insertion at the Tn7 site, the syp genes were subcloned into
the mini-Tn7 delivery vector pEVS107 [206]. For sypA Tn7 insertions, the sypA genes
were subcloned along with the upstream PsypA promoter. For Tn7-insertion of sypE, the
sypE genes were subcloned along with the upstream PlacZ promoter. The alleles were
inserted into the chromosomal Tn7 site of the indicated V. fischeri strains using a
tetraparental mating as previously described [206]. To generate site-directed mutations in
sypA and sypE, we utilized the QuikChange Site-Directed Mutagenesis Kit (Stratagene,
La Jolla, CA) using the primer Phos-lacZ-up-rev and select mutagenic primers (Table 3).
Generation of the desired mutations was confirmed by sequence analysis using the
Genomics Core Facility at the Center for Genetic Medicine at Northwestern University
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(Chicago, IL) and ACGT, inc (Wheeling, IL). FLAG and Hemagglutinin (HA)
epitope fusions to the C-terminus of SypE and SypA were generated by standard PCR
using the primers listed in Table 3. Analysis of the epitope tagged-syp alleles indicated
that the introduction of the epitopes impacted the activity of certain Syp proteins. In
particular, I found that introduction of a C-terminal HA tag impaired SypE regulatory
activity. I also observed that introduction of a C-terminal FLAG-epitope impaired SypA
phosphorylation by SypE in vivo, but not in vitro.
To construct the ΔsypA deletion, I used PCR to amplify and clone sequences
approximately 2 kb upstream and downstream of sypA into the pJET1.2 cloning vector
and subsequently plasmid pEVS79 [207]. I then ligated these fragments to form a
plasmid, pARM37, which was subsequently used to introduce the ΔsypA deletion into V.
fischeri strains as previously described [27]. Colony PCR analysis was performed to
confirm deletion of sypA.
To restore wild-type sypA or insert the mutant sypA allele at the native locus, I
generated plasmids pARM135 and pARM160, which contained 750 bp upstream and 500
bp downstream of sypA and sypAS56A, respectively.

The sypA genes and flanking

sequences were confirmed by sequence analysis using ACGT, inc (Wheeling, IL). I
introduced the plasmids into the recipient strain [KV4716] by conjugation and isolated
stably Cm resistant (cmR) colonies, indicating integration of the sypA suicide construct
into the chromosome. Stable cmR colonies were then cultured in LBS containing 0.2%
arabinose to induce expression of the ccdB toxin gene, and plated onto LBS agar plates
containing 0.2% arabinose. Arabinose induction selects for those cells that have
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undergone a second recombination event, resulting in excision of the suicide plasmid
and either restoration of the original ΔsypA allele or replacement with the wild-type or
sypAS56A allele. Colony PCR was performed to identify those colonies containing the
restored sypA allele.
Wrinkled colony formation assay. To observe wrinkled colony formation, the
indicated V. fischeri strains were streaked onto LBS agar plates containing the necessary
antibiotics. Single colonies were then cultured with shaking in LBS broth containing
antibiotics overnight at either 24°C (for rscS overexpressing strains) or 28°C (for sypG
overexpressing strains). The strains were then sub-cultured the following day to an
OD600 of 0.1 in 5 mL of fresh medium. Cells were spun down, washed twice in 70%
artificial seawater (ASW) (280 mM MgSO4, 56 mM CaCl2, 1.68 M NaCl, 56 mM KCl),
and re-suspended in 70% ASW and diluted to an OD of 0.1. 10 µL of re-suspended
cultures were spotted onto LBS agar plates, containing necessary antibiotics, and grown
for 48 h at either ~ 24°C (for rscS overexpressing strains) or 28°C (for sypG
overexpressing strains). Images of the spotted cultures were acquired at the indicated
time points using the Zeiss stemi 2000-C dissecting microscope. For RscS-induced
wrinkling time course assays, spot development was followed over a course of 48 h and
images taken at indicated time points [208].
Pellicle formation assay. The indicated V. fischeri strains were grown with shaking in
either HMM or LBS containing necessary antibiotics. Cultures were grown at either 24°C
(for rscS overexpressing strains) or 28°C (for sypG overexpressing strains) overnight, and
then subcultured the next day to an OD of 0.1 in 1.5 mL of fresh medium in 24-well
	
  

	
  

81	
  

microtiter dishes. Cultures were then grown statically at ~ 24°C (for rscS
overexpressing strains) or 28°C (for sypG overexpressing strains) for 48 h. The strength
of each pellicle was qualitatively evaluated by disrupting the air-liquid interface with a
sterile pipette tip after 48 h of incubation. A pellicle is observed as a disruption at the
culture surface. Cultures with no observable pellicle were scored as (-); cultures with an
intermediate/weak pellicle were scored as (+); cultures with a strong pellicle that was
able to be lifted from the culture intact were scored as (++).
Confocal microscopy. The indicated V. fischeri strains expressing green fluorescent
protein (GFP) were grown statically in HMM containing Tc in 12 well microtiter plates
with glass cover slips partially submerged into the culture medium. Cover slips were
incubated with bacteria at room temperature for 24 h and removed for biofilm
examination. A Zeiss LSM 510 confocal microscope (40X objective) was used to collect
xy plane and z sections (xz and yz plane) images of the biofilms. Representative images
were prepared using the Zeiss LSM Image Browser software.
Symbiont aggregation assays. Log-phase cells (OD600 0.3 to 0.6) were grown in 2 ml
SWT medium at 22°C. Bacterial cells were then inoculated into filtered ASW at a
concentration of 106 cells per ml. Juvenile squid were then placed into inoculated
seawater and the two organisms were allowed to associate at room temperature for 3 h
prior to dissection. The juvenile squid were removed to vials containing 2 ml filtersterilized seawater and 5 µM of the counter-stain, CellMask (Invitrogen, Eugene, OR).
The animals were then anesthetized in filtered artificial seawater containing 2% ethanol.
Each squid was placed ventral side up on a depression well slide and dissected to remove
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the mantle and funnel and expose the light organ. Fluorescently labeled light organs
(blue) and GFP-labeled (green) bacteria were viewed using a Zeiss LSM 510 confocal
microscope.
Symbiotic colonization assays. Colonization assays were performed using the indicated
V. fischeri strains. To perform single-strain colonization assays, juvenile squid were
placed into artificial seawater (ASW) (Instant Ocean; Aquarium Systems, Mentor, OH)
containing roughly 1,000-1,500 V. fischeri cells per mL of seawater. Colonization assays
were allowed to proceed for 16-18 h post inoculation, at which time the animals were
washed twice in ASW and homogenized to release the light organ contents. Serial
dilutions of the light organs were plated and colony-forming units (CFU) calculated. For
competitive colonization assays, juvenile squid were placed into ASW containing
approximately 1,000 V. fischeri cells per mL of seawater. Juvenile squid were inoculated
with an approximate 1:1 ratio of mutant and wild-type cells, and colonization was
allowed to proceed for 18 h. For these assays, one strain was marked with an
erythromycin resistance (EmR) cassette within the chromosome at the Tn7 site.
Reciprocal experiments were also performed in which the other strain carried the EmR
marker. The ratio of bacterial strains within the light organs of the animals was assessed
through homogenization/plating assays as described previously [20]. The competitive
colonization data are reported as the log-transformed relative competitive index (Log
RCI). This index is generated by dividing the ratio of mutant to wild-type in the
homogenate by the ratio present in the inoculum and calculating the log10 value of that
number.
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β-galactosidase assays. The indicated V. fischeri strains that contained the PsypAlacZ reporter fusion were grown (in triplicate) with shaking in LBS containing the
necessary antibiotics at either 24°C (for rscS overexpressing strains) or 28°C (for sypG
overexpressing strains). The following day, the strains were sub-cultured into fresh
medium and grown with shaking for up to 24 h. Aliquots (1 mL) of cells were removed
at 8 h and 24 h post-inoculation, concentrated, resuspended in Z-buffer, and lysed. The
β–galactosidase activity [209] and total protein concentration [210] of each sample were
assayed. β–galactosidase units are reported as units of activity per mg of protein.
Co-Immunoprecipitation of SypE and SypA proteins. The plasmids SypA-HA
ΔNTD

(pARM36) and SypE-FLAG (pARM80), SypENTD-FLAG (pARM136), SypE

–

FLAG (pARM162), or the appropriate empty control vectors, were introduced by
conjugation into ΔsypA ΔsypE V. fischeri cells. Bacterial strains were cultured in LBS
containing Tc and Cm at 28 °C overnight with shaking and subsequently sub-cultured to
an OD600 of 0.5. Cells (~0.10 g) were harvested by centrifugation (13,000 x g for 10 min),
and washed in 1 mL of phosphate-buffered saline (PBS). Samples were subsequently
prepared and immunoprecipitated using the Dynabeads Co-immunoprecipitation Kit
(Invitrogen, Oslo, Norway). Cell samples were re-suspended and lysed in 900 uL of
Extraction Buffer (EB) (1X IP buffer, 100 mM NaCl, 1 mM DTT) (Invitrogen, Oslo,
Norway). Rabbit anti-FLAG and anti-HA antibodies (25 µg, Sigma-Aldrich, St. Louis,
MO) were coupled to magnetic Dynabeads (5 mg, Invitrogen) according the
manufacturer’s protocol. As a negative control, dynabeads (1.5 mg) were coupled with
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non-specific mouse anti-rabbit IgG antibody (5 µg, Promega). For the coimmunoprecipitation, antibody-coupled beads were incubated with 900 µL of whole cell
extracts at 4°C with rocking for 1 h. Eluted samples were diluted with sample buffer and
resolved using SDS-PAGE. Samples were then transferred to PVDF membrane and
proteins were detected using rabbit anti-FLAG and anti-HA antibodies followed by a
HRP-conjugated secondary antibody.
Purification of SypA and SypE proteins. Wild-type and mutant sypE and sypA-FLAG
genes were PCR amplified using the primers listed in Table 3, and subsequently cloned
into the GST-fusion vector pGEX-5X-1 (Amersham Biosciences) to generate N-terminal
glutathione-S-transferase (GST) fusions (Table 2). The resulting plasmids were
transformed into E. coli Tam1 cells. E. coli cultures were grown at 28°C to an OD600 of
0.5 and overexpression of the GST-fusion proteins was induced by the addition of 0.4
mM IPTG followed by further culturing overnight. Cells were harvested by
centrifugation (10,000 x g) and resuspended and lysed in BugBuster protein extraction
reagent (Novagen, EMD Chemicals Inc, San Diego, CA). The resuspended cells were
incubated with rocking at room temperature for 20 mins and subsequently diluted in
resuspension buffer (50 mM Na2HPO4, 1 M NaCl, 0.1% Tween-20, pH 8.0). Samples
were centrifuged (12,000 x g) and the soluble supernatants applied to a Glutathione
Sepharose 4B column (GE Healthcare, Piscataway, NJ), washed with cold 1X PBS, and
the bound proteins were eluted by the addition of glutathione elution buffer (10 mM
reduced glutathione, 50 mM Tris-HCl, pH 8.0). Eluted proteins were dialyzed using
Slide-A-Lyzer dialysis cassettes in storage buffer (50% glycerol, 10 mM Tris-HCl, 100
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mM KCl, 10 mM MgCl2, 1 mM dithiothreitol [DTT], 0.1 mM EDTA) (10 K MWCO,
Thermo Scientific). Following dialysis, the concentration of purified protein was
determined using a standard lowry assay.
To obtain purified phosphorylated SypA (SypA~P), E. coli GT115 cells were cotransformed with the GST-SypA-FLAG plasmid (pARM157) and either plasmid
pCLD64 expressing only the N-terminal kinase domain of SypE or empty vector
pVSV105. Overexpression and purification of the proteins was performed as described
above.
Western blot analysis of V. fischeri cell lysates
The indicated V. fischeri strains were cultured in LBS containing the appropriate
antibiotics overnight at either 24 °C (for rscS-expressing strains) of 28 °C (for sypGexpressing strains). 1 mL of cell cultures were spun down and cells lysed in 500 µL 2X
sample (4% SDS, 40 mM Tris pH 6.3, 10% glycerol) buffer. Samples were resolved on
10-15% SDS-PAGE gels (10% 29:1 acrylamide: N, N’-methylene-bis-acrylamide, 375
mM Tris pH 8.6, 0.1% SDS), and transferred to PVDF membranes. The indicated Syp
proteins were detected by western blot analysis using either a rabbit anti-FLAG antibody
or rabbit anti-HA antibody (Sigma-Aldrich, St. Louis, MO) followed by a secondary,
donkey anti-rabbit IgG antibody (Sigma-Aldrich, St. Louis, MO) conjugated to
horseradish peroxidase (HRP), and visualized using SuperSignal West Pico
Chemiluminescent Substrate (Thermo Fischer Scientific, Rockford, IL).
in vitro kinase assay. Purified GST-SypA containing a C-terminal FLAG epitope tag
(either wild-type SypA or SypAS56A; 1 µg) was incubated at 28°C for 10 min in
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phosphorylation buffer (50 mM Tris-HCl, pH 7.5, 50 mM KCl, 5 mM MgCl2, 1 mM
DTT, 0.1 mM EDTA) in the presence or absence of 2 mM ATP (ATP Disodium,
Trihydrate; Fischer Scientific, Fairlawn, NJ).. Purified wild-type GST-SypE (2 µg) was
added to the reactions and the samples incubated for an additional 30 min. Reactions
were terminated by the addition of sample buffer and proteins were resolved on 10%
SDS-PAGE gels containing 20-30 µM Phos-tagTM acrylamide (WAKO chemicals,
Richmond, VA) and 40-60 µM MnCl2. Gels were fixed for 15 min in standard transfer
buffer (20% MeOH, 50 mM Tris, 40 mM glycine) containing 1 mM EDTA to remove
Mn2+ from the gel. Gels were incubated for an additional 20 min in transfer buffer
without EDTA. Proteins were transferred to a PVDF membrane and detected by western
blot analysis using an anti-FLAG antibody (Sigma-Aldrich).
in vitro phosphatase assay. Phosphorylated SypA protein (SypA~P) was purified from
E. coli cells co-expressing the N-terminal kinase domain of SypE (SypENTD). To confirm
the phosphorylation state of the purified protein, samples were analyzed using PhosTagTM acrylamide SDS-PAGE coupled with anti-FLAG western blotting, as described
earlier. For the phosphatase assay, purified SypA~P was preincubated alone in
phosphatase buffer (50 mM Tris-HCl, 10 mM NaCl, 10 mM MgCl2, 1 mM DTT) at
28°C, followed by the addition of increasing concentrations of purified SypECTD protein.
Samples were incubated at 28°C for an additional 30 min and the reactions were
terminated by the addition of 2X SDS sample buffer. To assess the phosphorylation state
of SypA, samples were analyzed using Phos-TagTM acrylamide SDS-PAGE coupled with
anti-FLAG western blot analysis as described for the in vitro kinase assay.
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Assessment of SypA phosphorylation in vivo. The indicated V. fischeri strains were
cultured overnight with shaking in LBS containing the appropriate antibiotics at either
24°C (for rscS overexpressing strains) or 28 °C (for sypG overexpressing strains).
Aliquots of cells (1 mL) were spun down, washed twice with 1X PBS, and standardized
to the same amounts using OD600 measurements. Samples were lysed in 2X SDS sample
buffer and resolved on SDS-PAGE gels containing 25-30 µM Phos-tagTM acrylamide
(WAKO chemicals, Richmond, VA) and 50-60 µM MnCl2. Gels were fixed for 15 min in
standard transfer buffer containing 1 mM EDTA, and then incubated an additional 20 min
in transfer buffer without EDTA. Proteins were transferred to a PVDF membrane and the
proteins were detected by western blot analysis using an anti-HA antibody (SigmaAldrich, St. Louis, MO).
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Table 1. Bacterial strains used in this study
Strains	
  
	
  E.

Relevant Genotype

Reference

coli

DH5α	
  

endA1 hsdR17 (rK- mK+) supE44 thi-1 recA1 relA Δ(lacIZYA-argF)U169 phoA
[φ80dlacΔ(lacZ)M15]

TAM1 λ	
  pir	
  

mcrA Δ(mrr-hsdRMS-mcrBC) Φ80Δ(lacZ)M15 ΔlacX74 recA1 araD139 Δ(ara-leu)7697
galU galK rpsL endA1 nupG attλ::pir+

GT115

F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 endA1 Δdcm
uidA(ΔMluI)::pir-116 ΔsbcC-sbcD

Invitrogen
Active Motif
InvivoGen

V. fischeri
ES114

Wild-type V. fischeri

[60]

KV3246

ES114 attTn7::PsypA-lacZ

[211]

KV3299

ΔsypE	
  

[27]

KV4366

glpR-rscS::Tn5 (Cm)

KV4389

ES114 attTn7::erm

[212]

KV4390

ΔsypE attTn7::erm	
  

[212]

KV4715

ΔsypA

[213]

KV4716

ΔsypA ΔsypE

[213]

KV4819

ΔsypE attTn7:: PlacZ-sypE+ (erm)	
  

[212]

KV4885

ΔsypE attTn7:: PlacZ-sypED192A (erm)	
  

[212]

KV4886

ΔsypE attTn7:: PlacZ-sypED443A (erm)	
  

[212]

KV4887

ΔsypE attTn7:: PlacZ-sypE D495A (erm)	
  

[212]

KV4925

ΔsypA attTn7::PsypA-lacZ (erm)

This Study

KV4926

ΔsypE attTn7::PsypA-lacZ (erm)

[211]

KV5079

ΔsypA attTn7::erm

[213]

KV5124

ΔsypE attTn7:: PlacZ-sypEΔNTD (erm)	
  

[212]

KV5129

ΔsypE attTn7:: PlacZ-sypENTD (erm)	
  

[212]

KV5142

ΔsypE attTn7:: PlacZ-sypEN52A (erm)	
  

[212]

KV5143

ΔsypE attTn7:: PlacZ-sypENTD, N52A (erm)	
  

[212]

KV5204

ΔsypE attTn7:: PlacZ-sypECTD (erm)	
  

[212]

Source: Mark
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KV5205

ΔsypE attTn7:: PlacZ-sypEN52A, D192A (erm)	
  

[212]

KV5314

ΔsypE attTn7:: PlacZ-sypECTD, D443A (erm)	
  

[212]	
  

KV5315

ΔsypE attTn7:: PlacZ-sypEΔCTD (erm)	
  

[212]	
  

KV5345

ΔsypE attTn7:: PlacZ-sypECTD, D495A (erm)	
  

[212]	
  

KV5379

ΔsypE attTn7:: PlacZ-sypEN52A, D443A (erm)	
  

[212]	
  

KV5479

ΔsypA attTn7:: sypA+ (erm R)

[213]	
  

KB5480

ΔsypA attTn7:: sypAS56D (erm)

[213]	
  

KV5481

ΔsypA attTn7:: sypAS56A (erm)

[213]	
  

KV6205

ΔsypE (sypA+)

[213]	
  

KV6206

ΔsypE sypAS56D

[213]	
  

KV6213

ΔsypE (sypA+) attTn7:: sypE+ (erm)

[213]	
  

KV6214

ΔsypE (sypA+) attTn7:: sypED192A (erm)

[213]	
  

KV6215

ΔsypE	
  sypAS56A attTn7:: sypE+ (erm)

[213]	
  

KV6216

ΔsypE sypAS56A attTn7:: sypED192A (erm)

[213]	
  

KV6392

ΔsypA ΔsypE attTn7:: erm R

[213]	
  

KV6393

ΔsypA	
  ΔsypE attTn7:: sypA+ (erm)

[213]	
  

KV6424

ΔsypA	
  ΔsypE attTn7:: sypE+ (erm)

[213]	
  

KV6425

ΔsypA	
  ΔsypE attTn7:: sypED192A (erm)

[213]	
  

KV6578

ΔsypA attTn7:: sypA-HA (erm R)

[211]

KV6579

ΔsypA attTn7:: sypAS56A-HA (erm R)

[211]

KV6580

ΔsypA ΔsypE attTn7:: sypA-HA (erm R)

[211]
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Table 2. Plasmids used in this study
Plasmid	
  
pARM3	
  

Relevant	
  Genotype	
  

Reference	
  
This	
  Study	
  

pVSV105 containing 1.2 kb sypEΔNTD

pARM4	
  

pVSV105 containing 1.5 kb sypEN52A

pARM7	
  

EcoRI partial digest of pKG11 (rscS1); tetR

[212]	
  

pARM9	
  

pVSV105 containing 1.7 kb sypG

[213]	
  

pARM13	
  

pKV282 containing 770 bp sypA (EcoR1 partial digest of pJLE4)

[213]	
  

pARM25	
  

pKV282 containing 770 bp sypAS56D

[213]	
  

pARM29	
  

pKV282 containing 770 bp sypAS56A

[213]	
  

pARM35	
  

pKV282 containing 770 bp sypA-FLAG

[213]	
  

pARM36	
  

pKV282 containing 770 bp sypA-HA

[213]	
  

pARM37	
  

pEVS79 containing 2.3 kb sequences flanking sypA

[213]	
  

pARM47	
  

pEVS107	
  containing	
  1.5	
  kb	
  sypE	
  

[212]	
  

pARM54	
  

pEVS107	
  containing	
  1.5	
  Kb	
  sypED192A	
  

[212]	
  

pARM55	
  

pEVS107	
  containing	
  1.5	
  Kb	
  sypED443A	
  

[212]	
  

pARM56	
  

pEVS107	
  containing	
  1.5	
  Kb	
  sypED495A	
  

[212]	
  

pARM68	
  

pVSV105	
  containing	
  4	
  Kb	
  sypE-sypF	
  

This	
  Study	
  

pARM77	
  

pKV282 containing 770 bp sypAS56D-FLAG

[213]	
  

pARM78	
  

pKV282 containing 770 bp sypAS56A-HA

[213]	
  

pARM79	
  

pKV282 containing 770 bp sypAS56A-FLAG

[213]	
  

	
  pARM80	
  

pVSV105 containing 1.5 kb sypE-FLAG

[212]	
  

pARM81	
  

pEVS107	
  containing	
  1.2	
  Kb	
  sypEΔNTD	
  

[212]	
  

pARM82	
  

pEVS107	
  containing	
  700	
  bp	
  sypECTD	
  

[212]	
  

pARM89	
  

pEVS107	
  containing	
  500	
  bp	
  sypENTD	
  

[212]	
  

pARM90	
  

pEVS107	
  containing	
  1.5	
  Kb	
  sypEN52A	
  

[212]	
  

pARM91	
  

pEVS107	
  containing	
  500	
  bp	
  sypENTD,	
  N52A	
  

[212]	
  

pARM101	
  

pEVS107	
  containing	
  1.5	
  Kb	
  sypEN52A,	
  D192A	
  

[212]	
  

pARM109	
  

pEVS107	
  containing	
  700	
  bp	
  sypECTD,	
  D443A	
  

[212]	
  

This	
  Study	
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pARM110	
  

pEVS107	
  containing	
  1.0	
  Kb	
  sypEΔCTD	
  

[212]	
  

pARM112	
  

pEVS107	
  containing	
  700	
  bp	
  sypECTD,	
  D495A	
  

[212]	
  

pARM125	
  

pEVS107	
  containing	
  1.5	
  Kb	
  sypEN52A,	
  D443A	
  

[212]	
  

pARM131	
  

pEVS107 containing sypA

[213]	
  

pARM132	
  

pEVS107 containing 1.1 kb sypAS56D

[213]	
  

pARM133	
  

pEVS107 containing 1.1 kb sypAS56A

[213]	
  

pARM134	
  

pJET1.2 containing 1.5 kb sypA and flanking sequences

[213]	
  

pARM135	
  

pKV363 containing 1.5 kb sypA and flanking sequences

[213]	
  

pARM136	
  

pVSV105 containing 500 bp sypENTD-FLAG

[213]	
  

pARM141	
  

pGEX-5X-1 containing 1.5 kb sypE

[213]	
  

pARM152	
  

pGEX-5X-1 containing 700 bp sypECTD

[213]	
  

pARM157	
  

pGEX-5X-1 containing 350 bp sypA-FLAG

[213]	
  

pARM158	
  

pGEX-5X-1 containing 350 bp sypAS56A-FLAG

[213]	
  

pARM160	
  

pKV363 containing 1.5 kb sypAS56A and sequences flanking native sypA

[213]	
  

pARM162	
  

pVSV105 containing 1.2 kb sypEΔNTD-FLAG

[213]	
  

pCLD46	
  

pVSV105 + 2.7 kb rscS1

[212]	
  

pCLD48	
  	
  

pVSV105 containing 1.5 kb sypE+

[27]	
  

pCLD56	
  

pKV282 containing 1.7 kb sypG

pCLD64	
  

pVSV105 containing 400 bp sypENTD

pCLD65	
  

pVSV105 containing 400 bp sypENTD, N52A

This	
  Study	
  

pCLD67	
  

pVSV105 containing 670 bp sypECTD

This	
  Study	
  

pEVS104	
  

Conjugal	
  helper	
  plasmid	
  (tra	
  trb),	
  KanR	
  

[207]	
  

pEVS107	
  

Mini-‐Tn7	
  delivery	
  plasmid;	
  oriR6K,	
  mob;	
  KanR,	
  EmR	
  

[206]	
  

pGEX-‐5X-‐1	
  

GST tag protein expression vector, ApR

Amersham	
  
Biosciences	
  

pJET1.2	
  

Commercial cloning vector; ApR

Fermentas	
  

pKV282	
  

Mobilizable vector; TetR

[212]	
  

pVSV105	
  

Mobilizable vector, R6Kori ori(pES213) RP4 oriT cat

[214]	
  

This	
  Study	
  
[212]	
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Table 3. Oligonucleotides used in this study
Gene/Promoter
Sequence (5’-3’)
	
  

Primer
	
  

	
  
TTTTTCTGCACTTATTGATTCTCAATTAACAGC

256	
  

ORF	
  1021	
  R	
  

GGTTGACAGGTTTCTTGGCG

423	
  

VFA1023infR	
  

CATATGGCACGATGGGATCC

461	
  

GTCCAAAGAAACCGATTTTTATC

462	
  

CTGCAGTTCCATAATAAGCTCCTAGG

798	
  

CTGCAGCATTAATTAGTGCAAAACACC

799	
  

TTTTTTGGATCCCCTGATTCTTGAGCATTAC

800	
  

CAGGAACGAAAATCGCATC

801	
  

sypA-‐F	
  

AGCTTCTTCCTTATAGTTATGATG

806	
  

sypA-R	
  

ATGTGTCATACAGTTAAAATGGTG

807	
  

CCTGTGTGAAATTGTTATCCG

849	
  

sypE-‐R	
  

sypE-‐F	
  
VFA1020R	
  
VFA1020stopR	
  
VFA1019R	
  
VFA1022intR	
  

Phos-‐lacZ-‐R	
  
sypE

ΔNTD

-‐F	
  

GTGGTGTAATCATGGAGCGTTCCCCTTCCCAT

868	
  

sypED192A	
  

GATTTAATTATCTCAGCTATTCAAATGCCTGAA

875	
  

sypE

	
  

TCTGAATGGAGCACCGCTCTAGTTTTGCACCCT

876	
  

N52A

sypAS56A	
  

GTAGCCTTTTTAGATGCGTCAGGTATTGGCGCT

877	
  

sypAS56D	
  

GTAGCCTTTTTAGATGACTCAGGTATTGGCGCT

878	
  

sypE

GTGGTGTAATCATGGCCCATACTCTATTACCACAA

910	
  

sypENTD-‐R	
  

CTTAATGGGAAGGGGAACGCTC

911	
  

sypE

D192E	
  

GATTTAATTATCTCAGAGATTCAAATGCCTGAA

914	
  

sypE

	
  

TTAGCATTATTTACTGCTGGGTTATTTGAATCA

915	
  

CTD

-‐F	
  

D443A

sypED495A	
  
sypE-‐	
  FLAG-‐R	
  
VFA1019-‐PstI-‐R	
  
sypA

S56A,	
  S57A	
  

HA-sypA-‐R	
  
FLAG-‐sypA-‐R	
  
sypENTD-‐FLAG-‐R	
  

GGGACACCACCCAATGCCGATGCATTATTGCTG
ACCCGGGTTATTTATCATCATCATCTTTATAATCTTGATTCTCA
ATTAACAG
CTGCAGTGTTTTATCCGAAGGTAACCC
GTAGCCTTTTTAGATGCGGCGGGTATTGGCGCTATT
ACCCGGGTTATGCATAATCTGGAACATCATATGGATAATGCGTT
GTTTTATTAACAGG
ACCCGGGTTATTTATCATCATCATCTTTATAATCATGCGTTGTTT
TATTAACAGG
ACCCGGGTTATTTATCATCATCATCTTTATAATCATGGGAAGGG
GAACGCTC

916	
  
921	
  
935	
  
976	
  
1040	
  
1041	
  
1043	
  

CAAATAGACATTATTGCTGATGCTATACCTTGGGATCCA

1301	
  

CATATCTTAATTGTTGAAAAGGATGCAATTCAATCAAAG

1302	
  

sypA-‐GST-‐F	
  

AAAGATCTTGGAACTACATCAATTCGAATCAAATG

1474	
  

sypE-‐GST-‐F	
  

AAAGATCTTGAATTCTACTTTACTTTTTTCAG

1475	
  

AAAGATCTTGGCCCATACTCTATTACCACAAG

1477	
  

sypED81A,G83A	
  
sypE

sypE

D150K

CTD

	
  

-GST-‐F	
  

	
  

CHAPTER THREE
EXPERIMENTAL RESULTS
SypE: A DUAL REGULATOR OF BIOFILMS AND SYMBIOTIC
COLONIZATION
Introduction
Biofilm regulation in V. fischeri involves a number of putative and characterized
regulatory proteins. Several of these regulators function to control the expression of the
syp biofilm locus, predicted to be involved in polysaccharide synthesis and export (Fig.
1)[21]. The syp locus is required for both biofilm formation and efficient host
colonization [21]. The syp locus is regulated at the transcriptional level by a twocomponent signaling (TCS) system consisting of the histidine sensor kinase (HK) RscS
and the syp-encoded response regulator (RR) SypG (Fig. 3) [20,27].
In addition to SypG, the syp locus encodes a second putative RR, SypE. The
SypE protein is unusual both in its structure and in its apparent function in biofilm
regulation and symbiosis. Bioinformatic analysis predicts a novel, multi-domain RR
with the regulatory REC domain in a central position flanked by two terminal effector
domains of putative opposing function: an N-terminal RsbW-like serine kinase and a Cterminal PP2C-like serine phosphatase domain. The presence of a central REC domain
flanked by two effector domains of apparent opposing functions distinguishes SypE as a
unique RR with a novel domain architecture.
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Previous studies identified SypE as a potential regulator of V. fischeri biofilms.
Hussa et al. (2008) demonstrated that overexpression of rscS in a strain lacking sypE
resulted in slightly diminished biofilm phenotypes, indicated by a decrease in wrinkled
colony formation relative to wild-type cells overexpressing rscS. These results suggested
a positive regulatory role for SypE. In contrast, SypE strongly inhibited biofilms induced
by SypG: sypG overexpression in wild-type cells did not lead to wrinkled colony or
pellicle formation, while its overexpression in a ΔsypE strain induced robust biofilms
similar to that of an rscS-overexpressing wild-type strain [27]. These initial studies
suggested that under distinct signaling conditions SypE may function to either negatively
or positively impact syp-dependent biofilm production. However, the mechanism by
which SypE exerts dual control over biofilm formation remained unclear. Additionally,
the relevance of SypE during symbiotic colonization had yet to be investigated.
To further assess the mechanisms by which V. fischeri regulates symbiotic biofilm
formation and host colonization, I chose to characterize the regulatory role of SypE in
syp-dependent biofilm formation. I hypothesized that SypE plays a novel role as a dual
regulator of biofilm formation, and that these opposing activities are mediated by the
activity of the protein’s terminal effector domains. I further reasoned that SypE’s
opposing regulatory activities must be controlled to permit biofilm formation and host
colonization. To investigate the regulatory role of SypE, I performed a structure-function
analysis of the SypE protein. Using a complementation approach, I assessed the potential
contribution of the individual SypE domains to the regulation of syp-dependent biofilm
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formation. Finally, I assessed the relevance of SypE’s regulatory activities during
symbiotic colonization of E. scolopes.
Impact of SypE on RscS induced biofilm phenotypes
To better understand the putative role of SypE as a regulator of syp biofilms, I
first examined the impact of sypE deletion on biofilm phenotypes induced by
overexpression of rscS. Deletion of sypE was previously shown to reduce the ability of
rscS overexpression to induce biofilm formation [27]. To better assess this subtle
phenotype, I examined biofilm development over time by wild-type (WT) and ΔsypE
mutant cells containing the rscS-expressing plasmid, pARM7 (pRscS) or the empty
vector (pKV282). In addition, to verify that any phenotypes of the ΔsypE mutant were
due to the loss of sypE, and were not the result of a polar effect on downstream genes, I
complemented the sypE null strain with a wild-type sypE allele (sypE+) inserted in the
chromosome at the Tn7 integration site. As a control, I inserted an empty Tn7 cassette
(EC) at the same site.
First, I evaluated the formation of wrinkled colonies and found that rscSexpressing wild-type cultures consistently exhibited wrinkled colony morphology within
14 h of growth, while a ΔsypE mutant consistently exhibited a 4-6 h delay, initiating
wrinkled colony formation at18-20 h post-spotting (Fig. 10A). As expected, vectorcarrying cells never formed wrinkled colonies (Fig. 10A). Complementation with wildtype sypE at the Tn7 site of a ΔsypE mutant fully restored the wild-type timing and
pattern of RscS-induced wrinkled colony development (Fig. 10A). At a late (48 h) time
point, all the strains exhibited a similar degree of wrinkled colony morphology, indicating
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that deletion of sypE results in a delay in RscS-induced wrinkled colony development.
Second, I evaluated the production of pellicles over time. When grown statically
in HEPES minimal medium (HMM), rscS-expressing wild-type cells produced a
structured pellicle at the air-liquid interface within 24 h of incubation, while vector
control cells failed to form any observable pellicle (Fig. 10B). The ΔsypE strain formed a
diminished pellicle at 24 h that was easily disrupted [27](Fig. 10B). To quantify this
subtle decrease in pellicle formation, I assessed by confocal microscopy pellicle biofilms
produced by wild-type and ΔsypE strains overexpressing both rscS and GFP at 24 h post
inoculation. rscS-expressing wild-type cells exhibited increased pellicle attachment
relative to vector-containing cells, with an average biofilm thickness of 15 (+/- 2) and 4
(+/- 1) µm, respectively (Fig. 10C). Compared to wild-type cells, the ΔsypE mutant
strain consistently exhibited a 50% reduction in RscS-induced pellicle attachment with an
average biofilm thickness of 8 (+/- 1) µm (Fig. 10C). Complementation with sypE+
restored the average biofilm thickness to 13 (+/- 1) µm (Fig. 10B and C). These results
confirm that loss of sypE impairs the development of biofilm formation, and support the
hypothesis that under RscS-overexpressing conditions SypE exerts positive regulatory
activity.
SypE domains and mutant library construction
I hypothesized that the ability of SypE to exert dual regulatory control over
biofilm formation may be mediated by the protein’s terminal, effector domains. To better
understand the mechanism by which SypE exerts dual control over syp biofilm formation,
I performed a BLAST bioinformatic analysis of the individual SypE domains. I
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Figure 10. Impact of SypE on RscS-induced biofilms. (A) Time course of wrinkled
colony formation. Cultures of the following strains were spotted onto LBS medium and
colony morphology was assessed over a 48 h period: wild-type (WT) cells containing the
empty Tn7 cassette (EC) [KV4389] and carrying RscS plasmid pARM7 or vector control
(pKV282); ΔsypE cells carrying pARM7 and containing either EC [KV4390] or
complemented with sypE+ [KV4819]. Black bar represents 2 mm. (B) Pellicle formation
in static culture. The following strains were grown in HMM in 24-well plates for 48 h:
WT cells containing EC [KV4389] and carrying the vector control pKV282 or pARM7;
pARM7-carrying ΔsypE containing EC [KV4390] or complemented with sypE+
[KV4819]. A pipette tip was dragged over the surface of the air-liquid interface to
visualize the pellicle, and relative pellicle strength was determined (C) Confocal
microscopy of pellicles. Pellicle attachment to glass cover slips was visualized via
confocal microscopy at 24h post inoculation. Representative views of the xy plane and z
sections are shown for GFP-labeled derivatives of the strains described in panel B. White
arrows indicate the air-liquid interface. Photographs are representative of at least 3
independent experiments.
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Figure 11. SypE domain structure and sequence alignments. (A) SypE contains a
central receiver (REC) domain flanked by a putative N-terminal RsbW-like serine kinase
domain and a putative C-terminal PP2C-like serine phosphatase domain. (B) Sequence
alignments of SypE’s N-terminal domain with the serine kinases RsbW and SpoIIAB
from B. subtilis and BtrW from B. bronchiseptica. (C) Sequence alignments of SypE’s
C-terminal domain with the serine phosphatases RsbU and SpoIIE from B. subtilis and
BtrU from B. bronchiseptica. Conserved residues within the individual domains are
indicated (see text for details).
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Figure 12. SypE domain mutants. Representations of the various SypE domain mutants
generated in this study are presented above. See text for a full description.
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subsequently used the CLUSTAL OMEGA software to generate multiple sequence
alignments of the SypE terminal domains with the predicted orthologous proteins [205].
These alignments were subsequently used to identify conserved residues within SypE’s
domains to target for mutagenesis (Fig. 11).
Bioinformatic analyses indicated that the terminal effector domains of SypE share
sequence similarity with serine kinase and serine phosphatases commonly found in
partner switching regulatory systems. Specifically, the N-terminal domain of SypE
exhibits sequence similarity to HPK-like serine kinases of the Gyrase, Hsp90, histidine
kinase, MutL (GHKL) superfamily [133]. Further analysis revealed that SypE’s Nterminal domain is most similar to a class of serine kinases/anti-sigmas, including RsbW
and SpoIIAB of Bacillus subtilis and BtrW of Bordetella bronchiseptica (Fig. 11B).
Sequence analysis revealed the presence of several conserved residues, including a highly
conserved asparagine (N52 in SypE) (Fig. 11B). In characterized HPK-like serine
kinases, this invariant asparagine is located within the N-box motif, and is required for
coordination of a Mg2+ ion involved in ATP binding and kinase activity [95].
In contrast, the C-terminal effector domain of SypE exhibits sequence similarity
to serine phosphatases of the PP2C family. These include the partner-switching
regulatory phosphatases RsbU and SpoIIE of Bacillus subtilis and BtrU of B.
bronchiseptica [133](Fig. 11C). Proteins of the PP2C family are Mg2+/Mn2+-dependent
phosphatases. Analysis of characterized PP2C phosphatases identified conserved amino
acid residues involved in phosphatase activity, including several invariant aspartate
residues required for coordination of divalent cation binding and catalytic activity
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[145,146]. Sequence alignments revealed that these catalytic aspartates are conserved in
SypE (Asp-443 and Asp-495)(Fig. 11C).
To investigate the putative regulatory activities of SypE’s terminal effector
domains, I performed a structure-function analysis of SypE. With the help of a research
technician, Cynthia Darnell, I generated a library of SypE domain mutants (Fig. 12). I
then assessed the potential regulatory activity of the SypE mutants using a
complementation approach.
SypE mediated positive regulation of RscS-induced biofilms
To determine the role(s) of the individual SypE domains in the positive regulation
of RscS-induced V. fischeri biofilms, I introduced the mutant sypE alleles into the Tn7
site of a ΔsypE strain, and then assessed complementation by assaying for the restoration
of RscS-induced biofilm phenotypes (i.e. wrinkled colony formation).
As previously observed, RscS-induced wild-type cells initiated wrinkled colony
development within 16 h (Fig. 13A), while the ΔsypE strain exhibited a relative delay in
RscS-induced wrinkling (Fig. 13C). Complementation with a wild-type copy of sypE
restored wild-type biofilm development (Fig. 13D). Similar to WT sypE, I found that
expression of a SypE N-terminal deletion mutant (SypEΔNTD) (Fig. 12) fully
complemented the sypE deletion for wrinkled colony morphology (Fig. 13E). This
mutant lacks the N-terminal 135 amino acids encoding the putative serine kinase domain
but retains an intact C-terminal serine phosphatase domain and REC domain. These data
indicate that the positive regulatory activity of SypE is retained in this mutant and thus
does not require the N-terminal domain. I hypothesized that the positive activity retained
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in the SypEΔNTD mutant protein may reside in the protein’s C-terminal, effector domain.
Indeed, a deletion derivative that expresses only the C-terminal 245 amino acids
(SypECTD) fully complemented the ΔsypE deletion, restoring wrinkled colony
morphology to wild-type levels (Fig. 13F). These data thus demonstrate that the Cterminal effector domain of SypE alone is active and positively regulates RscS-induced
biofilms.
The C-terminal domain exhibits sequence similarity to PP2C-like serine
phosphatases and possesses several conserved residues, including conserved aspartate
residues (D443 and D495) required for phosphatase activity (Fig. 11C). We reasoned
that if SypE’s C-terminal domain functions as a phosphatase, then these conserved
residues were likely required for the observed positive regulatory activity. We generated
alanine substitutions in the context of both the C-terminal domain alone (SypECTD, D443A
and SypECTD, D495A) and of the full-length protein (SypED443A and SypED495A). Mutation
of either conserved aspartate in the context of the C-terminal domain alone (SypECTD,
D443A

and SypECTD, D495A) resulted in failure to complement the ΔsypE defect: these

mutants exhibited delayed wrinkled colony morphology similar to the uncomplemented
ΔsypE control (Fig. 13G and 13H, respectively). I concluded that the positive regulatory
activity of the SypE C-terminal domain requires the conserved aspartate residues (D443
and D495), suggesting that SypE likely functions as a phosphatase to promote biofilms.
In the context of the full-length SypE, the SypED443A and SypED495A mutants again
failed to complement the sypE deletion as observed at the early (16 h) time point (Fig.
13I and 13J, respectively), but unexpectedly also completely inhibited biofilm formation,
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as indicated by smooth colony morphology even at 48 h (Fig. 14E and 14F). I
hypothesized that loss of function in SypE’s C-terminus “locked” SypE into an inhibitory
state. Consistent with that interpretation, a SypEΔCTD mutant, which contains the Nterminus and the central REC domain, but lacks the C-terminal domain, exhibited the
same phenotype: this strain failed to form wrinkled colonies even at late time points (48 h
post-incubation) (Fig. 14G). Taken together, these results demonstrate that an intact Cterminal domain is required for the positive regulatory activity of SypE and that loss of
the C-terminal function results in a protein with constitutive inhibitory activity.
Negative regulation of RscS-induced biofilms by SypE
I hypothesized that the inhibitory activity observed upon disruption of SypE’s Cterminal domain likely resided in the protein’s N-terminal effector domain. To test this
hypothesis, I evaluated biofilm formation in a ΔsypE strain that expressed only the 140
amino acids comprising the N-terminal domain (SypENTD). This strain failed to form
biofilms, as indicated by the smooth colony morphology at 48 h (Fig. 14H). These
results demonstrate that the isolated SypE N-terminal effector domain is active and
sufficient to inhibit the development of RscS-induced biofilm phenotypes.
The N-terminal domain of SypE exhibits sequence similarity to HPK-like serine
kinases, and possesses a conserved asparagine residue located within the N box motif
predicted to be required for serine kinase activity (Fig. 11B). I asked whether the
conserved asparagine N52 is required for the inhibitory activity of SypE by substituting
alanine at that position. In the context of the inhibitory N-terminal domain alone
(SypENTD, N52A), this substitution resulted in loss of inhibitory activity: expression of
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Figure 13. Positive regulation of biofilm formation by SypE. Cultures of the
following strains were spotted onto LBS medium at RT and wrinkled colony formation
was assessed at an early time point (16 h) post-spotting: WT cells containing EC
[KV4389] and carrying either RscS plasmid pARM7 (A) or vector control pKV282 (B),
and ΔsypE mutants carrying pARM7 and containing EC (KV4390) (C) or complemented
with WT sypE+ [KV4819] (D), sypEΔNTD [KV5124] (E), sypECTD [KV5204] (F), sypECTD,
D443A
[KV5314] (G), sypECTD, D495A [KV5345] (H), sypED443A [KV4886] (I), sypED495A
[KV4887] (J), sypEΔCTD [KV5315] (K), or sypEN52A, D192A [KV5205] (L). Photographs are
representative of at least 3 independent experiments.
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SypENTD, N52A in the ΔsypE strain resulted in wrinkled colony formation (Fig. 14I).
Western blot analysis confirmed that the SypENTD, N52A protein was expressed at levels
similar to the SypENTD control, indicating that the loss of inhibitory activity results from
the N52A mutation (data not shown). As expected, the N52A mutation in the context of
the full-length protein (SypEN52A) permitted complementation of the sypE deletion; the
SypEN52A strain exhibited wrinkled colony morphology similar to the wild-type and sypE
complemented strains (data not shown). These results indicate that the N52A mutation
disrupts the inhibitory activity of the SypE protein, but does not impact its positive
regulatory activity.
Regulation of SypE’s opposing activities
The above results demonstrated that SypE exerts both negative and positive
control over biofilm formation through the opposing activities of its N- and C-terminal
effector domains, respectively. In general, RR activity is regulated by the
phosphorylation of a conserved aspartate residue located in the protein’s REC domain
[71]. I therefore hypothesized that the phosphorylation state of the central REC domain
likely controls the opposing activities of SypE’s terminal effector domains. To test this
hypothesis, I evaluated biofilm formation by cells expressing a SypE mutant containing
an alanine substitution at the conserved asparate residue (D192), the predicted site of
phosphorylation [27](Fig. 11). This substitution in other RRs results in a protein that
cannot become phosphorylated, and whose activity therefore mimics that of the nonphosphorylated state (e.g., [82]). The SypED192A mutant not only failed to complement
the sypE deletion but also completely inhibited wrinkled colony as observed at the late
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(48 h) time point (Fig. 15E). This inhibitory activity was not due to aberrant protein
expression as western blot analysis indicated that the SypED192A protein was expressed at
levels similar to wild-type SypE (data not shown). These results indicate that the
conserved Asp residue (D192) in the REC domain is required for the positive regulatory
activity of SypE. Thus, the phosphorylation state of this residue is likely important in
controlling SypE regulatory activity.
I hypothesized that the D192A substitution “locks” SypE into a conformation that
favors the activation of the inhibitory N-terminal domain. I reasoned that if the D192A
mutation indeed “locks” SypE in a constitutive inhibitory state, then this activity should
require an intact N-terminal domain and the invariant asparagine (N52). To test this, I
combined the D192A and N52A mutations (SypEN52A, D192A). In contrast to the inhibitory
SypED192A mutant, cells carrying SypEN52A, D192A exhibited biofilm formation
indistinguishable from the uncomplemented (EC) control (Fig. 15F). This result could
not be attributed to a defect in protein production of the double mutant (data not shown).
These data demonstrate that the N52A mutation is epistatic to the D192A mutation, and
that the constitutive inhibitory activity of the D192A mutant requires an intact N-terminal
domain. While the SypEN52A, D192A mutant lost inhibitory activity, the protein remained
incapable of complementing the sypE deletion despite the fact that the positive-acting Cterminal domain remained intact (Fig 13L). These data therefore demonstrate that residue
D192 is also required for promoting SypE’s positive regulatory
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Figure 15. Role of the REC domain in controlling SypE activity. Cultures of the
following strains were spotted onto LBS agar medium at RT and wrinkled colony
formation was assessed at a late time point (48 h) post-spotting: WT cells containing EC
[KV4389] and either RscS plasmid pARM7 (A) or vector control pKV282 (B); and
ΔsypE mutants carrying pARM7 and containing EC [KV4390] (C) or complemented with
WT sypE+ [KV4819] (D), sypED192A [KV4885] (E), sypEN52A, D192A [KV5205] (F).
Photographs are representative of at least 3 independent experiments.
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activity SypE, suggesting that phosphorylation may function to both activate the positive
C-terminal domain and to inactivate the inhibitory N-terminal.
We noted that the constitutive inhibitory activity of the SypED192A mutant
mimicked that observed previously in a C-terminal domain mutant, SypED443A. We
predicted that the inhibitory activity of the SypED443A mutant would similarly depend
upon residue N52, and tested this by generating a SypEN52A, D443A double mutant. As
expected, a SypEN52A, D443A mutant failed to inhibit biofilm formation, and exhibited
delayed wrinkled colony similar to uncomplemented ΔsypE control (Fig.14K). Western
blot analysis confirmed that the SypEN52A, D443A protein was expressed at levels similar to
wild-type SypE+ (data not shown)[212]. These data demonstrate that the N52A mutation
is also epistatic to the D443A mutation, and suggest that in all cases SypE inhibitory
activity requires an intact N-terminal domain.
Role of SypE in regulating symbiotic colonization
The ability to produce syp-dependent biofilms is essential for V. fischeri cells to
efficiently colonize host squid [20,21]. Because SypE exerts both a subtle positive effect
and a strong negative effect over biofilm formation, I asked if either or both of these
activities were important to host colonization. I evaluated the role of SypE in colonization
of juvenile E. scolopes using both single strain inoculations and mixed strain
competitions. I found that deletion of sypE did not substantially impact the ability of V.
fischeri to colonize squid, when in competition or presented alone (Fig. 16A and 16B,
respectively), although there was a small advantage for wild-type cells to out-compete the
ΔsypE mutant (mean Log RCI, -0.21 +/- 0.63). Similar results were also observed when
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juvenile squid were exposed to a mixture of wild-type and ΔsypE cells both
overexpressing rscS: the squid contained roughly equal numbers of both strains (data not
shown). These results demonstrate that loss of sypE does not greatly impact colonization
fitness, suggesting that the minor, positive activity SypE exerts over biofilm formation is
not likely critical during colonization.
My in vitro studies suggested that, of the two roles of SypE, the inhibitory activity
appears to play a more important role with respect to biofilm formation. I therefore asked
whether the inhibitory activity of SypE impacts symbiotic colonization. To address this,
I utilized the SypED192A mutant, which exhibited constitutive inhibitory activity. I
exposed squid to a mixture of wild-type and ΔsypE mutant cells complemented with
either wild-type sypE+ or the inhibitory sypED192A allele. While the SypE+ strain
competed well for colonization with the wild-type strain (mean Log RCI, -0.07 +/- 0.44),
the SypED192A mutant exhibited a strong colonization defect (mean Log RCI, -1.59 +/0.52), with all squid colonized predominantly by the wild-type cells (Fig. 16C and 16D,
respectively). These data indicate that the inhibitory activity of SypE is detrimental to
colonization.
To explore this possibility further, I performed single-strain colonization
experiments using strains that did not carry the rscS overexpression plasmid. Squid
inoculated with wild-type cells contained levels of bacteria between 104 and 105 colonyforming units per animal, and those inoculated with the ΔsypE mutant complemented
with wild-type sypE+ were similarly proficient at colonization (Fig. 16E). However, the
ΔsypE mutant complemented with sypED192A exhibited a dramatic defect in host
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colonization relative to wild-type cells: multiple squid remained completely uncolonized,
while the others had a severe decrease in their level of colonization (2-3 log decrease)
(Fig. 16E). These data demonstrate that residue D192 within the central REC domain, is
necessary to promote efficient host colonization.
Finally, to confirm that the colonization disadvantage of the SypED192A strain is
due to the activity of the inhibitory domain, I assessed colonization by the SypEN52A, D192A
expressing strain. Whereas the SypED192A mutant inhibited host colonization, the
SypEN52A, D192A double mutant achieved near wild-type levels of colonization (Fig. 16E).
These data thus support our earlier observations that the inhibitory activity of a SypED192A
mutant resides in the N-terminal effector domain. These results are consistent with the
biofilm phenotypes observed in culture, and suggest that the constitutive inhibition of
colonization resulting from disruption of the predicted site of phosphorylation (D192) is
mediated by the N-terminal effector domain. Together, these findings indicate that the
inhibitory activity of SypE is relevant during host association, and the ability of the cell
to turn off this activity is critical to permit symbiotic colonization.
Impact of SypE on symbiotic aggregate formation
syp-dependent biofilm formation is essential for the initial stages of host
colonization, when V. fischeri cells aggregate in the squid-secreted mucus on the light
organ surface. To determine if SypE impacts this early stage in symbiotic colonization,
another graduate student, Valerie Ray, and I performed aggregation studies with the help
of Elizabeth Heath-Heckman in the laboratory of Dr. Margaret McFall-Ngai at the
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Figure 16. Impact of SypE on symbiotic colonization. (A, C, D) Competitive
colonization with WT and sypE strains. Newly hatched squid were exposed to a mixed
inoculum of WT (ES114) and sypE cells. The Log relative competitive index (Log RCI)
is plotted on the x-axis. Position on the Y-axis is arbitrary. The black diamond and error
bars indicate the average Log RCI and standard deviation for indicated data set. (B and E)
Single-strain colonization assays. Newly hatched squid were exposed for 18 h to either
WT cells or: (B) ΔsypE cells; (E) ΔsypE cells complemented with either sypE+,
sypED192A, or sypEN52A, D192A. As a negative control, aposymbiotic (APO) juvenile squid
were maintained in bacteria free water. Each circle represents the number of V. fischeri
cells recovered from an individual animal. The dashed line indicates the limit of
detection. The black bar indicates the average CFU and standard deviation for 15
animals. The data shown above are from one experiment and are representative of at
least 3 independent experiments.
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Figure 17. Inhibition of symbiotic aggregation by SypE. Newly hatched juvenile squid
were inoculated with GFP-labeled derivatives of the following strains: (A) pARM7
(pRscS) in WT cells [KV4389] or ΔsypE cells complemented with WT sypE+ [KV4819]
(B), sypED192A [KV4885] (C), or sypEN52A, D192A [KV5205] (D). After 3 h, animals were
stained with CellMask stain (blue color) and the light organs were examined by confocal
microscopy. Representative images of V. fischeri cells aggregating on the light organ
surface are shown. White arrows indicate the surface of the light organ appendages. The
white, dashed arrow indicates single V. fischeri cells on the light organ surface.
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Figure 18. Impact of SypE on host colonization in rscS mutant cells. Competitive
colonization assay with ΔrscS and ΔrscS ΔsypE mutant cells. Colonization assays were
performed and Log RCI of the competing bacterial strains was calculated as described in
Figure 7. Each circle represents a single animal. Closed circles represent animals in
which no ΔrscS cells were present in the homogenate. The position of the circles on the
y-axis is merely for spacing. The black diamond and error bars indicate the average Log
RCI and standard deviation for 15 animals. The data shown above are from one
experiment and are representative of at least 3 independent experiments.

	
  

115	
  
University of Wisconsin (Madison). Briefly, we assessed symbiotic aggregate formation
by wild-type and sypE mutant strains expressing GFP. To promote aggregate formation,
these studies were performed using strains that also overexpressed rscS. In agreement
with previous data [20], wild-type cells exhibited large aggregates (green color) on the
light organ surface (blue color) (Fig. 17A), as did the ΔsypE strain complemented with
wild-type sypE+ (Fig. 17B). In contrast, the SypED192A mutant strain formed no
observable aggregates; only single cells were occasionally observed on the light organ
surface (dashed arrow) (Fig. 17C). As expected, the aggregation defect of this mutant
depended upon the inhibitory N-terminal domain, as a SypEN52A, D192A double mutant
formed large aggregates similar to control (SypE+) cells (Fig. 17D). These data suggested
that the colonization defect of the SypED192A mutant likely resulted from a loss of
bacterial aggregation at the initiation stage. Thus, SypE appears to impact bacterial
aggregation, a critical stage in the initiation of host colonization. Finally, these results
support our earlier conclusion that the inhibitory activity of SypE must be deactivated to
promote efficient aggregation and host colonization.
Deletion of sypE improves colonization by an rscS mutant
The previous experiments demonstrated that the conserved site of
phosphorylation in the SypE REC domain is necessary to inactivate the inhibitory activity
of the N-terminus and promote its positive activity. Furthermore, although SypE
expressed from its native site in the chromosome inhibits biofilm formation induced by
the overexpression of the RR SypG, it does not inhibit RscS-induced biofilm formation.
These data indicate that upon RscS induction, this inhibitory activity of SypE must be
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turned off. We therefore hypothesized that in a strain lacking rscS, SypE is likely to
exhibit constitutive inhibitory activity and negatively impact host colonization. We
reasoned that this phenomenon could account, at least in part, for the severe colonization
defect of an rscS mutant [26]. To determine whether this is the case, I utilized a ΔrscS
ΔsypE double mutant generated by another graduate student, Valerie Ray, and assessed
the ability of this strain to compete with the ΔrscS parent to colonize juvenile squid.
Indeed, the ΔrscS ΔsypE mutant cells dramatically outcompeted the ΔrscS single mutant
(mean Log RCI, 1.76 +/- 0.66) with the majority of the animals exclusively colonized by
the double mutant (open circles) (Fig. 18). These results indicate that SypE contributes to
the colonization defect observed in an rscS mutant, supporting our hypothesis and linking
SypE-mediated regulation of colonization to the activity of RscS.
Summary
In this section, I identified a novel role for the RR SypE in controlling biofilm
formation and host colonization by V.fischeri. My initial interest in characterizing SypE
was prompted both by its unusual domain architecture and by earlier studies that
suggested that SypE contributes to biofilm regulation [27,28]. Bioinformatics indicated
that SypE is a RR with a novel domain architecture: a central REC domain flanked by
two effector domains with apparently opposing enzymatic activities. I hypothesized that
SypE could exert dual regulatory control over syp biofilm formation, depending on which
of the terminal effector domains was active.
Using a genetic analysis of sypE activity, I determined that SypE indeed exerts
dual control over syp-dependent biofilm formation. Specifically, the N-terminal putative
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serine kinase domain inhibited RscS-induced biofilms, while the C-terminal, putative
serine phosphatase domain positively impacted biofilm formation. Furthermore, the
regulator activities of the N- and C-terminal effector domains required conserved
residues consistent with these domains possessing serine kinase and serine phosphatase
activity, respectively. These opposing activities appear to be controlled by the protein’s
central REC domain, as mutation of the predicted site of phosphorylation (D192) resulted
in loss of SypE positive activity. I interpret these data to indicate that REC
phosphorylation shifts the equilibrium of the SypE conformational states such that the
inhibitory N-terminus is inactivated, while the positively acting C-terminus is activated.
I also determined that the activity SypE is relevant during symbiotic colonization.
While the minor positive role of SypE in promoting biofilm formation is relatively
unimportant during host colonization, I showed that inhibition by SypE is a significant
activity that must be overcome during the colonization process. Further studies
established that SypE impacts host colonization during the initiation stage, in which V.
fischeri forms aggregates in the squid-derive mucus on the light organ surface. SypE
mutants that failed to produce biofilms exhibited severe defects in host colonization,
which could be attributed to the inability of these cells to efficiently aggregate. Finally, I
determined that the inhibitory activity of SypE contributes to the colonization defect
observed in an rscS mutant. This work, published in Molecular Microbiology,
establishes SypE as a key regulator of host colonization, restricting colonization to
conditions in which RscS is overexpressed or activated [212].
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SypE CONTROLS BIOFILMS AND SYMBIOTIC COLONIZATION THROUGH
REGULATION OF SypA ACTIVITY
Introduction
In the previous section, I established that SypE controls biofilms both negatively
and positively through the opposing activities of its putative N-terminal serine kinase and
C-terminal serine phosphatase domains. However, the downstream target of SypE’s
regulatory activities and the mechanisms by which SypE restricts biofilms and
colonization remained unknown. Given the results from my previous experiments, I
reasoned that SypE likely regulates biofilm formation by controlling the phosphorylation
state of a downstream regulatory protein, possibly another partner switching-like protein.
SypE is encoded downstream of another putative regulatory gene, sypA, which
encodes a protein with sequence similarity to the B. subtilis antagonist protein RsbV
[21,133](Fig. 2). Like RsbV, SypA contains a single STAS domain indicative of
regulatory proteins that function as anti-sigma factor antagonists (Fig. 19)[133]. A role
for SypA in regulating syp-dependent biofilm formation and/or symbiotic colonization
had yet to be identified. However, given the similarity to characterized partner-switching
regulators and genetic proximity to sypE, we speculated that SypA may represent the
target of SypE regulatory activities
In order to investigate the potential role of SypA as a regulatory target of SypE, I
first assessed whether SypE interacts with SypA in vivo by performing coimmunoprecipitation assays. I then asked whether SypE’s N- and C-terminal effector
domains indeed possess serine kinase and serine phosphatase activities, respectively, and
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whether SypA represents a target of these opposing activities. To address these
questions, I established both in vitro and in vivo assays to assess the impact of SypE
activity on the phosphorylation state of SypA. Finally, I investigated whether SypE
mediates control over biofilm formation and symbiotic colonization through regulation of
SypA activity via epistasis analyses. The studies described in this section provide insight
into the mechanism by which SypE restricts biofilm formation and symbiotic
colonization.
Analysis of SypE interaction with SypA in vivo
To determine if SypE targets SypA to regulate biofilm formation, I first asked
whether SypE interacts with SypA in vivo by performing a co-immunoprecipitation
assay. Briefly, I generated FLAG- and HA-epitope tag fusions to the C-termini of SypE
and SypA, respectively, and expressed the epitope-tagged alleles in a V. fischeri ΔsypA
ΔsypE strain [KV4716]. I used anti-FLAG or anti-HA antibodies to immunoprecipitate
either SypE or SypA, respectively, and then detected the immunoprecipitated proteins
using western blotting analyses. Upon immunoprecipitation using anti-FLAG antibody, I
detected not only immunoprecipitated SypE, but also SypA (Fig. 20A, left panel). In
reciprocal experiments, I found that immunoprecipitation of SypA with anti-HA antibody
resulted in the co-immunoprecipation of SypE (Fig. 20A, right panel). These results
indicate that SypA and SypE interact in vivo, a result that is consistent with the model
that SypA serves as a target of SypE’s regulatory activity.
I next examined the domains of SypE required for mediating this binding to
SypA. Based on similarity to B. subtilis orthologues, in which RsbW directly binds
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Figure 19. SypA domain structure and sequence alignment. (A) SypA contains a
sulfate transport and anti-sigma factor antagonist (STAS) domain indicative of regulatory
proteins that function as anti-sigma factors antagonists. (B) Sequence alignments of SypA
with antagonist proteins RsbV and SpoIIAA from B. subtilis and BtrV from B.
bronchiseptica. The predicted phosphorylated serine residue (S56) of SypA is indicated.
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RsbV [153], I hypothesized that binding to SypA would depend upon SypE’s N-terminal,
RsbW-like domain. I first tested the ability of SypA to interact with an N-terminal
deletion mutant of SypE (SypEΔNTD), a SypE derivative that lacked the first 135 amino
acids (comprising the putative serine kinase domain) but retained positive regulatory
activity mediated by the C-terminal domain. The FLAG-SypEΔNTD mutant failed to coimmunoprecipitate with SypA (Fig. 20B, lanes 1 and 3). This result suggested that the Nterminus of SypE is required for interaction with SypA. To explore this possibility
further, I co-expressed SypA with a SypE mutant (SypENTD) that expressed only the first
140 amino acids of the N-terminus. I found that FLAG-SypENTD co-immunoprecipitated
with SypA, indicating that the N-terminal domain alone is sufficient to mediate
interaction with SypA (Fig. 20B, lanes 2 and 4). These data indicate that the N-terminal
domain of SypE interacts with SypA in vivo.
In vitro analysis of SypA phosphorylation by SypE
The identification of SypA as a target protein capable of interacting with SypE
provided a candidate substrate to test the activities of SypE’s terminal effector domains,
e.g., kinase and phosphatase activities. To assess SypE’s kinase activity, I purified
glutathione S-transferase (GST)-tagged versions of the proteins (SypE and SypA-FLAG).
I then incubated purified SypA in kinase buffer either in the absence or presence of
purified SypE. The samples were then resolved on SDS-PAGE gels containing PhostagTM acrylamide, which permits the separation of phosphorylated and nonphosphorylated forms of proteins by preferentially binding to and retarding the migration
of phosphorylated proteins [215,216]. Following electrophoresis, SypA protein was
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detected by western blotting using an anti-FLAG antibody. As shown in figure 21A,
purified SypA incubated in kinase buffer alone (lane 2) migrated as a single species,
corresponding to non-phosphorylated SypA. In contrast, upon co-incubation of SypA
with SypE, two major bands were observed: both a lower, faster migrating SypA band
(unphosphorylated SypA) and an upper, slower migrating band corresponding to
phosphorylated SypA (SypA~P) (lane 3). This shifted SypA band was not observed upon
resolving the reaction samples in parallel on gels lacking Phos-tagTM acrylamide,
suggesting that the upper band observed in our Phos-tagTM gels represents
phosphorylated SypA (data not shown). To confirm that the slower migrating, upper
band observed indeed represented phosphorylated SypA, we co-incubated SypA with
SypE in kinase buffer lacking ATP. As expected, only the lower (unphosphorylated)
SypA band was present, indicating that the shifted SypA band represented
phosphorylated SypA (Fig. 21A, lane 5). Together, these data demonstrate that SypE can
phosphorylate SypA.
Phosphorylation of B. subtilis RsbV, and similar STAS-domain containing
orthologs, occurs on a conserved serine residue [151], which in SypA corresponds to
serine-56 (S56) [133](Fig. 19). To assess whether this conserved serine was required for
SypA phosphorylation, I repeated the kinase reaction using a purified SypA mutant in
which S56 was substituted with an alanine (SypAS56A). The SypAS56A sample migrated
as a single, lower band, corresponding to unphosphorylated SypA (Fig. 21A, lane 4).
These data suggest that phosphorylation of SypA by SypE depends on the predicted site
of phosphorylation (S56) within SypA.
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SypE’s serine kinase activity is proposed to reside in the protein’s N-terminal
effector domain [212]. Unfortunately, attempts to assess the kinase activity of purified
SypE N-terminal domain alone (SypENTD) in vitro were unsuccessful, as the GSTSypENTD protein failed to promote SypA phosphorylation in our in vitro assay (data not
shown). As an alternative approach to assess whether the N-terminal domain of SypE
possesses kinase activity, I asked whether expression of SypE’s N-terminal domain could
promote SypA phosphorylation in E. coli cells. I introduced the GST-SypA plasmid into
E. coli cells carrying either an empty vector (pVSV105) or a plasmid (pCLD64)
expressing the untagged, N-terminal domain of sypE (SypENTD), which we have
previously shown is sufficient to inhibit biofilm formation (see Fig. 14). I then affinitypurified SypA from these SypENTD-expressing cells and assessed the phosphorylation
state of SypA. Whereas SypA purified from vector-containing cells appeared as a single,
faster migrating band corresponding to non-phosphorylated SypA (Fig. 21B, lane 1),
SypA purified from sypENTD-expressing cells predominately appeared as an upper, slower
migrating band corresponding to phosphorylated SypA, although a small amount of
unphosphorylated protein could be detected (Fig. 21B, lane 2). I conclude from these data
that SypE, and specifically its N-terminal domain, indeed possesses serine kinase activity
and can promote phosphorylation of SypA.
In vitro analysis of SypA dephosphorylation by SypE
The C-terminal domain of SypE exhibits sequence similarity to PP2C-like serine
phosphatases, including the B. subtilis phosphatase RsbU. Given our finding that the Nterminal domain of SypE can phosphorylate SypA, I next questioned whether SypE’s C	
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Figure 20. Co-immunoprecipitation of SypE and SypA. (A) Soluble lysates from
ΔsypA ΔsypE cells [KV4716] carrying plasmids expressing FLAG-SypE (pARM80),
HA-SypA (pARM36), or untagged SypE (pCLD48) and SypA (pARM13) control
plasmids were used in immunoprecipitation assays with non-specific anti-rabbit IgG
antibody (Lanes 1 and 5), anti-FLAG antibody (Lanes 2-4), or anti-HA antibody (Lanes
6-8). Samples were resolved using SDS-PAGE and subjected to western blot analysis
with anti-FLAG (top panel) or anti-HA (bottom panel) antibodies. (+) indicates cells
carrying the epitope tagged SypE (pARM80) and/or SypA (pARM36) plasmids. (-)
indicates cells carrying control plasmids pCLD48 or pARM13. (B) Soluble lysates from
ΔsypA ΔsypE cells [KV4716] carrying plasmids expressing HA-SypA (pARM36) and
either FLAG-SypE NTD (pARM162) [Lanes 1 and 3] or FLAG-SypENTD (pARM136)
[Lanes 2 and 4] were used in immunoprecipation assays with anti-FLAG or anti-HA
antibody. Lanes 5 and 6, ΔsypA ΔsypE cells [KV4716] carrying both pARM36 and either
pARM162 (lane5) or pARM136 (lane 6) were immunoprecipitated with non-specific,
anti-rabbit IgG. Samples were resolved using SDS-PAGE and subjected to western blot
analysis with anti-FLAG (top panel) or anti-HA (bottom panel) antibodies.
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Figure 21. in vitro phosphorylation of SypA by SypE. (A) in vitro phosphorylation of
SypA by SypE. Purified SypA-FLAG (3 mg) and/or SypE proteins (2 mg) were
incubated in kinase buffer in the presence or absence of ATP. Samples were resolved by
SDS-PAGE on a 25 mM Phos-tag acrylamide gel and the proteins were detected via
western blot analysis using an anti-FLAG antibody. Lane 1, SypE incubated in kinase
buffer. Lanes 2 and 3, wild-type (WT) SypA-FLAG protein incubated in kinase buffer
alone (Lane 2) or with SypE (Lane 3). Lane 4, SypAS56A-FLAG protein incubated with
SypE in kinase buffer. Lane 5, wild-type SypA-FLAG protein incubated with SypE in
kinase buffer lacking ATP. (+) indicates reactions containing WT SypA-FLAG or SypE
protein. (-) indicates reactions not containing purified protein. (S56A) indicates reactions
containing SypAS56A protein. (B) SypE-mediated phosphorylation of SypA in E. coli
cells. SypA-FLAG protein was purified from E. coli cells carrying both pARM157 and
either empty vector, pVSV105, (Lane 1) or plasmid pCLD64, which expresses the Nterminal, serine kinase domain of SypE (Lane 2). Samples were resolved using SDSPAGE on a 25 mM Phos-tagTM acrylamide gel and proteins were detected by anti-FLAG
western blot analysis. SypA~P denotes phosphorylated SypA.	
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Figure 22. SypE dephosphorylates SypA in vitro. Western blot analysis of in vitro
SypA samples analyzed on Phos-TagTM gels. Purified phosphorylated SypA protein
(SypA~P; 2 mg) was incubated in Mg2+-containing phosphatase buffer in the presence or
absence of increasing concentrations of purified SypE C-terminal phosphatase domain
(SypECTD; 2-10 mg). The reactions were terminated after 30’ minutes and the samples
resolved by SDS-PAGE on a 25 mM Phos-tag acrylamide gel. SypA proteins were
detected by western blot analysis using an anti-FLAG antibody. Lane 1, SypECTD
incubated in buffer alone. Lane 2, non-phosphorylated SypA incubated in buffer alone.
Lanes 3 and 7, phosphorylated SypA (SypA~P) incubated in buffer alone for 0’ (Lane 3)
and 30’ (Lane 7) minutes. Lanes 4-6, phosphorylated SypA (SypA~P) incubated for 30’
minutes in buffer containing 2 mg (Lane 4), 5 mg (Lane 5), or 10 mg (Lane 6) of purified
SypECTD. (+) indicates reactions containing SypA-FLAG or SypECTD protein. (-)
indicates reactions not containing purified protein.
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terminal domain possesses phosphatase activity and can dephosphorylate SypA~P. To
address this question, I incubated phosphorylated SypA (SypA~P) protein in phosphatase
buffer either in the presence or absence of the putative phosphatase domain of SypE
(SypECTD) and then assessed the phosphorylation state of SypA. Phosphorylated SypA
incubated in phosphatase buffer alone (in the absence of SypE) remained largely
phosphorylated as indicated by the presence of the upper (SypA~P) band (Fig. 22, Lanes
3 and 7), relative to the unphosphorylated SypA control (Fig. 22, Lane 2). Upon addition
of increasing amounts of SypECTD, I observed a decrease in the intensity of the upper
(SypA~P) band and a corresponding increase in the lower, unphosphorylated SypA band
(Fig. 22, Lanes 4-6). These data indicate that the C-terminal domain of SypE possesses
phosphatase activity and is capable of dephosphorylating SypA in vitro. Together with
the findings from the in vitro kinase assays, these results demonstrate that the N- and Cterminal domains of SypE indeed possess enzymatic activity and are sufficient to mediate
SypA phosphorylation and dephosphorylation, respectively.
Role of SypA in RscS-induced biofilm formation
To investigate what role, if any, SypA may play in the regulation of syp biofilm
formation, I first generated a sypA deletion strain and assessed biofilm formation upon
introduction of the rscS expression plasmid (pARM7). In contrast to wild-type cells that
displayed robust RscS-induced wrinkled colony morphology (Fig. 23B), the ΔsypA
mutant consistently failed to form biofilms, as indicated by the smooth colony
morphology similar to vector-containing cells (Fig. 23C). To confirm that the loss of
biofilm formation was indeed due to the absence of sypA, I introduced a wild-type copy
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of sypA into the chromosome at the Tn7 site. Single-copy expression of sypA fully
complemented the ΔsypA mutant (Fig. 23D). Together, these results identify SypA as an
essential, positive regulator of RscS-induced biofilm formation.
As previously discussed, the activity of RsbV-like anti-sigma factor antagonists is
regulated by the phosphorylation of a conserved serine residue, which inhibits protein
activity [151,153]. Above, I determined that a conserved serine residue (S56) of SypA is
required for SypA phosphorylation by SypE in vitro. To address the role of S56
phosphorylation in regulating SypA activity, I generated sypAS56D and sypAS56A mutant
alleles and assessed their ability to complement the ΔsypA mutant for biofilm formation.
The aspartate substitution (SypAS56D) was predicted to mimic the phosphorylated,
inactive, state [151,217], while the alanine substitution (SypAS56A) was predicted to
“lock” the protein in the non-phosphorylated, active, state [151]. The sypAS56D–
expressing strain was severely impaired in biofilm formation (Fig. 23E). This defect
could not be attributed to poor expression, as a FLAG-tagged version of this mutant was
present at steady-state levels similar to that of FLAG-tagged wild-type SypA protein and
the SypAS56A mutant (data not shown). In contrast to the aspartate mutant, the alanine
substitution mutant (SypAS56A) fully complemented the ΔsypA mutant, restoring wrinkled
colony morphology (Fig. 23F). Together, these results indicate that S56 of SypA is
critical for the regulation of SypA activity, and suggest that phosphorylation at this
residue, possibly by SypE, inhibits SypA activity.
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Epistasis analysis of SypA and SypE
Both SypA and SypE contribute to the regulation of syp biofilm formation. To
further characterize the role of SypA in biofilm regulation, I next assessed whether SypA
functions in the same regulatory pathway as SypE to control biofilm formation by
performing an epistasis analysis. Briefly, I generated a sypA sypE double mutant and
assessed the ability of this strain to form rscS-induced biofilms relative to that of the two
single mutants. The ΔsypE strain exhibited wrinkled colony morphology similar to wildtype cells (Fig. 24), albeit with a slight delay in wrinkling (data not shown) as observed
previously [212]. In contrast, the ΔsypA mutant failed to develop any observable biofilm
phenotypes (Fig. 24). Similar to the sypA single mutant, the ΔsypA ΔsypE double mutant
failed to produce biofilms (Fig. 24). Expression of sypA+ at the Tn7 site of the ΔsypA
ΔsypE strain fully restored both wrinkled colony development to a level indistinguishable
from the sypE single mutant (Fig. 24). These data demonstrate that SypA is epistatic to
SypE, indicating that SypA functions downstream of SypE in the regulatory pathway
controlling syp biofilm formation.
SypE inhibits biofilm formation by inactivating SypA.
The above results support the hypothesis that SypE functions upstream of SypA to
regulate syp biofilm formation. In my genetic analysis of SypE, I demonstrated that
expression of a sypED192A mutant constitutively inhibits biofilm formation in laboratory
culture and impairs host colonization in vivo (Fig. 17 and Fig. 16, respectively).
Additionally, the inhibitory activity of the SypED192A mutant required the protein’s Nterminal kinase domain, suggesting that SypED192A inhibits biofilm formation by
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Figure 23. Role of SypA in biofilm formation. The RscS plasmid (pARM7) was
introduced into wild-type (WT) or sypA strains. Cultures of the following strains were
spotted onto LBS medium at 24°C and wrinkled colony formation was assessed at 48 h
post-spotting: WT cells containing empty Tn7 cassette (EC) [KV4389] and carrying
empty vector pKV282 (A) or pARM7 (B); pARM7-carrying ΔsypA cells containing EC
[KV5079] (C), or complemented with WT sypA+ [KV5479] (D), sypAS56D [KV5480] (E),
or sypAS56A [KV5481] (F). Images are representative of at least three independent
experiments. Black bar represents 2 mm.
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Figure 24. Epistasis analysis of SypE and SypA. Assessment of RscS-induced wrinkled
colony formation. Cultures of the following strains were spotted onto LBS medium at
24°C and wrinkled colony formation was assessed at 48 h post-spotting: Wild-type (WT)
cells containing empty Tn7 cassette (EC) [KV4389] and carrying empty vector pKV282
(A) or pRscS plasmid pARM7 (B); ΔsypE cells containing EC [KV4390] and carrying
pARM7 (C); ΔsypA cells containing EC [KV5079] and carrying pARM7 (D); pARM7carrying ΔsypA ΔsypE cells containing either EC [KV6392] (E) or WT sypA+ [KV6393]
(F). Images are representative of at least three independent experiments. Black bar
represents 2 mm.
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constitutively activating the kinase domain to phosphorylate a downstream target protein
(Fig. 15 and Fig. 16). Given the current findings, I hypothesized that SypED192A inhibits
biofilm formation by promoting the phosphorylation, and therefore the inactivation, of
SypA. If so, then the “constitutively active”, non-phosphorylatable SypAS56A mutant,
should be insensitive to SypE’s inhibitory activity; therefore, expression of sypAS56A
should suppress the biofilm defect of the sypED192A mutant.
To test this hypothesis, I generated V. fischeri strains expressing combinations of
the sypA and sypE alleles: either the wild-type sypA+ or sypAS56A allele (expressed from
the native sypA locus) was combined with either the wild-type sypE+ or the constitutively
inhibitory sypED192A allele (expressed at the Tn7 site of a sypE deletion mutant). As
expected, SypE+ strains expressing either sypA or sypAS56A exhibited wrinkled colony
morphology (Figs. 25A and B), while a strain that expressed the inhibitory sypED192A
allele and wild-type sypA failed to produce biofilms (Figs.25C). However, a strain
expressing both the inhibitory sypED192A allele and the “constitutively active” sypAS56A
allele was fully competent to produce wrinkled colony morphology (Figs. 25D). These
data indicate that expression of sypAS56A suppresses the biofilm defect of the sypED192A
mutant and further support my earlier epistasis experiments suggesting that SypA
functions downstream of SypE to control biofilms.
Analysis of SypA phosphorylation in vivo
My genetic analyses suggested that the loss of biofilm formation in a SypED192A
mutant results from the inhibition of SypA activity, most likely mediated by the
phosphorylation of SypA. I therefore asked whether SypA is indeed phosphorylated in V.
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fischeri (in vivo), and whether phosphorylation of SypA corresponds with loss of biofilm
formation. To determine whether SypED192A promotes SypA phosphorylation in vivo, I
introduced plasmids expressing epitope-tagged SypA or SypAS56A into V. fischeri strains
expressing either wild-type sypE or the inhibitory sypED192A allele. I then assessed the in
vivo phosphorylation state of the tagged SypA proteins using the Phos-tagTM SDS-PAGE
assay coupled with western blot analysis. Cells expressing wild-type alleles of sypA and
sypE consistently exhibited two bands: a predominant, lower band corresponding to
unphosphorylated SypA and a faint, slower migrating band corresponding to
phosphorylated SypA (SypA~P) (Fig. 26, Lane 2). In contrast, cells expressing sypA+
and the inhibitory sypED192A allele exhibited only the upper SypA~P band (Fig. 26, Lane
3), indicating that the majority of the SypA protein was phosphorylated under those
conditions. As expected, cells co-expressing the sypAS56A mutant and either sypE+ (Fig.
26, Lane 4) or sypED192A (Fig. 26, Lane 5) exhibited only the lower band corresponding
to non-phosphorylated SypA. These results corroborate my in vitro analyses indicating
that residue S56 is required for SypA phosphorylation. Importantly, they demonstrate
that SypA is indeed phosphorylated in vivo, and that SypA phosphorylation corresponds
to inhibition of biofilm formation by SypE (e.g., in cells expressing inhibitory
SypED192A).
SypE inhibits symbiotic colonization by inactivating SypA.
The above studies identified SypA as a critical regulator of biofilm formation in
vitro, and previous work has shown a correlation between biofilm-formation and
symbiotic colonization by V. fischeri [20,21]. Thus, I sought to verify the in vivo
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Figure 25. A sypAS56A mutant suppresses the sypED192A biofilm defect. Assessment of
RscS-induced wrinkled colony formation. The pRscS plasmid pARM7 was introduced
into ΔsypE cells complemented with either wild-type sypE+ or the inhibitory sypED192A
allele and expressing either wild-type sypA+ or sypAS56A. Cultures of the following
strains were spotted onto LBS medium at 24°C and wrinkled colony formation was
assessed at 48 h post spotting: sypE+ cells expressing wild-type sypA [KV6213] (A) or
sypAS56A [KV6215] (B); sypED192A cells expressing either wild-type sypA [KV6214] (C)
or sypAS56A [KV6216] (D). Images are representative of at least three independent
experiments. Black bar represents 2 mm.
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Figure 26. Assessment of SypA phosphorylation in vivo. Western blot analysis of V.
fischeri cell lysates analyzed on Phos-TagTM gels. Soluble lysates from indicated V.
fischeri strains were resolved by SDS-PAGE on 25 µM Phos-tagTM acrylamide gels and
the proteins were detected by western blot analysis using anti-HA antibody. ΔsypA
ΔsypE cells containing wild-type sypE+ [KV6424] and carrying pRscS plasmid
(pCLD46) and plasmids expressing either untagged sypA+ (pARM13) (Lane 1), HAtagged sypA+ (pARM36) (Lane 2), or HA-tagged sypAS56A (pARM78) (Lane 4); ΔsypA
ΔsypE cells containing inhibitory sypED192A [KV6425] and carrying pRscS plasmid
(pCLD46) and plasmids expressing either HA-tagged sypA+ (pARM36) (Lane 3), or HAtagged sypAS56A (pARM78) (Lane 5). (+) indicates cells expressing wild-type sypA-HA
and/or sypE. (S56A) indicates cells expressing sypAS56A. (D192A) indicates cells
expressing sypED192A. (-) indicates cells expressing untagged sypA. Images are
representative of at least three independent experiments.
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relevance of sypA during host colonization using the various sypA mutant strains. First, I
competed ΔsypA mutant cells against wild-type cells in mixed inoculation experiments,
and found that the sypA mutant exhibited a dramatic competitive colonization defect
(mean Log Relative Competitive Index (RCI), 1.38 +/- 0.51) (Fig. 27A). This defect in
colonization could be abrogated by complementation with a wild-type allele of sypA+
(mean Log RCI, 0.15 +/- 0.47) (Fig. 27B). These data indicated that sypA is required for
efficient symbiotic colonization of E. scolopes.
Next, I performed single-strain colonization assays. 18 h after exposure to V.
fischeri, animals inoculated with wild-type cells contained bacterial levels of about 105
colony-forming units (CFU) per animal (mean= 1.2 x105 cfu; Fig. 27C). In contrast,
animals exposed to ΔsypA cells largely remained uncolonized, while those that were
colonized contained significantly fewer (2-3 logs decreased) bacteria (mean= 3.9 x 102
CFU; Fig. 27C). As in the competitive colonization assays, we found that
complementation with a wild-type allele of sypA+ restored colonization to levels similar
to that of wild-type cells (mean= 8.1 x 104 cfu; Fig. 27C).
Our in vitro biofilm studies suggested that phosphorylation inhibits SypA activity.
To explore the dependence of symbiotic colonization on unphosphorylated SypA, I
assessed colonization by the ΔsypA mutant expressing the SypAS56D protein, which
mimics the phosphorylated state of SypA and failed to promote biofilms. As expected,
the SypAS56D strain exhibited a severe colonization defect, similar to that observed for the
ΔsypA mutant (mean= 1.1 x 103 cfu; Fig. 27C). Together, these data suggest that

	
  

137	
  
phosphorylation may serve to inhibit SypA activity, resulting in loss of biofilms and
symbiotic colonization.
Finally, to test the hypothesis that SypE inhibits colonization through
phosphorylation of SypA, I examined the ability of the “constitutively active” sypAS56A
allele to bypass the inhibition of colonization resulting from the sypED192A (constitutive
kinase) allele. As previously observed, animals exposed to wild-type V. fischeri cells
contained roughly 105 cfu/animal (mean= 6.8 x 105 cfu; Fig. 28), while sypED192A (sypA+)
cells exhibited a severe defect in colonization: several animals remained un-colonized,
while colonized animals exhibited a 2-3 log decrease in bacterial loads (mean = 5.66 x
103 cfu; Fig. 28) [212]. In contrast, sypED192A cells expressing the sypAS56A allele
colonized to levels similar to wild-type V. fischeri (mean= 3.68 x 105 cfu; Fig. 28).
These data demonstrate that the colonization defect of the sypED192A mutant can be
suppressed by a constitutively active, SypE-insensitive derivative of SypA, indicating
that the effect of SypED192A during colonization is to inhibit SypA activity. Furthermore,
these results support my in vitro biofilm assays, demonstrating that SypE functions
through SypA to control both biofilms and colonization.
Impact of SypA on syp locus activation
To further investigate the positive role of SypA in promoting syp-dependent
biofilm formation, I examined the effect of sypA expression on syp locus transcription.
To determine if SypA regulates syp transcription, I utilized a sypA promoter-lacZ fusion
inserted in single copy in the chromosome of the wild-type and ΔsypA strains, and then
assessed reported activity upon introduction of the rscS plasmid (pCLD46).
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Figure 27. Role of SypA in symbiotic colonization. (A and B) Competitive colonization
with wild-type (WT) V. fischeri and sypA strains. Newly hatched squid were exposed to a
mixed inoculum of WT and either ΔsypA [KV5079] cells (A) or ΔsypA cells
complemented with sypA+ [KV5479] (B). The Log RCI is plotted on the x-axis. The
position on the y-axis is arbitrary. Each circle represents a single animal. Closed circles
indicate animals containing no sypA mutant cells. The black diamond and errors bars
indicate the average Log RCI ± SD for indicated data set. Data shown are representative
of at least three independent experiments. (C) Single-strain colonization by WT and sypA
mutant strains. Newly hatched squid were exposed for 18 h to WT cells carrying empty
vector (EC) [KV4389] or ΔsypA cells complemented with empty vector (EC) [KV5079],
sypA+ [KV5479] or sypAS56D [KV5480]. As a negative control, aposymbiotic (APO)
juvenile squid were maintained in bacteria free water. Each circle represents the number
of V. fischeri cells recovered from an individual animal. The dashed line indicates the
limit of detection (14 CFU/squid). The black bar indicates the average CFU for 10
animals. Data shown are from one experiment and are representative of at least three
independent experiments.
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Figure 28. SypE inhibits colonization through SypA inactivation. Single-strain
colonization by wild-type (WT) V. fischeri and select mutant strains. Newly hatched
squid were exposed for 18 h to either WT containing empty Tn7 cassette (EC) [KV4389]
or sypED192A mutant cells expressing wild-type sypA [KV6214] or sypAS56A [KV6216].
As a negative control, aposymbiotic (APO) juvenile squid were maintained in bacteria
free water. Each circle represents the number of V. fischeri cells recovered from an
individual animal. The dashed line indicates the limit of detection. The black bar
indicates the average CFU for 10 animals. Data shown are from one experiment and are
representative of at least three independent experiments.
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Figure 29. Impact of SypA on syp locus activation. Transcription of the syp locus was
monitored using a β-galactosidase activity assay. A transcriptional reporter construct
consisting of the sypA promoter region fused upstream of a promoter-less lacZ gene was
inserted at the chromosomal Tn7 site of wild-type [KV3246] or ΔsypA [KV4925] cells
carrying pRscS plasmid (pCLD46) and either the pSypA plasmid (pARM13) or empty
vector pKV282. Vector corresponds to pKV282 or, in the case of wild-type carrying two
vectors, pVSV105 and pKV282. Cells were grown in LBS containing Tc and Cm for 24
h. Results shown are representative of at least 3 independent experiments. Error bars
indicated the standard deviation.
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Overexpression of rscS in either the WT or ΔsypA reported strains resulted in similar
levels of reporter activity, approximately 10-fold induction over vector control cells (Fig.
29), indicating that loss of sypA does not affect syp activation. Similarly, introduction of a
sypA overexpression plasmid (pARM13) into the rscS-overexpressing strains had no
impact on reporter activity in either a wild-type or ΔsypA background (Fig. 29).
Together, these data demonstrate SypA does not contribute to the regulation of syp
transcription, indicating that SypA, and thus SypE, regulates biofilm formation
downstream of syp activation.
Summary
Based on sequence similarity partner switching regulatory proteins, I
hypothesized that SypE controls biofilms and colonization through regulation of the
activity of the syp-encoded regulator, SypA. Using a co-immunoprecipitation approach, I
demonstrated that SypE interacts with SypA in vivo, in a manner dependent upon its Nterminal, serine kinase domain. Furthermore, I established in vitro and in vivo assays to
confirm that SypE’s N- and C-terminal effector domains indeed possess serine kinase and
serine phosphatase activities, respectively, and that SypA serves as a target of these
opposing activities. Mutational analyses determined that SypA plays an essential role in
promoting biofilm and host colonization. Importantly, I determined that the ability of
SypE to inhibit biofilm formation and host colonization is dependent upon its
phosphorylation, and thus inactivation, of SypA. Together, these data indicate that
regulation of SypA activity by SypE is an important mechanism by which V. fischeri
controls biofilm formation and symbiotic colonization. This study investigating the
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interaction between SypE and SypA, and their impact on biofilm formation and
colonization, was published in Molecular Microbiology [213].
THE ROLE OF SypE AS A NEGATIVE REGULATOR OF SypG-INDUCED
BIOFILMS
Introduction
Previous studies established that biofilm formation in V. fischeri can be induced
by the overexpression of either rscS or sypG. Although overexpression of rscS and sypG
similarly induce activation of the syp locus in wild-type cells, SypG fails to promote the
robust biofilm phenotypes (i.e. wrinkled colony or pellicle formation) as observed for
rscS-expressing cells [27]. As previously discussed, the inability of sypG overexpression
to induce biofilm formation is due to the inhibitory activity of SypE: overexpression of
sypG in a ΔsypE mutant resulted in dramatic biofilm formation similar to that observed
with rscS-overexpressing wild-type cells [27]. This suggests that sypG overexpression
fails to mimic the effects of rscS in regards to the regulation of SypE activity.
In the previous chapters, I investigated the regulation of biofilms induced by
overexpression of rscS, a condition in which SypE functions as a positive regulator.
Therefore, assessment of SypE’s inhibitory activity required the use of mutant sypE
alleles (e.g. a SypED192A mutant). To better understand the mechanism by which SypE
negatively regulates biofilm formation, I also examined SypE regulatory activity under
sypG overexpression conditions, in which SypE naturally inhibits biofilm production.
Using this approach, I asked whether SypE’s ability to naturally inhibit biofilms induced
by sypG overexpression occurs through mechanisms similar to those observed with rscS
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overexpression.

In particular, I investigated whether the N-terminal, serine kinase

domain of SypE was also required to mediate inhibition of SypG-induced biofilm
formation. Additionally, I asked whether the inability of sypG overexpression to induce
biofilms was due to the inhibition of SypA activity by SypE.
Negative regulation of SypG-induced biofilms by SypE
To better understand the mechanism by which SypE inhibits biofilms under sypGoverexpressing conditions, I utilized a complementation approach similar to that
described previously (see part one of this chapter). Using the collection of sypE alleles
that contained or lacked the individual SypE domains, I assessed the domains of SypE
required for inhibition of SypG-induced biofilm phenotypes. I utilized a dual plasmid
complementation approach, in which I co-expressed sypG and the mutant sypE alleles in
a ΔsypE mutant and assessed complementation (i.e. restoration of biofilm inhibition). As
previously reported, wild-type cells failed to produce biofilms, indicated by the smooth
colony morphology on solid agar media (Fig. 30A), while ΔsypE cells exhibited dramatic
SypG-induced biofilm phenotypes (Figs. 30B) [27]. Co-expression of wild-type sypE
(pCLD48) fully complemented the sypE mutant and restored inhibition of biofilms,
resulting in smooth colony morphology similar to wild-type cells (Fig. 30C).
I next examined the regulatory activity of a SypEΔNTD mutant (pARM3) that lacks
the N-terminal kinase domain, and found that it failed to complement the sypE mutant,
but instead permitted wrinkled colony formation similar to vector-containing cells (Figs.
30D). Similarly, expression of the C-terminal domain alone (pCLD67) failed to
complement the sypE mutant and inhibit biofilm formation (Figs. 30E).
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Figure 30. Regulation of SypG-induced biofilms by SypE. The SypG expression
plasmid (pCLD56) was introduced into either wild-type cells [A] or ΔsypE mutant cells
[KV3299] carrying either empty vector (pVSV105) [B] or the indicated SypEcomplementing plasmids: full-length SypE (pCLD48)[C], SypE NTD (pARM3)[D],
SypECTD (pCLD67)[E], SypENTD (pCLD64)[F], SypEN52A (pARM4)[G], SypENTD, N52A
(pCLD65)[H]. Cultures were spotted onto agar plates and wrinkled colony morphology
was assessed at 48 h post-spotting. Images are representative of at least three independent
experiments.
Δ
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These results indicate that inhibition of SypG-induced biofilms requires the N-terminal
domain of SypE. In my earlier analysis of SypE, I demonstrated that both the sypEΔNTD
and sypECTD alleles were capable of promoting biofilms induced by rscS overexpression,
indicating the resulting proteins were indeed produced and retained positive activity (see
part one of this chapter). Although the sypEΔNTD and sypECTD mutants retained positive
regulatory activity under rscS-overexpressing conditions, this activity was not apparent
under our current (sypG overexpressing) conditions (i.e. expression of these alleles did
not enhance or increase the rate of biofilm formation).
To further investigate the inhibitory role of the N-terminal domain, I assessed the
inhibitory activity of a SypENTD mutant (pCLD64), which expresses only the N-terminal
serine kinase domain and was shown to inhibit RscS-induced biofilms (Fig. 14). Similar
to full-length SypE, SypENTD fully complemented the sypE mutant, restoring inhibition of
wrinkled colony formation (Fig. 30F). Together, these data support the results from my
rscS-overexpression studies, and demonstrate that the N-terminal domain of SypE is both
necessary and sufficient to inhibit SypG-induced biofilm formation.
In my earlier analysis of SypE function, I found that the ability of SypE to inhibit
RscS-induced biofilms required an intact N-terminal domain. In particular, a conserved
asparagine (N52) was required for a mutant SypE variant to inhibit biofilms induced by
RscS (Fig. 14). In characterized HPK-like serine kinases, this asparagine is required for
catalytic kinase activity [151,179]. To ask whether the ability of SypE to inhibit SypGinduced biofilms also required this conserved asparagine, I assessed the inhibitory
activity of a SypEN52A mutant (pARM4), which contains an alanine substitution at this
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site. As expected, expression of sypEN52A failed to complement the ΔsypE mutant: the
colonies exhibited strong SypG-induced wrinkling (Figs. 30G). Similarly, this mutation
in the context of the inhibitory N-terminal domain alone, SypENTD, N52A (pCLD65),
resulted in the loss of inhibitory activity: cells co-expressing sypENTD, N52A and sypG
exhibited robust wrinkled colony morphology (Figs. 30H). The failure to complement
cannot be attributed to protein instability, as epitope-tagged versions of both the
SypEN52A and SypENTD, N52A proteins are stably expressed (data not shown)[212]. These
results demonstrate that the inhibitory activity of SypE’s N-terminal, kinase domain
requires conserved residue N52, consistent with that seen for other characterized HPKlike serine kinases. Together, these data support my earlier studies of SypE function
under RscS activating conditions, and suggest that SypE functions as an inhibitory kinase
to negatively regulate biofilm formation.
Co-overexpression of sypG and sypA overcomes inhibition by SypE
Our results indicate that SypE inhibits SypG-induced biofilms through the activity
of its N-terminal, serine kinase domain. These findings suggest that SypE primarily
functions as a kinase under SypG-inducing conditions, and likely inhibits biofilms by
phosphorylating a downstream target protein. I hypothesized that SypE exerts negative
control over SypG-induced biofilms by phosphorylating SypA [213]. I reasoned that if
SypE prevents SypG-induced biofilms through phosphorylation of SypA, then cooverexpression of sypG and sypA may result in sufficiently high levels of SypA such that
some of it could escape phosphorylation and thus inhibition by SypE. To test this, I cooverexpressed sypA and sypG from compatible plasmids in a wild-type (sypE+)
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background and assessed biofilm formation. As controls, I first evaluated strains
overexpressing either sypG or sypA alone, and found that biofilm formation was not
induced (Fig. 31A and B). In contrast, cells co-overexpressing both sypG and sypA
exhibited robust biofilm formation (Fig. 31C). These data indicate that providing excess
SypA overcomes the inhibition of SypG-induced biofilms by SypE, and further suggest
that SypA is the target for SypE’s inhibitory, kinase activity. In addition, the fact that
biofilms were only induced upon co-overexpression of sypG and sypA, but not when sypA
was overexpressed alone, indicates that sypG is still required to induce syp transcription
and the production of the Syp structural proteins.
SypE inhibits SypG-induced biofilms through phosphorylation of SypA
The previous results indicated that the inhibition of biofilm formation by SypE
depends upon its ability to phosphorylate SypA. I reasoned that if this is correct, then
expression of a SypA mutant (SypAS56A) that cannot become phosphorylated should
bypass the inhibition of SypG-induced biofilms by SypE. I thus assayed SypG-induced
biofilm formation by cells that expressed from single copy in the chromosome the mutant
protein SypAS56A; this protein contains a substitution at a conserved serine required for
phosphorylation, and fails to become phosphorylated either in vitro or in vivo when rscS
is overexpressed (see part two of this chapter)[213]. I found that sypE+ cells expressing
SypAS56A, but not those that expressed wild-type sypA or contained the empty cassette,
formed robust biofilms upon overexpression of sypG (Fig. 32). These data demonstrate
that the non-phosphorylatable SypAS56A mutant is insensitive to the inhibitory activity of
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SypE, thus supporting the hypothesis that SypE inhibits the formation of SypG-induced
biofilms via phosphorylation of SypA.
To assess directly whether SypA becomes phosphorylated under SypG-inducing
conditions, I evaluated the in vivo phosphorylation state of SypA under both biofilminhibitory conditions (i.e. sypG-overexpressing wild-type cells) and biofilm-permissive
conditions (i.e. sypG-overexpressing ΔsypE cells). Briefly, I introduced an epitopetagged wild-type sypA allele (containing a C-terminal HA tag) in single copy in the
chromosome (at the Tn7 site) of either ΔsypA cells or ΔsypA ΔsypE cells. I then
overexpressed sypG and assessed the in vivo phosphorylation state of SypA by resolving
cell lysates on SDS-PAGE gels containing Phos-tagTM acrylamide. SypA-HA proteins
were detected by western blot analysis using an anti-HA antibody. As observed in figure
33, sypG-overexpressing wild-type cells (lane 2) exhibited a single, upper band
corresponding to phosphorylated SypA (SypA~P). These data indicate that in wild-type
cells overexpressing sypG, the majority of, if not all, SypA protein is in the
phosphorylated state. In contrast, sypG-overexpressing ΔsypE cells (which are competent
to produce biofilms) exhibited a single, lower band representing unphosphorylated SypA
(Fig. 33, lane 3). Complementation with a wild-type allele of sypE (SypE+) restored
SypA phosphorylation as indicated by the presence of the shifted SypA band (SypA~P)
(Fig. 33, lane 4). Finally, I confirmed that the SypAS56A mutant also fails to become
phosphorylated in sypG-overexpressing cells (Fig. 33, lane 5). These results demonstrate
that SypE promotes SypA phosphorylation under SypG-inducing conditions, and
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Figure 31. Co-overexpression of sypG and sypA induces biofilm formation. Biofilm
formation by wild-type ES114 carrying either the sypG overexpression plasmid (pARM9)
[A], the sypA overexpression plasmid (pARM13) [B], or both [C]. For A and B, the
indicated vectors are pKV282 and pVSV105, respectively. The strains were cultured in
LBS broth containing Tet and Cm. Cultures were spotted onto agar plates and wrinkled
colony morphology was assessed at 48 h post-spotting. Images are representative of at
least three independent experiments.
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Figure 32. A sypA S56A mutant permits SypG-induced biofilm formation.
Assessment of SypG-induced wrinkled colony formation by sypG-overexpressing
(pCLD56) wild-type cells (A), and sypG-overexpressing ΔsypA cells complemented with
either wild-type sypA+ [KV5479] (B) or the sypAS56A allele [KV5481] (C). Cultures were
spotted onto LBS medium containing Cm at 28°C and wrinkled colony formation was
assessed at 48 h post spotting. Images are representative of at least three independent
experiments.
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Figure 33. Phosphorylation of SypA under SypG-inducing conditions. Western blot
analysis of V. fischeri cell lysates resolved on Phos-tagTM gels. Soluble lysates from
indicated strains were resolved by SDS-PAGE on 30 µM Phos-tagTM acrylamide gels and
the proteins were detected by western blot analysis using anti-HA antibody. SypGexpressing (pCLD56) ΔsypA cells containing untagged sypA [KV5479] [lane 1] or HAtagged wild-type sypA [KV6578] [lane 2]; ΔsypA ΔsypE cells expressing HA-tagged
wild-type sypA+ [KV6580] and carrying pCLD56 [lane 3]; ΔsypA ΔsypE expressing HAtagged wild-type sypA+ [KV6580] and carrying pCLD56 and pSypE plasmid
(pCLD48)[lane 4]; ΔsypA cells expressing HA-tagged sypAS56A [KV6579] and carrying
pCLD56 [lane 5]. (+) indicates cells expressing wild-type sypA-HA and/or sypE. (S56A)
indicates cells expressing sypAS56A. (-) indicates cells expressing untagged sypA or
deleted for sypE. Images are representative of at least three independent experiments.
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corroborate my biofilm assays indicating that, under SypG-inducing conditions, SypE
functions as a kinase. Importantly, they verify that phosphorylation of SypA is critical for
biofilm inhibition.
Impact of SypE on syp locus activation
Previous studies examining the regulation of the syp locus suggested that SypE
may impact syp activation induced by sypG overexpression [27]. However, my results
demonstrate that SypE regulates biofilm formation through control of SypA activity,
which impacts biofilms downstream of syp activation. To address this apparent
discrepancy and further characterize the regulatory role of SypE, I assessed the impact of
the various sypE mutant alleles on SypG-induced syp transcription. I utilized a sypA
promoter-lacZ fusion inserted in single copy in the chromosome of the wild-type and
ΔsypE strains. I then assessed sypA promoter activity by measuring β-galactosidase
activity upon co-expression of sypG and the sypE alleles.
As previously observed [27], wild-type cells overexpressing sypG exhibited high
levels of syp transcription, as indicated by the significant increase in β-galactosidase
activity relative to vector control cells (Fig. 34). Compared to the wild type, cells deleted
for sypE exhibited a moderate (~1.5-fold), but consistent, increase in SypG-induced syp
transcription (Fig. 34). Co-expression of wild-type sypE and sypG in the ΔsypE mutant
restored syp transcription to near wild-type levels (Fig. 34). These results suggested that
SypE does have a minor effect on SypG-induced syp transcription.
To further determine whether this effect on syp transcription could account for the
observed biofilm phenotypes, I asked whether inhibition of transcription required the
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SypE’s inhibitory N-terminal domain. I first tested whether a sypE mutant lacking the
inhibitory, N-terminal domain (SypEΔNTD), and thus unable to inhibit biofilm formation,
impacted activation of syp transcription by SypG. Surprisingly, I found that coΔNTD

expression of SypE

and sypG in ΔsypE cells resulted in a decrease in syp

transcription similar to cells expressing wild-type sypE, a result opposite to the observed
biofilm phenotype (Fig. 34). These results suggested that while SypE may have a slight
impact on syp transcription, it is not sufficient to account for the observed effects of SypE
on SypG-induced biofilms. In support of this, I found that expression of the N-terminal
domain alone (SypENTD), which is sufficient to inhibit SypG-induced biofilm formation,
had no observable impact on syp transcription (Fig. 34). These data reveal that SypE
indeed has a minor effect on syp transcription, but that this effect is not sufficient to
account for the dramatic effects on biofilm formation.
Deletion of sypE confers a competitive colonization advantage.
The ability of V. fischeri to produce syp-dependent biofilms in laboratory culture
directly correlates with the ability of the bacteria to efficiently colonize host juvenile
squid [20,22,212]. We previously observed that the deletion of sypE in otherwise wildtype cells did not significantly impact host colonization (Fig. 16)[33,212]. However, I
questioned whether the presence of sypE would impact colonization when sypG is
overexpressed. In other words, would the ability of the sypG-overexpressing sypE mutant
cells to produce robust biofilms also promote colonization competence, or would the
absence of sypE have no impact? To address this question, I examined the ability of
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Figure 34. Impact of SypE on syp locus activation. Transcription of the syp locus was
monitored using a β-galactosidase activity assay. A transcriptional reporter construct
consisting of the sypA promoter region fused upstream of a promoterless lacZ gene was
inserted at the chromosomal Tn7 site of wild-type [KV3246] or ΔsypE [KV4926] cells
carrying the pSypG plasmid (pCLD56) and indicated SypE expression plasmids: wildtype SypE (pCLD48), SypEΔNTD (pARM3), and SypENTD (pCLD64). Vector corresponds
to pVSV105 or, in the case of wild-type carrying two vectors, pVSV105 and pKV282.
Cells were grown in LBS containing Tc and Cm for 24 h. Results shown are
representative of at least 3 independent experiments. Error bars indicated the standard
deviation.
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Figure 35. Deletion of sypE promotes host colonization. Competitive colonization
assay with sypG-overexpressing wild-type (WT) and sypE mutant strains. Newly hatched
squid were exposed to a mixed inoculum of WT carrying the pSypG plasmid (pCLD56)
and either ΔsypE [KV4390] cells (A) or ΔsypE cells complemented with wild-type sypE+
[KV4819] (B) and carrying pCLD56. The Log RCI is plotted on the x-axis. The position
of the circles on the y-axis is merely for spacing. Each circle represents a single animal.
Open symbols indicate animals containing no WT cells. The black diamond and error
bars indicate the average Log RCI and standard deviation for the indicated data set. Data
shown are representative of at least three independent experiments.
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sypG-overexpressing wild-type and ΔsypE strains to competitively colonize juvenile
squid. I found that ΔsypE cells dramatically outcompeted wild-type cells for host
colonization (Fig. 35A). These data suggest that upon overexpression of sypG, deletion
of sypE confers a competitive colonization advantage. To confirm that the loss of sypE
was responsible for the colonization advantage observed in the ΔsypE strain, I
complemented the ΔsypE strain with a wild-type allele of sypE in trans in the
chromosome. Indeed, the SypE-complemented (SypE+) cells failed to outcompete wildtype cells, when both were overexpressing sypG (Fig. 35B). These results reveal a
critical role for SypE in inhibiting SypG-induced biofilm formation and host
colonization.
Summary
In this portion of my dissertation, I continued my analysis of SypE function by
examining the regulatory activity of SypE under sypG overexpression conditions, in
which SypE naturally inhibits biofilm formation. Through complementation studies, I
determined that SypE inhibits SypG-induced biofilms through the activity of its Nterminal, serine kinase domain. Further analysis determined that the inhibitory activity of
the N-terminal domain required residue N52, a conserved asparagine that is necessary for
kinase activity in other characterized serine kinases [95]. These results parallel those
observed for the role of SypE in RscS-induced biofilm formation: expression of SypENTD
alone also inhibited biofilm formation in a manner that depended on N52.
Next, I used both genetic and biochemical approaches to test the hypothesis that
SypE inhibited SypG-induced biofilms by promoting the phosphorylation, and thus
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inactivation, of SypA. I found that the inhibition of SypG-induced biofilms by SypE
could be overcome by co-overexpressing sypA and sypG. This result suggested that
providing high levels of SypA overcomes the inhibitory activity of SypE, presumably
because some SypA escapes phosphorylation. In support of this idea, I demonstrated that
expression from the chromosome of a sypA mutant that does not become phosphorylated
(SypAS56A) also permitted the formation of SypG-induced biofilms in wild-type (SypE+)
cells. Phos-tagTM analysis confirmed that SypA indeed was predominantly
phosphorylated under biofilm-inhibiting conditions (i.e., upon overexpression of sypG in
wild-type cells), but unphosphorylated under biofilm-permissive conditions (i.e. upon
overexpression of sypG in ΔsypE cells). Together, these studies demonstrate that under
SypG-inducing conditions, SypE functions as an inhibitory kinase, and prevents biofilms
by phosphorylating, and thus inactivating, SypA.
Finally, I observed that the enhanced ability of the ΔsypE strain to form biofilms
upon overexpression of sypG provided these cells with a competitive colonization
advantage, presumably due to enhanced aggregation outside of the symbiotic light organ.
This work emphasizes the critical role of SypE in restricting syp biofilm formation, and
subsequently symbiotic colonization.

	
  

CHAPTER FOUR
DISCUSSION
The goal of my dissertation was to characterize the mechanism by which the
novel RR SypE regulates syp-dependent biofilm formation and, as a result, symbiotic
colonization by V. fischeri. My interest in characterizing SypE was initially prompted
both by its novel domain architecture and by earlier studies suggesting that SypE may
both negatively and positively impact biofilm formation [27,28]. Bioinformatic analyses
predicted that SypE was an unusual RR, with its three putative domains arranged in a
unique configuration: a central REC domain flanked by two effector domains with
apparently opposing activities. Based on these data, I hypothesized that SypE could exert
dual regulatory control over syp biofilm formation, depending on which of the terminal
effector domains was active. Given their similarity to regulatory proteins found in
partner-switching systems, I speculated that SypE might control the activity of another
syp-encoded regulator, SypA. Finally, I proposed that the mechanisms that I uncovered
would provide insights into the process by which V. fischeri colonizes its symbiotic host.
All of my hypotheses were supported by the work described in this dissertation. In
addition, I made several unexpected and novel observations that I discuss in more detail
below.
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Characterization of SypE as a dual regulator of biofilm formation
To understand how SypE’s individual domains contributed to the protein’s
apparent dual regulatory activities, I performed a genetic analysis by generating a variety
of truncation and point mutant sypE alleles, expressing them in V. fischeri, and analyzing
the resulting biofilm phenotypes. Using the truncation and deletion mutants, I found that
SypE indeed possesses both negative and positive regulatory activities that are mediated
by the N- and C- terminal effector domains, respectively. I also determined that these
effector domains likely function as a serine kinase and serine phosphatase, respectively,
using point mutants predicted to be disrupted for these activities.
Additionally, I investigated the putative roles of these domains through
biochemical approaches. Experiments to test the putative enzymatic activities of SypE
confirmed that SypE’s N-terminal serine kinase domain does, in fact, function as a
kinase, while the C-terminal serine phosphatase domain exhibits phosphatase activity
(Fig. 21 and 22, respectively). Although I was unable to observe kinase activity of the
purified (GST-tagged) N-terminal domain of SypE in vitro, I did find that expression of
SypE’s untagged N-terminal domain promoted phosphorylation of its target substrate in
E. coli cells (Fig. 21B). Specifically, I determined that SypE controls the
phosphorylation state of the syp-encoded protein, SypA. These findings corroborate my
genetic analysis of SypE and allow us to assign kinase and phosphatase activity to
SypE’s N- and C-terminal domains, respectively.
Although each domain was necessary and sufficient for the respective activities,
my data suggested that one domain could influence the activity of another. In particular,
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mutations within the C-terminal domain not only resulted in loss of SypE positive
activity but, in the context of the full-length protein, shifted the protein’s activity to an
inhibitory state. For example, expression of the sypED443A or sypED495A alleles, which
were predicted to lack the positive activity and thus behave in a manner similar to vector
control, completely inhibited biofilm formation (Figs. 14E and 14F). This inhibitory
activity depended on an intact N-terminal domain, as a SypEN52A, D443A double mutant
exhibited a loss of inhibitory activity (Fig. 14K). I interpret these data to suggest that the
SypE protein structure is sensitive to molecular perturbations. In support of this, I found
that introduction of a HA-epitope tag to the C-terminus of the SypE protein also caused
aberrant protein activity, such that the protein appeared “locked” in the constitutive
inhibitory state (data not shown). I speculate that disruption of the C-terminal effector
domain likely alters the protein conformation to favor activation of the inhibitory Nterminal domain, perhaps indirectly by impacting phosphorylation of the protein. This
would not be unprecedented: mutations within the C-terminal DNA-binding effector
domain of the RR OmpR not only affect DNA-binding, but also impact the
phosphorylation state of the N-terminal REC domain [218]
In contrast to the C-terminus, disruption of the inhibitory, N-terminal domain of
SypE did not appear to “switch” protein activity (i.e. constitutively activate the positive,
C-terminal domain). It is possible that mutation of SypE’s N-terminal domain does
indeed promote the activity of the positive, C-terminal domain, but that this effect is not
apparent under the experimental conditions tested. Indeed, my data indicate that SypE
functions as a positive regulator under RscS-inducing conditions, suggesting that the
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inhibitory domain is typically inactivated under these conditions. Therefore, a mutation
in the inhibitory domain of SypE is not likely to produce an observable effect on protein
function. Together, these data indicate that the terminal effector domains of SypE are
indeed active and, more importantly, exert opposing regulatory control over sypdependent biofilm formation.
Regulation of SypE activity by the central REC domain
I next tested the hypothesis that SypE’s central REC domain regulates the
opposing activities of the terminal domains. In general, RR activity is controlled
through the phosphorylation of a conserved aspartate residue located in the REC domain
[71]. REC domains are proposed to exist in an equilibrium of conformational states,
which either activate or inactivate an attached effector domain [76]. Phosphorylation is
proposed to shift this equilibrium and promote a particular conformational state,
resulting in RR activation or inactivation [76]. My results indicate that an intact REC
domain is required to promote the positive regulatory activity of SypE. I found that a
SypE mutant that mimics the unphosphorylated state (SypED192A) exhibits constitutive
inhibitory activity, thus preventing biofilm formation (Fig. 15E). I interpret these data to
indicate that phosphorylation of SypE at residue D192 is required to overcome SypE’s
default inhibitory activity (Fig. 36). In support of this hypothesis, the inhibitory activity
of the D192A mutant indeed depended upon an intact N-terminal domain. Interestingly,
the loss of inhibitory activity in the SypEN52A, D192A mutant failed to permit the protein to
exert its positive activity (Fig. 13L), suggesting that phosphorylation at residue D192
was still required for activation of the C-terminal domain and, thus, positive activity. I
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similarly found that the conserved aspartate was required for positive regulatory activity
ΔNTD

displayed by a SypE mutant lacking the N-terminus (SypE

) (data not shown). Based

on these data, I propose that REC phosphorylation shifts the equilibrium of the SypE
conformational states such that the inhibitory N-terminus is inactivated, while the
positively acting C-terminus is activated (Fig. 36). In my assessment of the REC
domain, I attempted to identify mutations that would mimic the phosphorylated state of
SypE, resulting in “constitutively active” SypE and dominant positive activity. However,
I found that several mutations reported to mimic the phosphorylated state in select RRs,
such as a SypED192E [219] or a SypED192E, D150K [220] mutant, failed to result in the
constitutive activation of the positive C-terminal domain (data not shown). The inability
of these mutations to result in a SypE mutant that mimics the phosphorylated state is not
surprising, as few mutations have been found to universally activate all RRs [221].
Indeed, these common mutations have failed to activate several well-characterized RRs
[74,222,223]. I hypothesize that, due to the complex domain structure of SypE, these
mutations likely fail to mimic the conformational changes induced and/or stabilized by
phosphorylation.
While my genetic evidence strongly suggests a role for phosphorylation in
controlling SypE activity, confirmation that SypE indeed becomes phosphorylated
awaits further investigation. In preliminary studies using V. fischeri strains expressing an
epitope-tagged SypE, I attempted to assess the in vivo phosphorylation state of SypE
under biofilm promoting or inhibiting conditions. However, the results from these
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Figure 36. Model of syp biofilm regulation by SypE. (i) The RscS-SypG pathway
induces transcription of the syp polysaccharide locus to promote biofilm formation and
colonization. (ii) Under non-RscS activating conditions (i.e. upon induction with SypG),
SypE functions as a serine kinase to phosphorylate SypA and inhibit biofilms and
colonization. (iii) Under RscS activating conditions, phosphorylation of SypE is
proposed to inactivate to the inhibitory kinase domain, while promoting activation of the
positive C-terminal phosphatase (PPase) domain. Phosphorylated SypE promotes the
dephosphorylation, and thus activation, of SypA, resulting in biofilm formation and
colonization. The dashed arrow indicates potential direct phosphorylation of SypE by
RscS, resulting in inactivation of SypE inhibitory activity.
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studies were inconclusive (data not shown). The difficulty in detecting SypE
phosphorylation in vivo is not particularly surprising, given the labile nature of the
phospho-Asp bond, which typically undergoes rapid hydrolysis [224]. Therefore, future
studies of SypE phosphorylation may require the development of in vitro
phosphotransfer assays using purified SypE and potential phosphodonors, such as acetyl
phosphate or purified HK proteins (e.g. RscS).
SypE as a negative regulator of symbiotic colonization
In this work, I established a critical role for SypE in the regulation of symbiotic
colonization of E. scolopes. Using the sypE mutant strains characterized in the in vitro
biofilm assays, I assessed whether SypE’s positive and/or negative regulatory activities
contributed to V. fischeri colonization fitness. My results indicate that the minor positive
role of SypE in promoting biofilm formation is relatively unimportant, as deletion of
sypE did not substantially affect host colonization (Fig. 16). It remains possible that the
positive activity of SypE does indeed contribute to colonization fitness, but that this
impact may not be readily evident given our current experimental conditions. Indeed,
my in vitro biofilm studies indicate that loss of SypE’s positive activity only results in a
delay in biofilm development (Fig. 10). This positive impact of SypE on RscS-induced
biofilms is subtle, and not readily apparent at late time points (Fig. 10). Given these
findings, it is possible that SypE may also have a subtle, positive impact on colonization,
and therefore time course assays may also be necessary to assess this effect.
In contrast to the positive activity, I found that inhibition by SypE is a significant
activity that must be overcome during the colonization process. V. fischeri cells
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expressing SypED192A , a mutant disrupted at the predicted site of phosphorylation,
exhibited a severe defect in host colonization (Fig. 16), which could be attributed to the
inability of these cells to efficiently aggregate in the squid-derived mucus on the light
organ surface, an essential stage in the initiation of host colonization (Fig. 17C). Thus,
residue D192 within the central REC domain is absolutely required to inactivate the
inhibitory activity of SypE. I propose that phosphorylation at residue D192 is necessary
to shift the activity of SypE away from the inhibitory N-terminal domain, and permit
activation of the positive C-terminal domain. Consistent with this hypothesis and my
biofilm results, the inhibition of both host colonization and symbiotic aggregation by the
SypED192A mutant depended upon an intact N-terminal domain, as a SypEN52A, D192A
double mutant exhibited near wild-type levels of colonization and aggregation (Fig. 16C
and 17D). These results suggest that during normal colonization, the inhibitory activity
of SypE must be “turned off”, to permit aggregate formation and efficient host
colonization.
In support of the proposed negative role of SypE during colonization, I found
that the enhanced ability of a ΔsypE strain to form biofilms upon overexpressing SypG
provided these cells with a competitive colonization advantage, presumably due to
enhanced aggregation outside of the symbiotic light organ (Fig. 35). The inhibitory role
for wild-type SypE under sypG-overexpressing conditions is in direct contrast to my
earlier analysis of a ΔsypE mutant under rscS-overexpressing conditions, in which I
observed little impact of SypE on host colonization (Fig. 16). That SypE permits
biofilms and colonization upon overexpression/activation of RscS, yet inhibits under
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SypG-overexpressing conditions, suggests that a primary function of SypE is to prevent
aberrant biofilm formation induced by the phosphorylation, and thus activation, of SypG
in the absence of RscS signaling/activation. It is currently unclear under what conditions
SypG may become activated without signaling through RscS. It remains possible that
SypG may receive phosphoryl groups and become activated through other regulatory
inputs in addition to RscS. Recently, Ray and Visick (2012) demonstrated that
regulatory components within the Lux phosphorelay controlling bioluminescence also
impact the regulation of syp biofilm formation. Importantly, this impact on syp biofilms
appears to occur at the level of SypG and syp locus activation [225]. Thus, it is possible
that, under conditions in which the Lux phosphorelay promotes SypG activation and syp
induction, SypE functions as a negative regulator to prevent biofilm formation and
restrict colonization. Alternatively, SypE may be important for preventing biofilm
formation under conditions in which SypG might get phosphorylated due to inadvertent
“cross-talk” from other sensor kinases that are activated. These possibilities remain to be
investigated.
Regulation of SypE activity by the HK RscS
My genetic studies suggest that phosphorylation serves to regulate SypE activity.
Although the identity of the cognate HK(s) that directly phosphorylates SypE remains to
be verified, my current data does suggest that SypE activity is modulated, directly or
indirectly, by RscS activation/overexpression. Our lab previously demonstrated that
SypE inhibits biofilms induced by the RR SypG [27]. In contrast, I have shown here
that upon rscS overexpression, SypE exhibits positive regulatory activity. These data
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suggest that RscS expression/activation alters the activity of SypE (i.e. inactivates the
protein’s inhibitory activity). The ability of RscS to inactivate SypE’s inhibitory activity
depended upon the REC domain of SypE, as a SypED192A mutant that cannot become
phosphorylated failed to promote biofilm formation (Fig. 15E). I interpret these results
to suggest that RscS modulates SypE activity through REC phosphorylation.
In addition to these genetic studies, I used an in vivo Phos-tagTM approach to
evaluate the influence of RscS on the kinase activity of SypE. Specifically, I monitored
the phosphorylation state of SypE’s downstream target protein, SypA. I found that
SypA was predominantly phosphorylated under biofilm-inhibiting conditions (i.e., upon
overexpression of sypG in wild-type cells), but unphosphorylated under biofilmpermissive conditions (i.e. upon overexpression of rscS in wild-type cells or
overexpression of sypG in ΔsypE cells) (Fig. 26 and Fig. 33). These results support the
genetic studies, confirming that SypE indeed functions as a serine kinase to
phosphorylate SypA and inhibit syp biofilm formation. Importantly, these data also
demonstrate that overexpression of rscS inactivates the inhibitory kinase activity of
SypE, subsequently promoting SypA dephosphorylation and biofilm formation.
Consistent with the results of my biofilm assays, the regulation of SypE’s kinase activity
by RscS required the intact REC domain of SypE: cells expressing the inhibitory
SypED192A mutant failed to produce RscS-induced biofilms, and this biofilm defect could
be attributed to the constitutive phosphorylation of SypA by SypE (Fig. 26). These data
thus suggest that RscS, directly or indirectly, promotes SypE phosphorylation at D192,
resulting in the inactivation of SypE’s inhibitory kinase domain (Fig. 36).
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Given the results—that (1) SypE inhibitory activity must be inactivated to permit
biofilm formation and colonization, (2) inactivation of this inhibitory activity depends
upon the REC domain and likely phosphorylation at D192, and (3) the HK RscS
promotes this inactivation—we generated a model for the severe colonization defect
observed in an rscS mutant [26](Fig. 36). In this model, RscS would function to both
induce syp transcription and inactivate the inhibitory activity of SypE. We hypothesized
that if this were true, then a ΔrscS ΔsypE double mutant should colonize better than an
rscS single mutant. Indeed, I found that the ΔrscS ΔsypE mutant dramatically
outcompeted the ΔrscS mutant for colonization (Fig. 18). Although deletion of sypE did
improve colonization fitness in an rscS mutant, it did not fully restore colonization
competency to wild-type levels (data not shown). I predict that this is likely due to the
additional role of RscS in activating SypG-dependent transcription of the syp locus and
biofilm formation [27]. These experiments further support the model that the
inactivation of SypE inhibitory activity is critical during symbiotic colonization. These
data also provide insight into the previously established requirement for RscS in
initiating colonization [26] by demonstrating that this regulator is necessary for the
inactivation of SypE. Whether RscS directly phosphorylates SypE remains unknown.
The possibility that RscS may serve as a phosphodonor to both SypG and SypE would
not be unprecedented, as other studies have reported a single HK interacting with
multiple RRs [e.g., [226]](Fig. 5).
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Role for the HK SypF in regulating SypE activity?
It remains possible that RscS may exert indirect control over SypE by
influencing the activity of another HK that can phosphorylate SypE. In many instances,
RRs are encoded adjacent to their cognate HKs. Intriguingly, SypE is encoded upstream
of the HK SypF, another known regulator of syp biofilm formation [28]. Given its
genetic context, it is tempting to speculate that SypF may function with RscS to control
SypE phosphorylation. Indeed, I have preliminary data that suggest that SypF, similar to
RscS, can influence SypE’s activity. In my earlier SypE complementation studies, I
originally utilized a dual plasmid complementation approach to assess SypE function.
However, I found that overexpression of wild-type sypE from a multi-copy plasmid not
only failed to complement a ΔsypE mutant under RscS-inducing conditions, but also
completely inhibited biofilm formation (see appendix). Given my data indicating that
phosphorylation is required to modulate SypE activity, I hypothesized that the inability
of wild-type sypE to complement when overexpressed may be due to an excess of SypE
protein relative to the levels of its cognate HK. As such, the majority of SypE protein
could remain largely unphosphorylated and thus exhibit negative regulatory function. I
reasoned that if this were the case, then co-expressing SypE with its cognate HK could
restore this balance, and permit SypE to complement when overexpressed. Interestingly,
I found that co-overexpressing sypE with sypF on a multi-copy plasmid permitted
complementation of the ΔsypE mutant and restoration of RscS-induced biofilms (see
appendix). Importantly, co-expressing sypF did not impact SypE’s inhibitory activity
under SypG-inducing conditions, in which SypE naturally functions as a negative
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regulator. These preliminary studies suggest that SypF may work in conjunction with
RscS to modulate the activity of SypE. The role of SypF in biofilm regulation and its
possible interaction with SypE and/or RscS is currently being investigated.
SypE-SypA regulatory network and biofilm regulation
As part of my dissertation, I established that SypE regulates biofilm formation
and colonization through controlling the phoshorylation state of the syp-encoded
regulator SypA. I initially focused on SypA as a target for SypE based on the similarity
of these proteins to partner-switching regulators. Specifically, the N- and C-terminal
effector domains of SypE are similar to the B. subtilis partner-switching proteins RsbW
and RsbU, respectively, while SypA is similar to the STAS-domain protein RsbV [133].
In B. subtilis, RsbW and RsbU interact with and regulate the phosphorylation state of
RsbV [151](Fig. 9). Using co-immunoprecipitation studies, I confirmed that SypE
likewise interacts with SypA in V. fischeri (Fig. 20). Interaction with SypA appeared to
be mediated by the N-terminus of SypE, as a derivative that included only the Nterminal domain co-immunoprecipitated with SypA, while an N-terminal deletion
mutant failed to do so (Fig. 20). The observation that SypE’s RsbW-like domain
mediates interaction with SypA is consistent with that reported for characterized B.
subtilis orthologues, in which binding of RsbV to RsbW inhibits the anti-sigma activity
of RsbW [153].
It currently remains unknown what role, if any, the binding between SypE’s Nterminus and SypA plays in biofilm regulation. One formal possibility is that SypA
binding is necessary for SypE to efficiently phosphorylate, and thereby inactivate, SypA.
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Another possibility is that binding by SypE may serve to sequester SypA, and in this
manner control SypA activity. Mutational studies of RsbW homologs in other bacterial
systems have demonstrated that these separate activities (i.e. binding to and
phosphorylation of RsbV) can indeed be distinguished, and their regulatory roles
examined [179,227]. In particular, the conserved aspartate and glycine residues located
in the G-1 box motif of RsbW-like regulators are required for the binding of these
proteins to their cognate RsbV antagonists [179,227]. Sequence analysis of SypE
identified these conserved residues correspond to Asp-81 and Gly-83 (see Fig. 11B).
What role, if any, these conserved residues may play in the inhibitory activity of SypE
awaits further analysis.
In addition to binding SypA, SypE both phosphorylates and dephosphorylates it.
Using Phos-tagTM analyses, I determined that SypE regulates the phosphorylation of
SypA at conserved serine residue (S56). Furthermore, in vivo Phos-tagTM studies
revealed that SypA phosphorylation correlated with the inhibition of biofilm formation
by SypE (Fig. 26). To better understand the regulatory role of SypA, I also examined
the impact of SypA mutants on syp biofilm formation and symbiotic colonization. Loss
of SypA disrupted both RscS-induced biofilm formation and natural symbiotic
colonization. In agreement with my biochemical studies, I also found that both biofilm
formation and colonization fitness correlated with the phosphorylation state of SypA: (1)
Cells expressing a phosphorylated mimic of sypA (sypAS56D) failed to produce biofilms
in response to rscS overexpression and were dramatically impaired in their ability to
colonize E. scolopes (Fig. 23 and 27, respectively); and (2) Expression of a non	
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phosphorylatable version of sypA (sypAS56A) suppressed the severe defect in biofilm
formation and symbiotic colonization caused by the constitutive kinase allele of sypE
(sypED192A ) (Fig. 25 and 28, respectively). Together, these experiments reveal a critical
role for SypA in promoting biofilm formation and symbiotic colonization.
In my characterization of the SypE-SypA signaling network, I performed
epistasis analyses to demonstrate that SypA functions downstream of SypE in a single
regulatory pathway to control biofilm formation (Fig. 24). Interestingly, this result
stands in stark contrast to the characterized partner switching networks described in B.
subtilis and other Gram-positive systems, in which the serine kinase/anti-sigma (RsbW)
functions as the downstream regulatory protein [151](Fig. 9). In the canonical partner
switching system, the interaction of the switch protein (RsbW) with either of its
“partner” proteins (RsbV or sB) dictates the output of the regulatory switch (i.e. sigma
factor activity), while the upstream antagonist (RsbV) indirectly controls the output
response (sigma factor activity) through antagonism of RsbW [151]. My studies,
however, demonstrate that the ability of SypE to regulate biofilms is fully dependent
upon SypA and the regulation of SypA activity. These results suggest that while SypE
and SypA share similarity with partner switching proteins, the regulatory cascade in
which these proteins participate likely deviates from the B. subtilis partner switching
paradigm.
Downstream target of the SypE-SypA regulatory pathway
A remaining question regarding the SypE-SypA regulatory pathway is the
mechanism by which SypA, as the downstream regulator, controls syp biofilm
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formation. I confirmed using transcriptional reporter assays that sypA expression (either
deletion or overexpression) does not affect RscS-induced activation of syp transcription
(Fig. 29). These results indicate that the SypA contributes to syp biofilm regulation at
some level downstream of SypG activation and syp transcription (Fig. 36). Interestingly,
I observed that expression of sypE did affect induction of syp transcription by SypG.
However, this effect on transcription was not sufficient to account for the observed
biofilm phenotypes (Fig. 34). Given that RscS appears to work upstream of both SypG
and SypE, I hypothesize that the REC domain of SypE may be responsible for the
observed impact on syp transcription. If both SypE and SypG do indeed receive signals
from the same upstream sensor kinase, then SypE’s REC domain may compete with
SypG for phosphorylation, resulting in a decrease in SypG activation and syp
transcription. This possibility awaits future study. In all, these studies indicate that the
SypE-SypA signaling pathway regulates biofilm formation downstream of syp
activation.
Based on the similarity of SypA to RsbV-like antagonist proteins, I originally
hypothesized that SypA would interact with an additional RsbW-like anti-sigma factor,
and thus indirectly control the activity of a downstream sigma factor involved in biofilm
formation. However, analysis of the V. fischeri genome for RsbW-like orthologues
(other than the N-terminal domain of SypE) failed to identify any potential candidate
genes. Additionally, my preliminary studies have yet to identify a potential sigma factor
whose activity might be regulated by SypA.
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The possibility also remains that SypA may function in a manner distinct from
that described in B. subtilis and the other Gram-positive systems, and thus may not
regulate activity of a sigma factor. Partner-switching orthologues have been described in
several other Gram-negative systems, including Bordetella bronchiseptica and
Chlamydia trachomatis. Interestingly, these reports suggest that while these partnerswitching regulators are conserved in these systems, their regulatory mechanisms also
appear to deviate from the partner-switching paradigm. For example, the btr partner
switching orthologues of B. bronchiseptica (BtrU-BtrV-BtrW) regulate type III secretion
(TTS), but do not impact transcription of the known TTS genes [178,179]. The authors
of this study proposed that the Btr partner switching proteins do not regulate a sigma
factor, but instead may function post-translationally to control TTS, perhaps by
interacting with hypothetical proteins involved in the secretory system [179]. Similarly,
a study examining partner switching orthologues in C. trachomatis (RsbU-RsbV1RsbV2-RsbW) failed to identify an interaction between these proteins and any of the
three sigma factors encoded by the C. trachomatis genome [180]. These studies indicate
that partner-switching regulators, although conserved in Gram-negative bacteria, may
function in a manner distinct from their Gram-positive orthologues.
Additional studies are necessary to identify the mechanism by which SypA
controls biofilm formation. Interestingly, my studies of SypA revealed that in addition
to promoting biofilm formation, overexpression of sypA also had a broad impact on cell
viability. In particular, a rotation student, Lindsay Callan, and I found that
overexpression of sypA was deleterious to V. fischeri viability, resulting in a “cell
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death” phenotype (see appendix). The “cell death” phenotype was observed as the
formation of opaque, non-viable colonies containing small papillae of viable cells (see
appendix). Initial characterization of the SypA-induced “cell death” phenotype,
determined that this phenotype was only observed upon culturing the cells on solid agar
media and at a higher temperature (28°C). We found that culturing the cells either in
liquid media or at a lower, permissive temperature (24°C) completely suppressed the
SypA-induced “cell death”, even if we subsequently shifted the temperature back up to
28°C. Through additional studies, we determined that this phenotype was enhanced
under conditions in which we predict would increase SypA activity. For example,
enhanced “cell death” was observed upon overexpression of sypA in a ΔsypE
background or upon overexpression of the enhanced activity allele of sypA (sypAS56A)
(See appendix). The observation that the cell death phenotype was enhanced in ΔsypE
mutant relative to wild-type (sypE+) cells further supports our earlier conclusion that a
primary function of SypE is to inhibit SypA activity. It remains unclear whether the
ability of SypE to suppress the SypA-induced cell death is due to the phosphorylation of
SypA and/or the binding of SypA by SypE. These possibilities await future testing.
Finally, this cell death phenotype occurred independent of biofilm formation, as
overexpression of sypA in a syp mutant background still caused cell death even in the
absence of biofilm formation (data not shown). Together, these studies suggest that
SypA may regulate a downstream target or cellular process that impacts cell viability, in
addition to biofilm formation. I expect that further characterization of SypA will not
only deepen our understanding of syp biofilm regulation in V. fischeri, but may also
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provide insight into the function of partner-switching orthologues in other Gramnegative bacteria.
Conservation of SypE and SypA regulators in other Vibrios
Genome analyses indicate that the syp locus is relatively conserved among
several Vibrio species, including both pathogenic and symbiotic bacteria [21]. Although
biofilm formation has been investigated in diverse Vibrio species, the role of the syp
cluster in species other than V. fischeri remains unclear. Several studies have
demonstrated that the syp locus contributes to biofilms formed by the pathogenic
bacterium Vibrio vulnificus [228,229]. In V. vulnificus, the syp cluster, termed the rbd
locus, was demonstrated to contribute to the production of exopolysaccharides and the
attachment of the cells to biotic and abiotic surfaces [228]. Given the conservation of
the syp locus among Vibrio species, I performed a bioinformatic survey of sypcontaining Vibrio genomes for genes encoding SypA and SypE homologues,
specifically, or other potential partner-switching proteins (see Appendix Table 1). While
SypA is well-conserved among the syp-containing Vibrio genomes, SypE appears to be
absent in several species. For example, V. vulnificus possesses a SypA homologue
(VV1633), but lacks any clear sypE-like genes. Intriguingly, the genome of V. vulnificus
contains genes for additional RsbW- and RsbU-like proteins, VVA0582 and VVA1682,
which encode a putative RsbW-like anti-sigma factor and an RsbU-like serine
phosphatase, respectively. The genomes of Vibrio parahaemolyticus and Aliivibrio
salmonicida similarly lack SypE, but encode RsbW and RsbU-like proteins elsewhere.
Thus, in several Vibrio species lacking sypE, other putative partner-switching
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components exist; whether or not they function as predicted or control the activity of
SypA remains to be determined.
Role for c-di-GMP in the regulation of syp biofilm formation
In addition to characterizing the regulatory role of SypE, I performed preliminary
studies to identify other factors involved in the regulation of syp biofilm formation,
including the potential role of cyclic-di-GMP. Cyclic-di-GMP is a common bacterial
second messenger, which in many bacterial systems contributes to the regulation of
motility and biofilm formation. Specifically, increased cyclic-di-GMP levels often
correspond to enhanced biofilm formation and decreased motility [230]. In support of a
role for cyclic-di-GMP in regulating biofilm formation in V. fischeri, I found that
overexpressing the putative phosphodiesterase genes (VF_0087 and VF_0091), which
were predicted to reduce c-di-GMP leves, impaired wrinkled colony formation in a
biofilm-producing strain (see Appendix). These preliminary data suggest that cyclic-diGMP may promote V. fischeri biofilm formation. Additional studies are necessary to
confirm that these genes indeed encode proteins with phosphodiesterase activity capable
of degrading cyclic-di-GMP. Furthermore, the mechanism in which cyclic-di-GMP
levels may impact biofilm formation remains to be determined.
Significance
This work provides further insight into the mechanisms by which V. fischeri
regulates biofilm formation and, as a result, symbiotic colonization of E. scolopes.
Importantly, these studies established a novel role for the unique RR SypE in restricting
host colonization by V. fischeri. My results demonstrate that inactivation of SypE’s
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inhibitory activity is critical to permit V. fischeri biofilm formation and the initiation
host colonization. That inactivation of SypE’s inhibitory activity is necessary for both
biofilm formation in vitro and host colonization in vivo, further emphasizes the utility of
the V. fischeri-E. scolopes symbiosis as a model system for understanding the role of
biofilms in host colonization. These studies not only deepen our understanding of
SypE’s regulatory function, but also provide insights into the requirement for the HK
RscS in initiating colonization by demonstrating that this regulator is necessary for the
inactivation of SypE. Together, this dissertation work thus identifies SypE as a key
regulator of symbiosis, and further contributes to our understanding of how V. fischeri
coordinates biofilm formation during colonization of E. scolopes.
In addition to SypE, these studies also identify SypA as an essential regulator of
biofilm formation and symbiotic colonization. Using both genetic and biochemical
approaches, I have shown that the regulation of SypA activity by SypE is a critical
mechanism by which V. fischeri controls the production of biofilms. My
characterization of the SypE-SypA signaling pathway reveals yet another layer of
regulatory control over symbiotic biofilm formation. Furthermore, the identification of
SypA as a regulator downstream of syp activation provides an exciting avenue in which
to identify new factors or processes involved in biofilm formation and host colonization.
The work described in this dissertation demonstrates that biofilm formation in V.
fischeri is a tightly controlled process, involving both traditional two-component
regulators and partner switching-like proteins. That regulatory elements from both
signaling systems are integrated in SypE distinguishes this protein from the traditional
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RR, and may represent a novel means by which a bacterium can control gene expression.
Interestingly, SypE-like RRs appear to be present in other bacterial systems, including
other Vibrios, such as A. salmonicida, and non-Vibrio species, including Aeromonas
veronii and Pseudomonas aeruginosa [133,149]. What role these SypE-like proteins
play in these other systems remains largely untested. However, a recent study in P.
aeruginosa identified a RR, PA3346, that exhibits a similar domain architecture as
SypE; PA3346 consists of an N-terminal REC domain, a central PP2C-like domain, and
a C-terminal HATP (histidine kinase/ATPase) domain [149]. Importantly, the RR
PA3346 was shown to regulate swarming motility through a partner-switching
mechanism involving a SypA-like protein, PA3347 [150]. Therefore, SypE-like
regulators may be utilized in other bacterial species as a means to integrate regulatory
elements from distinct signaling systems to provide tighter control over gene expression.
Biofilm formation has been established as a common mechanism by which
bacteria promote interaction with their eukaryotic hosts. In particular, the conservation
of the syp biofilm locus in various Vibrio species exhibiting varied lifestyles (pathogens
vs. mutualist symbionts) suggests that syp-dependent biofilms may play a role in diverse
responses, such as the colonization of respective hosts. Therefore, understanding the
cellular and molecular processes involved in regulating biofilms, and identifying
approaches to manipulate these processes, remain critical areas of research. My
characterization of the SypE-SypA regulatory pathway may provide novel insight into
the mechanisms by which these related Vibrios and other bacteria restrict biofilm
production.
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I. Overexpression of sypA induces a cell death phenotype
I previously found that co-overexpression of sypA and sypG overcomes inhibition
of biofilm formation by SypE and promotes biofilm formation in wild-type cells (Fig.
33). In my analysis of SypA, I observed that expression of sypA, in addition to
controlling biofilms, also impacted cell viability under under particular culture
conditions. Working with a rotation student, Lindsay Callan, we found that the coexpression of sypA and sypG in wild-type V. fischeri cells resulted in the formation of
opaque, non-viable colonies which contained small papillae of viable cells (Appendix
Fig. 1A). This cell death phenotype was primarily observed upon culturing the cells at a
higher temperature (28° C), and was largely suppressed by culturing the cells at a lower,
permissive temperature (24° C) (Appendix Fig. 1A). Furthermore, the cell death
phenotype was only observed for strains cultured on solid agar media; culturing of the
strains in liquid media appeared to suppress the cell death phenotype (data not shown).
Additional studies found that the cell death phenotype was enhanced in a ΔsypE
strain co-expressing sypA and sypG (Appendix Fig. 1A), suggesting that the presence of
SypE inhibits SypA activity and prevents cell death. To better understand this
phenotype, we also examined the impact of overexpressing SypAS56A, which I have
previously shown exhibits increased activity to promote biofilm formation. Compared to
wild-type sypA, overexpression of syAS56A , either alone or co-expressed with sypG,
enhanced the cell death phenotype (Appendix Fig. 1B). Together, these preliminary
studies suggest that overexpression of sypA is detrimental to cell viability. To identify
unknown cellular targets downstream of SypA, we performed a preliminary transposon
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mutagenesis screen using a mini-Tn5 transposon library generated in the ΔsypE mutant
strain. We overexpressed the sypAS56A allele in this mutant library and screened for
suppressors of SypA-induced cell death. Using this approach, we identified several
transposon mutants that failed to exhibit SypA-induced cell death. Subsequent analysis
determined the location of the transposon insertions and identified 3 disrupted genes:
VF0130 (MutM), VF0534 (MutS), and VFA0451 (HutU/Urocanate Hydratase). Initial
analyses suggest that these genes encode proteins involved in DNA mismatch repair.
Future studies are necessary to characterize these genes and to assess their potential roles
in biofilm formation and SypA-induced cell death.
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Appendix Figure 1. SypA-induced cell death phenotype. (A) Wild-type and ΔsypE
cells carrying the pSypG plasmid (pARM9) and either empty vector (pKV282) or the
pSypA plasmid (pARM13) were streaked onto LBS agar plates and grown for 24 h either
RT (~24° C) or 28° C. (B) Wild-type and ΔsypE cells carrying the pSypAS56A plasmid
(pARM9) were streaked onto LBS agar plates and grown for 24 h at either RT (~24° C)
or 28° C.
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II. Impact of SypF on SypE activity
To characterize the regulatory activity of SypE, I initially utilized a dual plasmid
complementation approach to dissect the activities of the SypE domains. For this
approach, I assessed the ability of the various sypE alleles to complement a ΔsypE mutant
upon co-overexpression with rscS. I found that overexpression sypE not only failed to
complement ΔsypE mutant for RscS-induced biofilms, but completely inhibited biofilm
formation induced by RscS (Appendix Fig. 2A). Interestingly, overexpression of sypE did
not inhibit RscS-induced biofilms in wild-type (sypE+) cells (Appendix Fig. 2A). I
hypothesized that the inhibitory activity observed upon overexpression of sypE may
result from an excess pool of SypE protein relative to the levels of its cognate HK
protein. Thus, a portion of the SypE protein pool would remain unphosphorylated and
function as an inhibitory kinase. I reasoned that if this were the case, then cooverexpression of sypE with its cognate HK could restore this balance, resulting in the
inactivation of SypE’s inhibitory activity and the production of RscS-induced biofilms.
To test this hypothesis, I asked whether co-expression of sypE with the
downstream HK sypF on a multi-copy plasmid (pARM68) could permit biofilm
formation in an rscS-overexpressing ΔsypE mutant. Indeed, I found that ΔsypE cells
carrying both the RscS and SypE-SypF plasmids produced biofilms similar to wild-type
cells (Appendix Fig. 2B). These data indicate that co-overexpression of sypF with sypE
inactivates the inhibitory activity of SypE and promotes RscS-induced biofilm formation.
Additionally, I found that co-overexpression of sypE and sypF also permitted
complementation of a ΔsypE mutant under SypG-inducing conditions: similar to sypE
	
  

[185]	
  
alone, co-expression of sypE-sypF, restored wild-type inhibition of SypG-induced
biofilms (Appendix Fig. 2B). Together, these data suggest that SypF may modulate SypE
activity, promoting the inactivation of SypE activity under RscS-inducing conditions.
Interestingly, although sypE overexpression inhibited biofilms in ΔsypE cells, I
found that its overexpression in wild-type cells permitted RscS-induced biofilms
(Appendix Fig. 2A). Considering my data indicating that SypF may affect SypE activity,
I speculate that this difference in SypE activity may be due to the inability of SypF to
inactivate SypE. In particular, it is possible that the co-production and/or co-localization
of SypE and SypF within the cell is necessary for SypF to regulate SypE activity.
Additional studies are necessary to explore these possibilities.
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Figure 2. Regulation of SypE activity by the HK SypF. The indicated V. fischeri strain
were spotted onto LBS plates and wrinkled colony formation assessed at 48 h postspotting. (A) Wild-type and ΔsypE cells carrying the pRscS plasmid (pARM7) and either
empty vector (pVSV105), pSypE plamsid (pCLD48) or the pSypE-SypF plasmid
(pARM68). (B) Wild-type and ΔsypE cells carrying the pSypG plasmid (pCLD56) and
either empty vector (pVSV105), pCLD48, or pARM68.
	
  

[187]	
  
Appendix Table 1. Putative partner switching genes among sequenced syp-containing
Vibrios.
Vibrio species
V. fischeri ES114
VFA1020 (sypA)
VFA1024 (sypE)

Predicted function (partner switching domain)
RsbV-like protein
N-terminal RsbW-like kinase
C-terminal RsbU-like phosphatase

V. vulnificus (YJ016)
VV1633 (sypA)
VVA1682
VV0459
VVA1683
VVA0582

sypA (RsbV-like)
RsbU-like phosphatase
RsbV-like protein
RsbV-like protein
RsbW-like kinase

V. vulnificus (CMCP6)
VV1_2658 (sypA)
VV1_0681
VV2_1159
VV2_0075
VV2_1158

sypA (RsbV-like)
RsbV-like protein
RsbV-like protein
RsbW-like kinase
RsbU-like phosphatase domain

V. splendidus (LGP32)
VS_1519
VS_2746

sypA (RsbV-like)
RsbV-like protein

A. salmonicida (LFI1238)
VFAL II0312
VSAL II0328
VSAL II0329

sypA (RsbV-like)
RsbV-like protein
RsbU-like phosphatase domain

V. parahaemolyticus
VP1476
VP2660
VPA 1049

sypA (RsbV-like)
RsbV-like protein
RsbU-like phosphatase domain

V. harveyi
VIBHAR_02233
VIBHAR_03654
VIBHAR_05599

sypA (RsbV-like)
RsbV-like protein
sypE homology (RsbW and RsbU-like domains)
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III. Role for c-di-GMP in the regulation of syp biofilm formation?
In addition to the characterization of the SypE-SypA regulatory pathway, I
investigated other potential determinants of syp biofilm formation. In particular, I
examined the potential role of cyclic diguanylate (c-di-GMP) in regulating biofilm
formation induced by rscS overexpression. C-di-GMP is a common second messenger in
bacteria and has been demonstrated to play an important role in promoting biofilm
formation in many bacteria [230]. The levels of c-di-GMP are controlled by the opposing
activities of diguanylate cyclases, which synthesize c-di-GMP, and phosphodiesterases
(PDEs), which degrade c-di-GMP.
To determine whether c-di-GMP may contribute to RscS-induced biofilms, I
assessed the impact of PDE overexpression on RscS-induced wrinkled colony formation.
I introduced plasmids pKV302 and pKV303, which overexpress the putative PDE genes
VF0087 and VF0091, respectively, into the biofilm forming V. fischeri strain, KV4366.
Compared to vector-containing cells which exhibited robust wrinkled colony formation,
cells carrying either pKV302 or pKV303 exhibited delayed wrinkled colony formation
(Appendix Fig. 3). Additionally, pKV302-carrying cells exhibited diminished wrinkled
colony formation even at later time points (Appendix Fig. 3). These preliminary data
suggest that a decrease in c-di-GMP levels upon overexpression of PDEs impairs biofilm
formation in V. fischeri. Further studies are necessary to confirm that VF0087 and
VF0091 indeed encode PDE proteins,	
  and	
  whether	
  their	
  overexpression	
  decreases	
  
intracellular	
  c-‐di-‐GMP	
  levels.	
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Appendix Figure 3. Impact of phosphodiesterase overexpression on biofilm
formation in V. fischeri. Time-course assay of wrinkled colony formation. Cultures of
the following strains were spotted onto LBS medium at RT and wrinkled colony
formation was assessed at various times up to 48 h post-spotting: Biofilm-forming V.
fischeri strain [KV4366] carrying empty vector (pKV69) or plasmids overexpressing the
putative phosphodiesterase genes VF0087 (pKV302) and VF0091 (pKV303).
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IV. UV random mutagenesis screen.
To identify unknown cellular targets downstream of the biofilm regulator SypA, I
performed a random UV mutagenesis screen. Briefly, a summer student, Colin Linke,
and I utilized a random UV mutagenesis screen of a ΔsypA mutant in order to identify
suppressor mutations that could restore biofilm formation. I previously demonstrated that
deletion of sypA (either in a wild-type or a ΔsypE background) results in the loss of both
RscS- and SypG-induced biofilm formation, which can be complemented by expressing
sypA in trans. In this screen, we UV mutagenized the ΔsypA ΔsypE mutant strain
carrying the sypG overexpression plasmid (pARM9). We then screened for colonies that
exhibited wrinkled colony formation, indicative of biofilm formation. We screened ~4050,000 colonies and identified 8 wrinkled colonies, that exhibited partial restoration of
SypG-induced wrinkling. We selected one of the isolated colonies (that which exhibited
the most apparent wrinkled colony phenotype) (Appendix Fig. 4), and sequenced the
genomes of both the isolated UV mutant strain and the control (parental) strain. Sequence
analysis indicates that the isolated UV mutant strain contains several unique nucleotide
polymorphisms and chromosomal deletions relative to the parental control strain
(Appendix Table 2). Future studies are necessary to determine which of the mutation(s),
or combination of mutations, contribute to suppression of the ΔsypA biofilm defect
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Appendix Figure 4. Wrinkled colony formation by UV-mutant strain. Cultures of the
following strains were spotted onto LBS medium at 28 °C and wrinkled colony formation
was assessed at 24 h post-spotting: ΔsypA ΔsypE mutant (Parental) strain or UVmutagenized ΔsypA ΔsypE strain carrying pSypG plasmid (pARM9).
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Appendix Table 2. Mutations	
  identified	
  in	
  UV	
  mutagenized	
  strain
Point mutations
(within genes)
Location (gene)

Predicted gene function

Amino Acid Change

VF_1697

Latent nuclear antigen

1035 (silent)

VF_1703

Endonuclease IV

86 (lose stop codon)

VF_1889

Chitoporin-

338 (silent)

VF_1889

Chitoporin

148 (Ala to Gly)

VF_1993

DnaJ- chaperone

146 (silent)

VFA_1022

Syp polysaccharide export protein

31 (Gly to Ser)

VF_2432

RNA-binding protein

113 (framshift at 3’ end)

VF_A1162

RtxA2- cytotoxin

Multiples

Point Mutations
(intergenic regions)
Location (gene)

Predicted gene function

Upstream of
VF_0318
Upstream of VF_1582

Crp/Fnr transcriptional regulator

Between VF_T0024-0025

tRNA-Arg genes

Upstream of VF_1757

Hypothetic (88 AA) protein

Upstream of VF_1812

Long-chain fatty acid transport
protein

Upstream of VF_A0276

GGDEF protein

Periplasmic protein of efflux
system

Chromosomal Deletions
Location (gene)

Predicted gene function

130 bp upstream of
VF_A1047

MgtE (magnesium transporter)

50 bp upstream of VF_1583

Exonuclease III

41 bp deletion in VF_1757

Predicted membrane protein
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